Unnamed: 0,activity_comment,activity_id,assay_chembl_id,assay_description,assay_type,bao_endpoint,bao_format,bao_label,canonical_smiles,document_chembl_id,document_journal,document_year,molecule_chembl_id,molecule_pref_name,parent_molecule_chembl_id,potential_duplicate,qudt_units,record_id,relation,src_id,standard_flag,standard_relation,standard_type,standard_units,standard_value,target_chembl_id,target_organism,target_pref_name,target_tax_id,toid,type,units,uo_units,value
93000,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7800080,CHEMBL1909152,"DRUGMATRIX: Glutamate, Kainate radioligand binding (ligand: [3H] Kainic acid)",B,BAO_0000192,BAO_0000249,cell membrane format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL1909046,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,1540224,,15,0,,Ki,,,CHEMBL612545,,Unchecked,,,Ki,,,
93001,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7800081,CHEMBL1909153,"DRUGMATRIX: Glutamate, NMDA, Agonism radioligand binding (ligand: [3H] CGP-39653)",B,BAO_0000190,BAO_0000249,cell membrane format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL1909046,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,1540224,,15,0,,IC50,,,CHEMBL612545,,Unchecked,,,IC50,,,
93002,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7800082,CHEMBL1909153,"DRUGMATRIX: Glutamate, NMDA, Agonism radioligand binding (ligand: [3H] CGP-39653)",B,BAO_0000192,BAO_0000249,cell membrane format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL1909046,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,1540224,,15,0,,Ki,,,CHEMBL612545,,Unchecked,,,Ki,,,
93003,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7800083,CHEMBL1909154,"DRUGMATRIX: Glutamate, NMDA, Phencyclidine radioligand binding (ligand: [3H] TCP)",B,BAO_0000190,BAO_0000249,cell membrane format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL1909046,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,1540224,,15,0,,IC50,,,CHEMBL612545,,Unchecked,,,IC50,,,
93004,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7800084,CHEMBL1909154,"DRUGMATRIX: Glutamate, NMDA, Phencyclidine radioligand binding (ligand: [3H] TCP)",B,BAO_0000192,BAO_0000249,cell membrane format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL1909046,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,1540224,,15,0,,Ki,,,CHEMBL612545,,Unchecked,,,Ki,,,
93005,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7800085,CHEMBL1909155,"DRUGMATRIX: Glycine, Strychnine-Sensitive radioligand binding (ligand: [3H] Strychnine)",B,BAO_0000190,BAO_0000249,cell membrane format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL1909046,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,1540224,,15,0,,IC50,,,CHEMBL3392921,Rattus norvegicus,Glycine receptor,10116.0,,IC50,,,
93006,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7800086,CHEMBL1909155,"DRUGMATRIX: Glycine, Strychnine-Sensitive radioligand binding (ligand: [3H] Strychnine)",B,BAO_0000192,BAO_0000249,cell membrane format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL1909046,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,1540224,,15,0,,Ki,,,CHEMBL3392921,Rattus norvegicus,Glycine receptor,10116.0,,Ki,,,
93007,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7800093,CHEMBL1909159,"DRUGMATRIX: Imidazoline I2, Central radioligand binding (ligand: [3H] Idazoxan)",B,BAO_0000190,BAO_0000249,cell membrane format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL1909046,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,1540224,,15,0,,IC50,,,CHEMBL612545,,Unchecked,,,IC50,,,
93008,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7800094,CHEMBL1909159,"DRUGMATRIX: Imidazoline I2, Central radioligand binding (ligand: [3H] Idazoxan)",B,BAO_0000192,BAO_0000249,cell membrane format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL1909046,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,1540224,,15,0,,Ki,,,CHEMBL612545,,Unchecked,,,Ki,,,
93009,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7800095,CHEMBL1909160,DRUGMATRIX: Insulin radioligand binding (ligand: [125I] Insulin),B,BAO_0000190,BAO_0000249,cell membrane format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL1909046,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,1540224,,15,0,,IC50,,,CHEMBL5486,Rattus norvegicus,Insulin receptor,10116.0,,IC50,,,
93010,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7800096,CHEMBL1909160,DRUGMATRIX: Insulin radioligand binding (ligand: [125I] Insulin),B,BAO_0000192,BAO_0000249,cell membrane format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL1909046,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,1540224,,15,0,,Ki,,,CHEMBL5486,Rattus norvegicus,Insulin receptor,10116.0,,Ki,,,
93011,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7800097,CHEMBL1909161,DRUGMATRIX: Interleukin IL-1 radioligand binding (ligand: [125I] interleukin 1beta),B,BAO_0000190,BAO_0000249,cell membrane format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL1909046,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,1540224,,15,0,,IC50,,,CHEMBL612545,,Unchecked,,,IC50,,,
93012,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7800098,CHEMBL1909161,DRUGMATRIX: Interleukin IL-1 radioligand binding (ligand: [125I] interleukin 1beta),B,BAO_0000192,BAO_0000249,cell membrane format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL1909046,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,1540224,,15,0,,Ki,,,CHEMBL612545,,Unchecked,,,Ki,,,
93013,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7800099,CHEMBL1909162,"DRUGMATRIX: Leukotriene, BLT (LTB4) radioligand binding (ligand: [3H]LTB4)",B,BAO_0000190,BAO_0000249,cell membrane format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL1909046,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,1540224,,15,0,,IC50,,,CHEMBL612545,,Unchecked,,,IC50,,,
93014,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7800100,CHEMBL1909162,"DRUGMATRIX: Leukotriene, BLT (LTB4) radioligand binding (ligand: [3H]LTB4)",B,BAO_0000192,BAO_0000249,cell membrane format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL1909046,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,1540224,,15,0,,Ki,,,CHEMBL612545,,Unchecked,,,Ki,,,
93015,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7800101,CHEMBL1909163,DRUGMATRIX: Leukotriene LTC4 Synthase enzyme inhibition (substrate: LTA4),B,BAO_0000190,BAO_0000221,tissue-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL1909046,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,1540224,,15,0,,IC50,,,CHEMBL1909043,Cavia porcellus,Leukotriene C4 synthase,10141.0,,IC50,,,
93016,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7800102,CHEMBL1909163,DRUGMATRIX: Leukotriene LTC4 Synthase enzyme inhibition (substrate: LTA4),B,BAO_0000192,BAO_0000221,tissue-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL1909046,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,1540224,,15,0,,Ki,,,CHEMBL1909043,Cavia porcellus,Leukotriene C4 synthase,10141.0,,Ki,,,
93017,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7800105,CHEMBL1909165,DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid),B,BAO_0000190,BAO_0000221,tissue-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL1909046,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,1540224,,15,0,,IC50,,,CHEMBL4358,Oryctolagus cuniculus,Arachidonate 15-lipoxygenase,9986.0,,IC50,,,
93018,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7800106,CHEMBL1909165,DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid),B,BAO_0000192,BAO_0000221,tissue-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL1909046,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,1540224,,15,0,,Ki,,,CHEMBL4358,Oryctolagus cuniculus,Arachidonate 15-lipoxygenase,9986.0,,Ki,,,
93019,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7800129,CHEMBL1909177,DRUGMATRIX: Nicotinic Acetylcholine radioligand binding (ligand: [125I] Epibatidine),B,BAO_0000190,BAO_0000249,cell membrane format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL1909046,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,1540224,,15,0,,IC50,,,CHEMBL612545,,Unchecked,,,IC50,,,
93020,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7800130,CHEMBL1909177,DRUGMATRIX: Nicotinic Acetylcholine radioligand binding (ligand: [125I] Epibatidine),B,BAO_0000192,BAO_0000249,cell membrane format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL1909046,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,1540224,,15,0,,Ki,,,CHEMBL612545,,Unchecked,,,Ki,,,
93021,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7800131,CHEMBL1909178,"DRUGMATRIX: Nitric Oxide Synthase, Neuronal (nNOS) radioligand binding (ligand: [3H]L-Arginine)",B,BAO_0000190,BAO_0000221,tissue-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL1909046,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,1540224,,15,0,,IC50,,,CHEMBL3048,Rattus norvegicus,"Nitric-oxide synthase, brain",10116.0,,IC50,,,
93022,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7800132,CHEMBL1909178,"DRUGMATRIX: Nitric Oxide Synthase, Neuronal (nNOS) radioligand binding (ligand: [3H]L-Arginine)",B,BAO_0000192,BAO_0000221,tissue-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL1909046,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,1540224,,15,0,,Ki,,,CHEMBL3048,Rattus norvegicus,"Nitric-oxide synthase, brain",10116.0,,Ki,,,
93023,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7800141,CHEMBL1909183,DRUGMATRIX: Phorbol Ester radioligand binding (ligand: [3H] PDBu),B,BAO_0000190,BAO_0000249,cell membrane format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL1909046,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,1540224,,15,0,,IC50,,,CHEMBL612545,,Unchecked,,,IC50,,,
93024,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7800142,CHEMBL1909183,DRUGMATRIX: Phorbol Ester radioligand binding (ligand: [3H] PDBu),B,BAO_0000192,BAO_0000249,cell membrane format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL1909046,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,1540224,,15,0,,Ki,,,CHEMBL612545,,Unchecked,,,Ki,,,
93025,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7800143,CHEMBL1909184,DRUGMATRIX: Phosphodiesterase PDE3 enzyme inhibition (substrate: [3H]cAMP + cAMP),B,BAO_0000190,BAO_0000221,tissue-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL1909046,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,1540224,,15,0,,IC50,,,CHEMBL612545,,Unchecked,,,IC50,,,
93026,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7800144,CHEMBL1909184,DRUGMATRIX: Phosphodiesterase PDE3 enzyme inhibition (substrate: [3H]cAMP + cAMP),B,BAO_0000192,BAO_0000221,tissue-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL1909046,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,1540224,,15,0,,Ki,,,CHEMBL612545,,Unchecked,,,Ki,,,
93027,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7802180,CHEMBL1909185,DRUGMATRIX: Phosphodiesterase PDE4 enzyme inhibition (substrate: [3H]cAMP + cAMP),B,BAO_0000190,BAO_0000219,cell-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL1909046,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,1540224,,15,0,,IC50,,,CHEMBL612545,,Unchecked,,,IC50,,,
93028,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7802181,CHEMBL1909185,DRUGMATRIX: Phosphodiesterase PDE4 enzyme inhibition (substrate: [3H]cAMP + cAMP),B,BAO_0000192,BAO_0000219,cell-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL1909046,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,1540224,,15,0,,Ki,,,CHEMBL612545,,Unchecked,,,Ki,,,
93029,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7802186,CHEMBL1909188,DRUGMATRIX: Platelet-Derived Growth Factor (PDGF) radioligand binding (ligand: [125I] PDGF),B,BAO_0000190,BAO_0000219,cell-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL1909046,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,1540224,,15,0,,IC50,,,CHEMBL612545,,Unchecked,,,IC50,,,
93030,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7802187,CHEMBL1909188,DRUGMATRIX: Platelet-Derived Growth Factor (PDGF) radioligand binding (ligand: [125I] PDGF),B,BAO_0000192,BAO_0000219,cell-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL1909046,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,1540224,,15,0,,Ki,,,CHEMBL612545,,Unchecked,,,Ki,,,
93031,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7802188,CHEMBL1909189,DRUGMATRIX: Potassium Channel [KATP] radioligand binding (ligand: [3H] Glyburide),B,BAO_0000190,BAO_0000249,cell membrane format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL1909046,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,1540224,,15,0,,IC50,,,CHEMBL612545,,Unchecked,,,IC50,,,
93032,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7802189,CHEMBL1909189,DRUGMATRIX: Potassium Channel [KATP] radioligand binding (ligand: [3H] Glyburide),B,BAO_0000192,BAO_0000249,cell membrane format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL1909046,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,1540224,,15,0,,Ki,,,CHEMBL612545,,Unchecked,,,Ki,,,
93033,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7802192,CHEMBL1909191,DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020),B,BAO_0000190,BAO_0000221,tissue-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL1909046,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,1540224,,15,0,,IC50,,,CHEMBL1909044,Bos taurus,Progesterone receptor,9913.0,,IC50,,,
93034,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7802193,CHEMBL1909191,DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020),B,BAO_0000192,BAO_0000221,tissue-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL1909046,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,1540224,,15,0,,Ki,,,CHEMBL1909044,Bos taurus,Progesterone receptor,9913.0,,Ki,,,
93035,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7802194,CHEMBL1909192,"DRUGMATRIX: Peptidase, Angiotensin Converting Enzyme enzyme inhibition (substrate: FAPGG)",B,BAO_0000190,BAO_0000221,tissue-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL1909046,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,1540224,,15,0,,IC50,,,CHEMBL4074,Oryctolagus cuniculus,Angiotensin-converting enzyme,9986.0,,IC50,,,
93036,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7802195,CHEMBL1909192,"DRUGMATRIX: Peptidase, Angiotensin Converting Enzyme enzyme inhibition (substrate: FAPGG)",B,BAO_0000192,BAO_0000221,tissue-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL1909046,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,1540224,,15,0,,Ki,,,CHEMBL4074,Oryctolagus cuniculus,Angiotensin-converting enzyme,9986.0,,Ki,,,
93037,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7802226,CHEMBL1909208,"DRUGMATRIX: Purinergic P2X radioligand binding (ligand: [3H] alpha, beta-Methylene-ATP)",B,BAO_0000190,BAO_0000249,cell membrane format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL1909046,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,1540224,,15,0,,IC50,,,CHEMBL612545,,Unchecked,,,IC50,,,
93038,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7802227,CHEMBL1909208,"DRUGMATRIX: Purinergic P2X radioligand binding (ligand: [3H] alpha, beta-Methylene-ATP)",B,BAO_0000192,BAO_0000249,cell membrane format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL1909046,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,1540224,,15,0,,Ki,,,CHEMBL612545,,Unchecked,,,Ki,,,
93039,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7802228,CHEMBL1909209,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT),B,BAO_0000190,BAO_0000249,cell membrane format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL1909046,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,1540224,,15,0,,IC50,,,CHEMBL273,Rattus norvegicus,Serotonin 1a (5-HT1a) receptor,10116.0,,IC50,,,
93040,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7802229,CHEMBL1909209,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT),B,BAO_0000192,BAO_0000249,cell membrane format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL1909046,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,1540224,,15,0,,Ki,,,CHEMBL273,Rattus norvegicus,Serotonin 1a (5-HT1a) receptor,10116.0,,Ki,,,
93041,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7802230,CHEMBL1909210,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol),B,BAO_0000190,BAO_0000249,cell membrane format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL1909046,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,1540224,,15,0,,IC50,,,CHEMBL3459,Rattus norvegicus,Serotonin 1b (5-HT1b) receptor,10116.0,,IC50,,,
93042,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7802231,CHEMBL1909210,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol),B,BAO_0000192,BAO_0000249,cell membrane format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL1909046,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,1540224,,15,0,,Ki,,,CHEMBL3459,Rattus norvegicus,Serotonin 1b (5-HT1b) receptor,10116.0,,Ki,,,
93043,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7802238,CHEMBL1909106,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT3 radioligand binding (ligand: [3H] GR-65630),B,BAO_0000190,BAO_0000249,cell membrane format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL1909046,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,1540224,,15,0,,IC50,,,CHEMBL612545,,Unchecked,,,IC50,,,
93044,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7802239,CHEMBL1909106,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT3 radioligand binding (ligand: [3H] GR-65630),B,BAO_0000192,BAO_0000249,cell membrane format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL1909046,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,1540224,,15,0,,Ki,,,CHEMBL612545,,Unchecked,,,Ki,,,
93045,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7802240,CHEMBL1909107,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT4 radioligand binding (ligand: [3H] GR-113808),B,BAO_0000190,BAO_0000249,cell membrane format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL1909046,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,1540224,,15,0,,IC50,,,CHEMBL5017,Cavia porcellus,Serotonin 4 (5-HT4) receptor,10141.0,,IC50,,,
93046,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7802241,CHEMBL1909107,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT4 radioligand binding (ligand: [3H] GR-113808),B,BAO_0000192,BAO_0000249,cell membrane format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL1909046,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,1540224,,15,0,,Ki,,,CHEMBL5017,Cavia porcellus,Serotonin 4 (5-HT4) receptor,10141.0,,Ki,,,
93047,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7802248,CHEMBL1909111,DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil),B,BAO_0000190,BAO_0000249,cell membrane format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL1909046,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,1540224,,15,0,,IC50,,,CHEMBL612545,,Unchecked,,,IC50,,,
93048,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7802249,CHEMBL1909111,DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil),B,BAO_0000192,BAO_0000249,cell membrane format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL1909046,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,1540224,,15,0,,Ki,,,CHEMBL612545,,Unchecked,,,Ki,,,
93049,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7802250,CHEMBL1909112,"DRUGMATRIX: Sodium Channel, Site 2 radioligand binding (ligand: [3H] Batrachotoxin)",B,BAO_0000190,BAO_0000249,cell membrane format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL1909046,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,1540224,,15,0,,IC50,,,CHEMBL612545,,Unchecked,,,IC50,,,
93050,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7802251,CHEMBL1909112,"DRUGMATRIX: Sodium Channel, Site 2 radioligand binding (ligand: [3H] Batrachotoxin)",B,BAO_0000192,BAO_0000249,cell membrane format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL1909046,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,1540224,,15,0,,Ki,,,CHEMBL612545,,Unchecked,,,Ki,,,
93051,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7802256,CHEMBL1909115,DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone),B,BAO_0000190,BAO_0000249,cell membrane format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL1909046,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,1540224,,15,0,,IC50,,,CHEMBL3072,Rattus norvegicus,Androgen Receptor,10116.0,,IC50,,,
93052,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7802257,CHEMBL1909115,DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone),B,BAO_0000192,BAO_0000249,cell membrane format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL1909046,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,1540224,,15,0,,Ki,,,CHEMBL3072,Rattus norvegicus,Androgen Receptor,10116.0,,Ki,,,
93053,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7802260,CHEMBL1909117,"DRUGMATRIX: Tumor Necrosis Factor (TNF), Non-Selective radioligand binding (ligand: [125I] TNF-alpha)",B,BAO_0000190,BAO_0000249,cell membrane format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL1909046,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,1540224,,15,0,,IC50,,,CHEMBL612545,,Unchecked,,,IC50,,,
93054,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7802261,CHEMBL1909117,"DRUGMATRIX: Tumor Necrosis Factor (TNF), Non-Selective radioligand binding (ligand: [125I] TNF-alpha)",B,BAO_0000192,BAO_0000249,cell membrane format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL1909046,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,1540224,,15,0,,Ki,,,CHEMBL612545,,Unchecked,,,Ki,,,
93055,,7843401,CHEMBL1912827,Antibacterial activity against Escherichia coli by micro-broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL1909533,Bioorg Med Chem Lett,2011.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1541986,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.5
93056,,7843426,CHEMBL1912958,Antibacterial activity against Staphylococcus aureus ATCC 25923 by micro-broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL1909533,Bioorg Med Chem Lett,2011.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1541986,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
93057,,7843431,CHEMBL1912959,Antibacterial activity against Klebsiella pneumoniae ATCC 27736 by micro-broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL1909533,Bioorg Med Chem Lett,2011.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1541986,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,4.0
93058,,7843448,CHEMBL1912960,Antibacterial activity against Pseudomonas aeruginosa by micro-broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL1909533,Bioorg Med Chem Lett,2011.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1541986,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,1.0
93059,,8031338,CHEMBL1954715,Displacement of ethidium bromide from human pre-hsa-mir-155 miRNA after 30 mins,B,BAO_0000034,BAO_0000225,nucleic acid format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL1949550,Bioorg Med Chem Lett,2012.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/Nanomolar,1577856,>,1,1,>,Kd,nM,100000.0,CHEMBL345,,Nucleic Acid,,,Kd,uM,UO_0000065,100.0
93060,,12399704,CHEMBL3063705,Antibacterial activity against Bacillus cereus at 10 ug/ml after 24 hr by agar well diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3045647,Med Chem Res,2012.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://qudt.org/vocab/unit#Millimeter,1799476,=,1,1,=,IZ,mm,19.0,CHEMBL613070,Bacillus cereus,Bacillus cereus,1396.0,,IZ,mm,UO_0000016,19.0
93061,,12399715,CHEMBL3063707,Antibacterial activity against Pseudomonas aeruginosa minced cow meet at 10 ug/ml after 24 hr by agar well diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3045647,Med Chem Res,2012.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://qudt.org/vocab/unit#Millimeter,1799476,=,1,1,=,IZ,mm,18.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,IZ,mm,UO_0000016,18.0
93062,,12399726,CHEMBL3063709,Antibacterial activity against Staphylococcus aureus minced cow meet at 10 ug/ml after 24 hr by agar well diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3045647,Med Chem Res,2012.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://qudt.org/vocab/unit#Millimeter,1799476,=,1,1,=,IZ,mm,19.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,IZ,mm,UO_0000016,19.0
93063,,12399737,CHEMBL3063258,Antibacterial activity against Listeria monocytogenes isolated from mastitic cow milk at 10 ug/ml after 24 hr by agar well diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3045647,Med Chem Res,2012.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://qudt.org/vocab/unit#Millimeter,1799476,=,1,1,=,IZ,mm,20.0,CHEMBL614974,Listeria monocytogenes,Listeria monocytogenes,1639.0,,IZ,mm,UO_0000016,20.0
93064,,12399748,CHEMBL3063260,Antibacterial activity against Salmonella enterica subsp. enterica serovar Typhimurium isolated from mastitic cow milk at 10 ug/ml after 24 hr by agar well diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3045647,Med Chem Res,2012.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://qudt.org/vocab/unit#Millimeter,1799476,=,1,1,=,IZ,mm,18.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,IZ,mm,UO_0000016,18.0
93065,,12399759,CHEMBL3063262,Antibacterial activity against Escherichia coli O157:H7 isolated from poultry at 10 ug/ml after 24 hr by agar well diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3045647,Med Chem Res,2012.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://qudt.org/vocab/unit#Millimeter,1799476,=,1,1,=,IZ,mm,20.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,IZ,mm,UO_0000016,20.0
93066,,12406174,CHEMBL3049077,Bactericidal activity against Klebsiella pneumoniae wound isolate after 24 hr by NCCLS dilution tube method,F,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3046735,Med Chem Res,2012.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,1794781,=,1,0,=,MBC,mg/L,24.1,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MBC,mg/L,,24.1
93067,,12406184,CHEMBL3049078,Bactericidal activity against Klebsiella pneumoniae urine isolate after 24 hr by NCCLS dilution tube method,F,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3046735,Med Chem Res,2012.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,1794781,=,1,0,=,MBC,mg/L,28.1,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MBC,mg/L,,28.1
93068,,12406194,CHEMBL3049079,Bactericidal activity against Pseudomonas aeruginosa wound isolate after 24 hr by NCCLS dilution tube method,F,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3046735,Med Chem Res,2012.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,1794781,=,1,0,=,MBC,mg/L,26.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MBC,mg/L,,26.5
93069,,12406204,CHEMBL3050396,Bactericidal activity against Pseudomonas aeruginosa urine isolate after 24 hr by NCCLS dilution tube method,F,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3046735,Med Chem Res,2012.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,1794781,=,1,0,=,MBC,mg/L,13.7,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MBC,mg/L,,13.7
93070,,12406214,CHEMBL3050397,Bactericidal activity against Staphylococcus saprophyticus bronchi isolate after 24 hr by NCCLS dilution tube method,F,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3046735,Med Chem Res,2012.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,1794781,=,1,0,=,MBC,mg/L,25.0,CHEMBL613764,Staphylococcus saprophyticus,Staphylococcus saprophyticus,29385.0,,MBC,mg/L,,25.0
93071,,12406224,CHEMBL3050398,Bactericidal activity against Staphylococcus epidermidis eye isolate after 24 hr by NCCLS dilution tube method,F,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3046735,Med Chem Res,2012.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,1794781,=,1,0,=,MBC,mg/L,50.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MBC,mg/L,,50.0
93072,,12406234,CHEMBL3052133,Bactericidal activity against Staphylococcus aureus urine isolate after 24 hr by NCCLS dilution tube method,F,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3046735,Med Chem Res,2012.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,1794781,=,1,0,=,MBC,mg/L,11.8,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC,mg/L,,11.8
93073,,12406244,CHEMBL3047133,Bactericidal activity against Staphylococcus aureus wound isolate after 24 hr by NCCLS dilution tube method,F,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3046735,Med Chem Res,2012.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,1794781,=,1,0,=,MBC,mg/L,17.3,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC,mg/L,,17.3
93074,,12406254,CHEMBL3047134,Bactericidal activity against Escherichia coli bronchi isolate after 24 hr by NCCLS dilution tube method,F,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3046735,Med Chem Res,2012.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,1794781,=,1,0,=,MBC,mg/L,74.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MBC,mg/L,,74.0
93075,,12406264,CHEMBL3047135,Bactericidal activity against Escherichia coli urine isolate after 24 hr by NCCLS dilution tube method,F,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3046735,Med Chem Res,2012.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,1794781,=,1,0,=,MBC,mg/L,64.3,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MBC,mg/L,,64.3
93076,,12406274,CHEMBL3047136,Bactericidal activity against multidrug-resistant Acinetobacter baumannii urine isolate after 24 hr by NCCLS dilution tube method,F,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3046735,Med Chem Res,2012.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,1794781,=,1,0,=,MBC,mg/L,78.1,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MBC,mg/L,,78.1
93077,,12406284,CHEMBL3047137,Bactericidal activity against multidrug-resistant Acinetobacter baumannii wound isolate after 24 hr by NCCLS dilution tube method,F,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3046735,Med Chem Res,2012.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,1794781,=,1,0,=,MBC,mg/L,83.3,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MBC,mg/L,,83.3
93078,,12406294,CHEMBL3047138,Bactericidal activity against multidrug-resistant Acinetobacter baumannii bronchi isolate after 24 hr by NCCLS dilution tube method,F,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3046735,Med Chem Res,2012.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,1794781,=,1,0,=,MBC,mg/L,68.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MBC,mg/L,,68.0
93079,,12580436,CHEMBL3071301,Antimicrobial activity against Streptococcus pyogenes 10535 assessed as growth inhibition after 24 hr by serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3045072,Med Chem Res,2013.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1837344,=,1,1,=,MIC,ug.mL-1,7.81,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,ug ml-1,UO_0000274,7.81
93080,,12580445,CHEMBL3071302,Antimicrobial activity against Staphylococcus aureus 209 assessed as growth inhibition after 24 hr by serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3045072,Med Chem Res,2013.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1837344,=,1,1,=,MIC,ug.mL-1,15.62,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,15.62
93081,,13434793,CHEMBL2422986,Inhibition of protein synthesis in Escherichia coli S30 extracts after 90 mins by coupled transcription/translation assay,F,BAO_0000190,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL2417431,J Med Chem,2013.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/Nanomolar,1913831,=,1,1,=,IC50,nM,15.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,IC50,uM,UO_0000065,0.015
93082,,13434808,CHEMBL2421305,Antibacterial activity against Streptococcus pyogenes Serotype M12 MGAS9429 by double-dilution technique,F,BAO_0002146,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL2417431,J Med Chem,2013.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1913831,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,ug ml-1,UO_0000274,64.0
93083,,13434823,CHEMBL2422987,Antibacterial activity against biofilm negative Staphylococcus epidermidis ATCC 12228 by double-dilution technique,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL2417431,J Med Chem,2013.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1913831,=,1,1,=,MIC,ug.mL-1,0.3,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.3
93084,,13434838,CHEMBL2422989,Antibacterial activity against Haemophilus influenzae ATCC 51907 by double-dilution technique,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL2417431,J Med Chem,2013.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1913831,=,1,1,=,MIC,ug.mL-1,18.8,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC,ug ml-1,UO_0000274,18.8
93085,,13434853,CHEMBL2422988,Antibacterial activity against Bacillus anthracis 34F2 Sterne by double-dilution technique,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL2417431,J Med Chem,2013.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1913831,=,1,1,=,MIC,ug.mL-1,9.4,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,MIC,ug ml-1,UO_0000274,9.4
93086,,13434868,CHEMBL2422990,Antibacterial activity against Escherichia coli MC1061 by double-dilution technique,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL2417431,J Med Chem,2013.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1913831,=,1,1,=,MIC,ug.mL-1,9.4,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,9.4
93087,,13434883,CHEMBL2422992,Antibacterial activity against Staphylococcus aureus expressing NorA by double-dilution technique,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL2417431,J Med Chem,2013.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1913831,=,1,1,=,MIC,ug.mL-1,9.4,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,9.4
93088,,13434898,CHEMBL2422991,Antibacterial activity against Staphylococcus aureus ATCC 29213 by double-dilution technique,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL2417431,J Med Chem,2013.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1913831,=,1,1,=,MIC,ug.mL-1,37.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,37.5
93089,,13434913,CHEMBL2421302,Antibacterial activity against Listeria monocytogenes ATCC 19115 by double-dilution technique,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL2417431,J Med Chem,2013.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1913831,=,1,1,=,MIC,ug.mL-1,18.8,CHEMBL614974,Listeria monocytogenes,Listeria monocytogenes,1639.0,,MIC,ug ml-1,UO_0000274,18.8
93090,,13434928,CHEMBL2421301,Antibacterial activity against Bacillus cereus ATCC 11778 by double-dilution technique,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL2417431,J Med Chem,2013.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1913831,=,1,1,=,MIC,ug.mL-1,75.0,CHEMBL613070,Bacillus cereus,Bacillus cereus,1396.0,,MIC,ug ml-1,UO_0000274,75.0
93091,,13434943,CHEMBL2422993,Antibacterial activity against Mycobacterium smegmatis str. MC2 155 by double-dilution technique,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL2417431,J Med Chem,2013.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1913831,=,1,1,=,MIC,ug.mL-1,0.6,CHEMBL613088,Mycolicibacterium smegmatis,Mycolicibacterium smegmatis,1772.0,,MIC,ug ml-1,UO_0000274,0.6
93092,,13434958,CHEMBL2421303,Antibacterial activity against Bacillus subtilis 168 harboring AAC(6')/APH(2'')-pRB374 by double-dilution technique,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL2417431,J Med Chem,2013.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1913831,=,1,1,=,MIC,ug.mL-1,9.4,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,ug ml-1,UO_0000274,9.4
93093,,13434973,CHEMBL2421304,Antibacterial activity against Bacillus subtilis 168 by double-dilution technique,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL2417431,J Med Chem,2013.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1913831,=,1,1,=,MIC,ug.mL-1,2.3,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,ug ml-1,UO_0000274,2.3
93094,,13466986,CHEMBL2433960,Antibacterial activity against Escherichia coli L58058.1 expressing ANT2''-1A after 24 hrs by geometric microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL2429794,J Med Chem,2013.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1922591,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,64.0
93095,,13466988,CHEMBL2433961,Antibacterial activity against Escherichia coli PAZ505H8101 expressing AAC6'-1B after 24 hrs by geometric microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL2429794,J Med Chem,2013.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1922591,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,32.0
93096,,13466990,CHEMBL2433962,Antibacterial activity against Escherichia coli ATCC 25922 after 24 hrs by geometric microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL2429794,J Med Chem,2013.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1922591,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.5
93097,,13466992,CHEMBL2433963,Antibacterial activity against Klebsiella pneumoniae ATCC 700603 after 24 hrs by geometric microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL2429794,J Med Chem,2013.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1922591,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,4.0
93098,,13466994,CHEMBL2434109,Antibacterial activity against Pseudomonas aeruginosa PA22 (PT629) expressing MexXY after 24 hrs by geometric microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL2429794,J Med Chem,2013.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1922591,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,1.0
93099,,13466996,CHEMBL2434110,Antibacterial activity against Pseudomonas aeruginosa F03 expressing AAC6'-2A after 24 hrs by geometric microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL2429794,J Med Chem,2013.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1922591,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,128.0
93100,,13466998,CHEMBL2434111,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 after 24 hrs by geometric microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL2429794,J Med Chem,2013.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1922591,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.5
93101,,13467000,CHEMBL2434112,Antibacterial activity against Acinetobacter lwoffii AI.88-483 expressing APH3'-6A after 24 hrs by geometric microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL2429794,J Med Chem,2013.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1922591,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,MIC,ug ml-1,UO_0000274,1.0
93102,,13467002,CHEMBL2434113,Antibacterial activity against Acinetobacter lwoffii ATCC 17925 after 24 hrs by geometric microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL2429794,J Med Chem,2013.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1922591,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,MIC,ug ml-1,UO_0000274,0.5
93103,,13500114,CHEMBL2443432,Antimicrobial activity against Pseudomonas aeruginosa PaM02 assessed as growth inhibition at 0.008 umol/ml by microtitre plate reader analysis,F,BAO_0000096,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL2439968,Bioorg Med Chem,2013.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://qudt.org/vocab/unit#Percent,1929089,=,1,0,=,GI,%,100.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,GI,%,UO_0000187,100.0
93104,,13842206,CHEMBL3095025,Antibacterial activity against GIM-1 expressing Pseudomonas aeruginosa isolate 197 after 18 to 24 hrs by two-fold broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3091449,Bioorg Med Chem,2013.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1953032,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,16.0
93105,,13842207,CHEMBL3095026,Antibacterial activity against SIM-1 expressing Acinetobacter baumannii isolate 170 after 18 to 24 hrs by two-fold broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3091449,Bioorg Med Chem,2013.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1953032,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,16.0
93106,,13842208,CHEMBL3095027,Antibacterial activity against CTX-15 expressing Escherichia coli isolate 235 after 18 to 24 hrs by two-fold broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3091449,Bioorg Med Chem,2013.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1953032,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,16.0
93107,,13842209,CHEMBL3095028,Antibacterial activity against TEM-1/SHV-12 expressing Escherichia coli isolate 237 after 18 to 24 hrs by two-fold broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3091449,Bioorg Med Chem,2013.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1953032,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,64.0
93108,,13842210,CHEMBL3095029,Antibacterial activity against CTX-15 expressing Escherichia coli isolate 4024 after 18 to 24 hrs by two-fold broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3091449,Bioorg Med Chem,2013.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1953032,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,32.0
93109,,13842211,CHEMBL3095030,Antibacterial activity against TEM-1/CTX-M-15 expressing Aeromonas caviae isolate 260 after 18 to 24 hrs by two-fold broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3091449,Bioorg Med Chem,2013.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1953032,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL613786,Aeromonas caviae,Aeromonas caviae,648.0,,MIC,ug ml-1,UO_0000274,32.0
93110,,13842212,CHEMBL3095031,Antibacterial activity against CTX-15 expressing Aeromonas caviae isolate 258 after 18 to 24 hrs by two-fold broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3091449,Bioorg Med Chem,2013.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1953032,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL613786,Aeromonas caviae,Aeromonas caviae,648.0,,MIC,ug ml-1,UO_0000274,32.0
93111,,13842213,CHEMBL3095032,Antibacterial activity against TEM-1/SHV-12 expressing Aeromonas hydrophila isolate 268 after 18 to 24 hrs by two-fold broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3091449,Bioorg Med Chem,2013.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1953032,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL612509,Aeromonas hydrophila,Aeromonas hydrophila,644.0,,MIC,ug ml-1,UO_0000274,16.0
93112,,13842214,CHEMBL3095200,Antibacterial activity against TEM-1/SHV-12/CTX-15 expressing Enterobacter intermedius isolate 243 after 18 to 24 hrs by two-fold broth microdilution assay,F,BAO_0002146,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3091449,Bioorg Med Chem,2013.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1953032,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,32.0
93113,,13842215,CHEMBL3095201,Antibacterial activity against CTX-15 expressing Enterobacter cloacae isolate 51 after 18 to 24 hrs by two-fold broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3091449,Bioorg Med Chem,2013.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1953032,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC,ug ml-1,UO_0000274,32.0
93114,,13842216,CHEMBL3095203,Antibacterial activity against TEM-1/SHV-12 expressing Enterobacter cloacae isolate 306 after 18 to 24 hrs by two-fold broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3091449,Bioorg Med Chem,2013.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1953032,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC,ug ml-1,UO_0000274,16.0
93115,,13842217,CHEMBL3095202,Antibacterial activity against TEM-1/CTX-M-15 expressing Enterobacter cloacae isolate 62 after 18 to 24 hrs by two-fold broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3091449,Bioorg Med Chem,2013.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1953032,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC,ug ml-1,UO_0000274,32.0
93116,,13842218,CHEMBL3095208,Antibacterial activity against TEM-1/SHV-12 expressing Klebsiella pneumoniae isolate 303 after 18 to 24 hrs by two-fold broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3091449,Bioorg Med Chem,2013.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1953032,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,2.0
93117,,13842219,CHEMBL3095210,Antibacterial activity against CTX-15 expressing Stenotrophomonas maltophilia isolate 125 after 18 to 24 hrs by two-fold broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3091449,Bioorg Med Chem,2013.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1953032,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,MIC,ug ml-1,UO_0000274,8.0
93118,,14553386,CHEMBL3225746,Antibacterial activity against Streptococcus mutans UA159 assessed as growth inhibition after 24 hrs by double dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3217422,Medchemcomm,2013.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2075777,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL612426,Streptococcus mutans,Streptococcus mutans,1309.0,,MIC,ug ml-1,UO_0000274,128.0
93119,,14553393,CHEMBL3225740,Antibacterial activity against Pseudomonas aeruginosa ATCC 33347 assessed as growth inhibition after 24 hrs by double dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3217422,Medchemcomm,2013.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2075777,>,1,1,>,MIC,ug.mL-1,128.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,128.0
93120,,14553395,CHEMBL3225744,Antibacterial activity against Enterococcus faecalis ATCC 29212 assessed as growth inhibition after 24 hrs by double dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3217422,Medchemcomm,2013.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2075777,>,1,1,>,MIC,ug.mL-1,128.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,128.0
93121,,14553396,CHEMBL3225745,Antibacterial activity against vancomycin-resistant Enterococcus assessed as growth inhibition after 24 hrs by double dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3217422,Medchemcomm,2013.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2075777,>,1,1,>,MIC,ug.mL-1,128.0,CHEMBL612318,Enterococcus,Enterococcus,1350.0,,MIC,ug ml-1,UO_0000274,128.0
93122,,14553398,CHEMBL3225747,Antibacterial activity against Methicillin-resistant Staphylococcus aureus assessed as growth inhibition after 24 hrs by double dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3217422,Medchemcomm,2013.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2075777,>,1,1,>,MIC,ug.mL-1,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,128.0
93123,,14553399,CHEMBL3225741,Antibacterial activity against Staphylococcus epidermidis ATCC 12228 assessed as growth inhibition after 24 hrs by double dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3217422,Medchemcomm,2013.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2075777,<,1,1,<,MIC,ug.mL-1,1.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,1.0
93124,,14553412,CHEMBL3225742,Antibacterial activity against Staphylococcus epidermidis ATCC 35984 assessed as growth inhibition after 24 hrs by double dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3217422,Medchemcomm,2013.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2075777,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,128.0
93125,,14553449,CHEMBL3225748,Antibacterial activity against Streptococcus pyogenes serotype M12 strain MGAS9429 assessed as growth inhibition after 24 hrs by double dilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3217422,Medchemcomm,2013.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2075777,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,64.0
93126,,14553455,CHEMBL3225395,Antibacterial activity against O-antigen negative Shigella sonnei clinical isolate 6831 assessed as growth inhibition after 24 hrs by double dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3217422,Medchemcomm,2013.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2075777,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL614595,Shigella sonnei,Shigella sonnei,624.0,,MIC,ug ml-1,UO_0000274,32.0
93127,,14553482,CHEMBL3225739,Antibacterial activity against O-antigen positive Shigella sonnei clinical isolate 6831 assessed as growth inhibition after 24 hrs by double dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3217422,Medchemcomm,2013.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2075777,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL614595,Shigella sonnei,Shigella sonnei,624.0,,MIC,ug ml-1,UO_0000274,16.0
93128,,14553494,CHEMBL3225743,Antibacterial activity against Staphylococcus aureus ATCC 9144 assessed as growth inhibition after 24 hrs by double dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3217422,Medchemcomm,2013.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2075777,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,16.0
93129,,14657943,CHEMBL3266202,Inhibition of N-terminal FITC-labeled MBM1 interaction to menin (unknown origin) after 1 hr by fluorescence polarization assay,B,BAO_0000192,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3259787,Bioorg Med Chem Lett,2014.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/Nanomolar,2099531,=,1,1,=,Ki,nM,59900.0,CHEMBL612545,,Unchecked,,,Ki,uM,UO_0000065,59.9
93130,,15029442,CHEMBL3363333,Antimicrobial activity against methicillin-sensitive Staphylococcus aureus ATCC 29213 after 18 to 20 hrs by microbroth dilution technique,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3352225,ACS Med Chem Lett,2014.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2253153,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
93131,,15622129,CHEMBL3587578,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 assessed as inhibition of bacterial growth incubated for 72 hrs by CLSI based method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3585328,Bioorg Med Chem,2015.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/Nanomolar,2484123,=,1,1,=,MIC,nM,6400.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,uM,UO_0000065,6.4
93132,,15638322,CHEMBL3592102,Antibacterial activity against patient-derived methicillin-resistant Staphylococcus aureus 7419 after 18 to 20 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3588802,Bioorg Med Chem Lett,2015.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2486995,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,32.0
93133,,15638328,CHEMBL3592103,Antibacterial activity against patient-derived methicillin-resistant Staphylococcus aureus B19506 after 18 to 20 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3588802,Bioorg Med Chem Lett,2015.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2486995,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,32.0
93134,,15638334,CHEMBL3592104,Antibacterial activity against patient-derived methicillin-resistant Staphylococcus aureus 7425 after 18 to 20 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3588802,Bioorg Med Chem Lett,2015.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2486995,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
93135,,15638340,CHEMBL3592105,Antibacterial activity against patient-derived methicillin-resistant Staphylococcus aureus 7386 after 18 to 20 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3588802,Bioorg Med Chem Lett,2015.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2486995,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,32.0
93136,,15638346,CHEMBL3592106,Antibacterial activity against patient-derived methicillin-resistant Staphylococcus aureus K1 after 18 to 20 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3588802,Bioorg Med Chem Lett,2015.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2486995,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
93137,,15638385,CHEMBL3592109,Antibacterial activity against methicillin-resistant Staphylococcus aureus after 18 to 20 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3588802,Bioorg Med Chem Lett,2015.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2486995,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,32.0
93138,,16405524,CHEMBL3745114,Antibacterial activity against Staphylococcus aureus assessed as growth inhibition incubated for 24 hrs at 37 degC by agar well diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3739282,Bioorg Med Chem Lett,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2737604,=,1,1,=,MIC,ug.mL-1,1.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.5
93139,,16406398,CHEMBL3745115,Antibacterial activity against Escherichia coli assessed as growth inhibition incubated for 24 hrs at 37 degC by agar well diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3739282,Bioorg Med Chem Lett,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2737604,=,1,1,=,MIC,ug.mL-1,3.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,3.0
93140,,16406413,CHEMBL3745116,Antibacterial activity against Bacillus subtilis assessed as growth inhibition incubated for 24 hrs at 37 degC by agar well diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3739282,Bioorg Med Chem Lett,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2737604,=,1,1,=,MIC,ug.mL-1,3.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,ug ml-1,UO_0000274,3.0
93141,,16406428,CHEMBL3745117,Antibacterial activity against Salmonella assessed as growth inhibition incubated for 24 hrs at 37 degC by agar well diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3739282,Bioorg Med Chem Lett,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2737604,=,1,1,=,MIC,ug.mL-1,3.0,CHEMBL614446,Salmonella,Salmonella,590.0,,MIC,ug ml-1,UO_0000274,3.0
93142,,16440921,CHEMBL3755601,Antimicrobial activity against Gram-positive Staphylococcus aureus ATCC 29213 after 16 to 24 hrs by micro-dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3751713,ACS Med Chem Lett,2015.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2744804,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
93143,,16440931,CHEMBL3755602,Antimicrobial activity against Gram-positive methicillin-resistant Staphylococcus aureus 1 after 16 to 24 hrs by micro-dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3751713,ACS Med Chem Lett,2015.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2744804,<=,1,1,<=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
93144,,16440947,CHEMBL3755599,Antimicrobial activity against Gram-positive Bacillus subtilis 168 after 16 to 24 hrs by micro-dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3751713,ACS Med Chem Lett,2015.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2744804,=,1,1,=,MIC,ug.mL-1,9.4,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,ug ml-1,UO_0000274,9.4
93145,,16440961,CHEMBL3755600,Antimicrobial activity against Gram-positive Listeria monocytogenes ATCC 19115 after 16 to 24 hrs by micro-dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3751713,ACS Med Chem Lett,2015.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2744804,=,1,1,=,MIC,ug.mL-1,2.3,CHEMBL614974,Listeria monocytogenes,Listeria monocytogenes,1639.0,,MIC,ug ml-1,UO_0000274,2.3
93146,,16440977,CHEMBL3755598,Antimicrobial activity against Gram-positive Bacillus cereus ATCC 17788 after 16 to 24 hrs by micro-dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3751713,ACS Med Chem Lett,2015.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2744804,=,1,1,=,MIC,ug.mL-1,9.4,CHEMBL613070,Bacillus cereus,Bacillus cereus,1396.0,,MIC,ug ml-1,UO_0000274,9.4
93147,,16440991,CHEMBL3755597,Antimicrobial activity against Gram-positive Bacillus anthracis str. Sterne after 16 to 24 hrs by micro-dilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3751713,ACS Med Chem Lett,2015.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2744804,>,1,1,>,MIC,ug.mL-1,128.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,MIC,ug ml-1,UO_0000274,128.0
93148,,16441014,CHEMBL3755603,Antimicrobial activity against Gram-positive methicillin-resistant Staphylococcus aureus 2 after 16 to 24 hrs by micro-dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3751713,ACS Med Chem Lett,2015.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2744804,>,1,1,>,MIC,ug.mL-1,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,128.0
93149,,16441028,CHEMBL3755604,Antimicrobial activity against Gram-negative Haemophilus influenzae ATCC 51907 after 16 to 24 hrs by micro-dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3751713,ACS Med Chem Lett,2015.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2744804,=,1,1,=,MIC,ug.mL-1,4.7,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC,ug ml-1,UO_0000274,4.7
93150,,16441042,CHEMBL3755605,Antimicrobial activity against Gram-negative Pseudomonas aeruginosa PAO1 after 16 to 24 hrs by micro-dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3751713,ACS Med Chem Lett,2015.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2744804,=,1,1,=,MIC,ug.mL-1,0.6,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.6
93151,,16441056,CHEMBL3755606,Antimicrobial activity against Mycobacterium smegmatis MC2-155 after 16 to 24 hrs by micro-dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3751713,ACS Med Chem Lett,2015.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2744804,>=,1,1,>=,MIC,ug.mL-1,128.0,CHEMBL613088,Mycolicibacterium smegmatis,Mycolicibacterium smegmatis,1772.0,,MIC,ug ml-1,UO_0000274,128.0
93152,,16516170,CHEMBL3784731,Antibacterial activity against Pseudomonas aeruginosa VW1633 clinical isolate after 16 to 20 hrs by microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3779859,Medchemcomm,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2766190,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.125
93153,,16516186,CHEMBL3784732,Antibacterial activity against Pseudomonas aeruginosa LES431 clinical isolate after 16 to 20 hrs by microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3779859,Medchemcomm,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2766190,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,2.0
93154,,16516202,CHEMBL3784733,Antibacterial activity against Pseudomonas aeruginosa KD491 clinical isolate after 16 to 20 hrs by microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3779859,Medchemcomm,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2766190,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,8.0
93155,,16516208,CHEMBL3784736,Antibacterial activity against Pseudomonas aeruginosa D599 clinical isolate after 16 to 20 hrs by microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3779859,Medchemcomm,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2766190,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.5
93156,,16516214,CHEMBL3784737,Antibacterial activity against Pseudomonas aeruginosa PAO1 clinical isolate after 16 to 20 hrs by microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3779859,Medchemcomm,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2766190,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,2.0
93157,,16516220,CHEMBL3784738,Antibacterial activity against Pseudomonas aeruginosa Clone C clinical isolate after 16 to 20 hrs by microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3779859,Medchemcomm,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2766190,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,1.0
93158,,16516226,CHEMBL3784739,Antibacterial activity against Pseudomonas aeruginosa VW1501 clinical isolate after 16 to 20 hrs by microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3779859,Medchemcomm,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2766190,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,4.0
93159,,16516232,CHEMBL3784740,Antibacterial activity against Pseudomonas aeruginosa kl 1.1 clinical isolate after 16 to 20 hrs by microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3779859,Medchemcomm,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2766190,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,4.0
93160,,16516238,CHEMBL3784741,Antibacterial activity against Pseudomonas aeruginosa KD557 clinical isolate after 16 to 20 hrs by microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3779859,Medchemcomm,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2766190,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,1.0
93161,,16516244,CHEMBL3784742,Antibacterial activity against Pseudomonas aeruginosa VW1540 clinical isolate after 16 to 20 hrs by microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3779859,Medchemcomm,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2766190,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.125
93162,,16516250,CHEMBL3784743,Antibacterial activity against Pseudomonas aeruginosa VW178 clinical isolate after 16 to 20 hrs by microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3779859,Medchemcomm,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2766190,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,32.0
93163,,16516256,CHEMBL3784745,Antibacterial activity against Pseudomonas aeruginosa VW1485 clinical isolate after 16 to 20 hrs by microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3779859,Medchemcomm,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2766190,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,16.0
93164,,16516262,CHEMBL3784746,Antibacterial activity against Pseudomonas aeruginosa VW0247 clinical isolate after 16 to 20 hrs by microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3779859,Medchemcomm,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2766190,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,4.0
93165,,16516268,CHEMBL3784747,Antibacterial activity against Pseudomonas aeruginosa kl 3.2 clinical isolate after 16 to 20 hrs by microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3779859,Medchemcomm,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2766190,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,16.0
93166,,16516274,CHEMBL3784748,Antibacterial activity against Pseudomonas aeruginosa VW1538 clinical isolate after 16 to 20 hrs by microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3779859,Medchemcomm,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2766190,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,8.0
93167,,16516280,CHEMBL3784749,Antibacterial activity against Pseudomonas aeruginosa MIDLANDS clinical isolate after 16 to 20 hrs by microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3779859,Medchemcomm,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2766190,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,2.0
93168,,16516286,CHEMBL3784750,Antibacterial activity against Pseudomonas aeruginosa LES400 clinical isolate after 16 to 20 hrs by microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3779859,Medchemcomm,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2766190,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,8.0
93169,,16516292,CHEMBL3784751,Antibacterial activity against Pseudomonas aeruginosa VW1471 clinical isolate after 16 to 20 hrs by microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3779859,Medchemcomm,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2766190,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,8.0
93170,,16516298,CHEMBL3784752,Antibacterial activity against Pseudomonas aeruginosa VW313 clinical isolate after 16 to 20 hrs by microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3779859,Medchemcomm,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2766190,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,16.0
93171,,16516304,CHEMBL3784753,Antibacterial activity against Pseudomonas aeruginosa LESB58 clinical isolate after 16 to 20 hrs by microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3779859,Medchemcomm,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2766190,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,8.0
93172,Active,16516324,CHEMBL3783819,Antibacterial activity against Pseudomonas aeruginosa KD491 clinical isolate assessed as delay in growth rate in exponential phase of bacterial growth curve at 1 ug/ml measured every 15 mins by microtiter plate reader method,F,BAO_0000375,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3779859,Medchemcomm,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2766190,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
93173,Active,16516325,CHEMBL3783820,Antibacterial activity against Pseudomonas aeruginosa LESB58 clinical isolate assessed as delay in growth rate in exponential phase of bacterial growth curve at 1 ug/ml measured every 15 mins by microtiter plate reader method,F,BAO_0000375,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3779859,Medchemcomm,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2766190,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
93174,Active,16516326,CHEMBL3783821,Antibacterial activity against Pseudomonas aeruginosa PAO1 clinical isolate assessed as delay in growth rate in exponential phase of bacterial growth curve at 0.25 ug/ml measured every 15 mins by microtiter plate reader method,F,BAO_0000375,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3779859,Medchemcomm,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2766190,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
93175,Active,16516327,CHEMBL3783822,Antibacterial activity against Pseudomonas aeruginosa Clone C clinical isolate assessed as delay in growth rate in exponential phase of bacterial growth curve at 0.25 ug/ml measured every 15 mins by microtiter plate reader method,F,BAO_0000375,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3779859,Medchemcomm,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2766190,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
93176,,16530520,CHEMBL3790396,Antimicrobial activity against Acinetobacter baumannii isolate 12 by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3784957,Medchemcomm,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2767183,>,1,1,>,MIC,ug.mL-1,8.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,8.0
93177,,16530533,CHEMBL3790395,Antimicrobial activity against Acinetobacter baumannii isolate 9 by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3784957,Medchemcomm,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2767183,>,1,1,>,MIC,ug.mL-1,8.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,8.0
93178,,16530546,CHEMBL3790394,Antimicrobial activity against Acinetobacter baumannii isolate 3 by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3784957,Medchemcomm,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2767183,<=,1,1,<=,MIC,ug.mL-1,1.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,1.0
93179,,16530565,CHEMBL3790678,Antimicrobial activity against Acinetobacter baumannii isolate 15 by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3784957,Medchemcomm,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2767183,>,1,1,>,MIC,ug.mL-1,8.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,8.0
93180,,16530578,CHEMBL3790679,Antimicrobial activity against Acinetobacter baumannii isolate 20 by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3784957,Medchemcomm,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2767183,>,1,1,>,MIC,ug.mL-1,8.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,8.0
93181,,16530591,CHEMBL3790680,Antimicrobial activity against Acinetobacter baumannii isolate 26 by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3784957,Medchemcomm,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2767183,<=,1,1,<=,MIC,ug.mL-1,1.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,1.0
93182,,16530604,CHEMBL3790681,Antimicrobial activity against Acinetobacter baumannii isolate 30 by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3784957,Medchemcomm,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2767183,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,8.0
93183,,16531214,CHEMBL3790682,Antimicrobial activity against Acinetobacter baumannii isolate 35 by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3784957,Medchemcomm,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2767183,>,1,1,>,MIC,ug.mL-1,8.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,8.0
93184,,16531227,CHEMBL3790683,Antimicrobial activity against Acinetobacter baumannii isolate 38 by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3784957,Medchemcomm,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2767183,>,1,1,>,MIC,ug.mL-1,8.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,8.0
93185,,16531240,CHEMBL3790684,Antimicrobial activity against Acinetobacter baumannii isolate 45 by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3784957,Medchemcomm,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2767183,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,8.0
93186,,16531253,CHEMBL3790685,Antimicrobial activity against Acinetobacter baumannii isolate 52 by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3784957,Medchemcomm,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2767183,<=,1,1,<=,MIC,ug.mL-1,1.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,1.0
93187,,16531266,CHEMBL3790686,Antimicrobial activity against Acinetobacter baumannii isolate 59 by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3784957,Medchemcomm,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2767183,<=,1,1,<=,MIC,ug.mL-1,1.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,1.0
93188,,16743505,CHEMBL3858077,Antibacterial activity against Staphylococcus aureus ATCC 29213 after 24 hrs by microtitre broth dilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3856229,J Med Chem,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798636,<=,1,1,<=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
93189,,16743513,CHEMBL3858078,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33592 after 24 hrs by microtitre broth dilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3856229,J Med Chem,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798636,<=,1,1,<=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
93190,,16743519,CHEMBL3858079,Antibacterial activity against methicillin-susceptible Staphylococcus epidermidis isolate CANWARD-2008 81388 after 24 hrs by microtitre broth dilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3856229,J Med Chem,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798636,<=,1,1,<=,MIC,ug.mL-1,0.25,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.25
93191,,16743525,CHEMBL3858080,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis isolate CAN-ICU 61589 after 24 hrs by microtitre broth dilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3856229,J Med Chem,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798636,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,1.0
93192,,16743531,CHEMBL3858081,Antibacterial activity against Enterococcus faecalis ATCC 29212 after 24 hrs by microtitre broth dilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3856229,J Med Chem,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798636,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,8.0
93193,,16743537,CHEMBL3858082,Antibacterial activity against Enterococcus faecium ATCC 27270 after 24 hrs by microtitre broth dilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3856229,J Med Chem,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798636,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,8.0
93194,,16743543,CHEMBL3858083,Antibacterial activity against Streptococcus pneumoniae ATCC 49619 after 24 hrs by microtitre broth dilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3856229,J Med Chem,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798636,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,2.0
93195,,16743549,CHEMBL3858084,Antibacterial activity against gentamicin-resistant Escherichia coli isolate CAN-ICU 61714 after 24 hrs by microtitre broth dilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3856229,J Med Chem,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798636,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,8.0
93196,,16743555,CHEMBL3858085,Antibacterial activity against amikacin-resistant Escherichia coli isolate CAN-ICU 63074 after 24 hrs by microtitre broth dilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3856229,J Med Chem,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798636,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,8.0
93197,,16743561,CHEMBL3858086,Antibacterial activity against gentamicin/tobramycin/ciprofloxacin-resistant Escherichia coli isolate CANWARD-2011 97615 harboring AAC3-2A after 24 hrs by microtitre broth dilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3856229,J Med Chem,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798636,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,128.0
93198,,16743567,CHEMBL3858087,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 after 24 hrs by microtitre broth dilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3856229,J Med Chem,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798636,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.5
93199,,16743573,CHEMBL3858088,Antibacterial activity against gentamicin-resistant Pseudomonas aeruginosa isolate CAN-ICU 62308 after 24 hrs by microtitre broth dilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3856229,J Med Chem,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798636,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,16.0
93200,,16743579,CHEMBL3858089,Antibacterial activity against gentamicin/tobramycin-resistant Pseudomonas aeruginosa isolate CANWARD-2011 96846 after 24 hrs by microtitre broth dilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3856229,J Med Chem,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798636,=,1,1,=,MIC,ug.mL-1,256.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,256.0
93201,,16743585,CHEMBL3858090,Antibacterial activity against Stenotrophomonas maltophilia isolate CAN-ICU 62584 after 24 hrs by microtitre broth dilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3856229,J Med Chem,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798636,>,1,1,>,MIC,ug.mL-1,512.0,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,MIC,ug ml-1,UO_0000274,512.0
93202,,16743591,CHEMBL3858091,Antibacterial activity against Acinetobacter baumannii isolate CAN-ICU 63169 after 24 hrs by microtitre broth dilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3856229,J Med Chem,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798636,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,32.0
93203,,16743597,CHEMBL3858092,Antibacterial activity against Klebsiella pneumoniae ATCC 13883 after 24 hrs by microtitre broth dilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3856229,J Med Chem,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798636,<=,1,1,<=,MIC,ug.mL-1,0.25,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.25
93204,,16743608,CHEMBL3858093,Antibacterial activity against multidrug/extremely drug-resistant/colistin-susceptible Pseudomonas aeruginosa isolate 100036,F,BAO_0002146,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3856229,J Med Chem,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798636,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,64.0
93205,,16743620,CHEMBL3858094,Antibacterial activity against multidrug/extremely drug-resistant/colistin-susceptible Pseudomonas aeruginosa isolate 101885,F,BAO_0002146,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3856229,J Med Chem,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798636,<,1,1,<,MIC,ug.mL-1,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.5
93206,,16743632,CHEMBL3858095,Antibacterial activity against multidrug/extremely drug-resistant/colistin-susceptible Pseudomonas aeruginosa isolate 259-96918,F,BAO_0002146,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3856229,J Med Chem,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798636,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,64.0
93207,,16743644,CHEMBL3858096,Antibacterial activity against multidrug/extremely drug-resistant/colistin-susceptible Pseudomonas aeruginosa isolate 260-97103,F,BAO_0002146,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3856229,J Med Chem,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798636,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,32.0
93208,,16743656,CHEMBL3858097,Antibacterial activity against multidrug/extremely drug-resistant/colistin-susceptible Pseudomonas aeruginosa isolate 262-101856,F,BAO_0002146,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3856229,J Med Chem,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798636,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,64.0
93209,,16743668,CHEMBL3858098,Antibacterial activity against multidrug/extremely drug-resistant/colistin-susceptible Pseudomonas aeruginosa isolate 264-104354,F,BAO_0002146,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3856229,J Med Chem,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798636,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,64.0
93210,,16743680,CHEMBL3858099,Antibacterial activity against pandrug-resistant Pseudomonas aeruginosa isolate 91433,F,BAO_0002146,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3856229,J Med Chem,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798636,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,8.0
93211,,16743692,CHEMBL3858100,Antibacterial activity against pandrug-resistant Pseudomonas aeruginosa isolate 101243,F,BAO_0002146,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3856229,J Med Chem,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798636,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,64.0
93212,,16743704,CHEMBL3858101,Antibacterial activity against Pseudomonas aeruginosa PAO1,F,BAO_0002146,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3856229,J Med Chem,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798636,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.5
93213,,16743712,CHEMBL3858076,Antibacterial activity against multidrug-resistant/tobramycin-susceptible Pseudomonas aeruginosa isolate 86052,F,BAO_0002146,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3856229,J Med Chem,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798636,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,1.0
93214,,16743722,CHEMBL3858102,Antibacterial activity against multidrug-resistant/tobramycin-susceptible Pseudomonas aeruginosa isolate 86053,F,BAO_0002146,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3856229,J Med Chem,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798636,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,1.0
93215,,16743732,CHEMBL3858103,Antibacterial activity against multidrug-resistant/tobramycin-susceptible Pseudomonas aeruginosa isolate 86067,F,BAO_0002146,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3856229,J Med Chem,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798636,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,64.0
93216,,16743742,CHEMBL3858104,Antibacterial activity against multidrug-resistant/tobramycin-susceptible Pseudomonas aeruginosa isolate 86079,F,BAO_0002146,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3856229,J Med Chem,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798636,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,2.0
93217,,16743752,CHEMBL3858105,Antibacterial activity against multidrug-resistant/tobramycin-susceptible Pseudomonas aeruginosa isolate 86141,F,BAO_0002146,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3856229,J Med Chem,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798636,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,1.0
93218,,16743762,CHEMBL3858106,Antibacterial activity against multidrug-resistant/tobramycin-susceptible Pseudomonas aeruginosa isolate 92014,F,BAO_0002146,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3856229,J Med Chem,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798636,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,1.0
93219,,16743772,CHEMBL3858107,Antibacterial activity against multidrug-resistant/tobramycin-susceptible Pseudomonas aeruginosa isolate 108590,F,BAO_0002146,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3856229,J Med Chem,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798636,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,4.0
93220,,16743782,CHEMBL3858108,Antibacterial activity against multidrug-resistant/tobramycin-susceptible Pseudomonas aeruginosa isolate 79199,F,BAO_0002146,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3856229,J Med Chem,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798636,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,2.0
93221,,16743792,CHEMBL3858109,Antibacterial activity against multidrug-resistant/tobramycin-susceptible Pseudomonas aeruginosa isolate 80621,F,BAO_0002146,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3856229,J Med Chem,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798636,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,2.0
93222,,16743802,CHEMBL3858110,Antibacterial activity against multidrug-resistant/tobramycin-susceptible Pseudomonas aeruginosa isolate 83182,F,BAO_0002146,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3856229,J Med Chem,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798636,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,1.0
93223,,16743812,CHEMBL3858111,Antibacterial activity against multidrug-resistant/tobramycin-susceptible Pseudomonas aeruginosa isolate 84745,F,BAO_0002146,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3856229,J Med Chem,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798636,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,1.0
93224,,16743822,CHEMBL3858112,Antibacterial activity against multidrug-resistant/tobramycin-susceptible Pseudomonas aeruginosa isolate 85322,F,BAO_0002146,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3856229,J Med Chem,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798636,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,1.0
93225,,16743831,CHEMBL3858113,Antibacterial activity against Escherichia coli ATCC 25922 after 24 hrs by microtitre broth dilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3856229,J Med Chem,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798636,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.5
93226,,16743858,CHEMBL3858138,Antibacterial activity against extremely drug-resistant Pseudomonas aeruginosa isolate 104354 infected in Galleria mellonella assessed as larvae survival at 50 mg/kg administered as single dose measured after 24 hrs (Rvb = 27 %),F,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3856229,J Med Chem,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://qudt.org/vocab/unit#Percent,2798636,=,1,0,=,Survival,%,20.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Survival,%,UO_0000187,20.0
93227,,16743861,CHEMBL3858139,Antibacterial activity against extremely drug-resistant Pseudomonas aeruginosa isolate 104354 infected in Galleria mellonella assessed as larvae survival at 75 mg/kg administered as single dose measured after 96 hrs,F,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3856229,J Med Chem,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://qudt.org/vocab/unit#Percent,2798636,=,1,0,=,Survival,%,0.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Survival,%,UO_0000187,0.0
93228,Dose-dependent effect,16743902,CHEMBL3858179,Induction of cytoplasmic membrane depolarization in Pseudomonas aeruginosa PAO1 by DiSC3(5) dye based fluorescence assay,F,BAO_0000375,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3856229,J Med Chem,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2798636,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
93229,,16743919,CHEMBL3858190,Inhibition of circular DNA translation in Escherichia coli S30 extract after 60 mins by luciferase reporter gene assay,B,BAO_0000190,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3856229,J Med Chem,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/Nanomolar,2798636,=,1,1,=,IC50,nM,6.2,CHEMBL612545,,Unchecked,,,IC50,uM,UO_0000065,0.0062
93230,,16743925,CHEMBL3858192,Ratio of MIC for Pseudomonas aeruginosa PAO1 after 25 serial passages to MIC for Pseudomonas aeruginosa PAO1 prior to 25 serial passages,F,BAO_0000193,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3856229,J Med Chem,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2798636,=,1,0,=,Ratio,,512.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Ratio,,,512.0
93231,,16758113,CHEMBL3861523,Antibacterial activity against Staphylococcus aureus ATCC 25923 by microdilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3860087,J Med Chem,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2801466,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
93232,,16758136,CHEMBL3861524,Antibacterial activity against NorA expressing Staphylococcus aureus 1 by microdilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3860087,J Med Chem,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2801466,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
93233,,16758159,CHEMBL3861525,Antibacterial activity against healthcare-acquired methicillin-resistant Staphylococcus aureus ATCC 33592 by microdilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3860087,J Med Chem,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2801466,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,64.0
93234,,16758182,CHEMBL3861526,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 by microdilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3860087,J Med Chem,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2801466,<,1,1,<,MIC,ug.mL-1,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.25
93235,,16758205,CHEMBL3861527,Antibacterial activity against AAC6'-2A expressing Pseudomonas aeruginosa F03 by microdilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3860087,J Med Chem,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2801466,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,128.0
93236,,16758228,CHEMBL3861528,Antibacterial activity against MexXY expressing Pseudomonas aeruginosa PA22 by microdilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3860087,J Med Chem,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2801466,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.5
93237,,16758251,CHEMBL3861529,Antibacterial activity against triABC deficient Pseudomonas aeruginosa PA406 by microdilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3860087,J Med Chem,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2801466,<,1,1,<,MIC,ug.mL-1,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.25
93238,,16758274,CHEMBL3861530,Antibacterial activity against Acinetobacter lwoffii ATCC 17925 by microdilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3860087,J Med Chem,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2801466,<,1,1,<,MIC,ug.mL-1,0.25,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,MIC,ug ml-1,UO_0000274,0.25
93239,,16758297,CHEMBL3861531,Antibacterial activity against APH3'-VIA expressing Acinetobacter lwoffii AI.88-483 by microdilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3860087,J Med Chem,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2801466,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,MIC,ug ml-1,UO_0000274,0.5
93240,,16758320,CHEMBL3861532,Antibacterial activity against Escherichia coli ATCC 25922 by microdilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3860087,J Med Chem,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2801466,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,1.0
93241,,16758343,CHEMBL3861533,Antibacterial activity against AAC6'-IB expressing Escherichia coli PAZ505H8101 by microdilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3860087,J Med Chem,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2801466,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,32.0
93242,,16758366,CHEMBL3861534,Antibacterial activity against ANT2''-IA expressing Escherichia coli L8058.1 by microdilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3860087,J Med Chem,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2801466,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,64.0
93243,,16758389,CHEMBL3861535,Antibacterial activity against Klebsiella pneumoniae ATCC 700603 by microdilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3860087,J Med Chem,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2801466,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,4.0
93244,See Activity_Supp For Individual Animal Data,17348769,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,ALT,U.L-1,25.8,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,9977.0,ALANINE AMINOTRANSFERASE,u/L,,25.8
93245,See Activity_Supp For Individual Animal Data,17348780,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834704,=,15,1,=,ALB,ug.mL-1,36400.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,9977.0,ALBUMIN,G/DL,UO_0000274,3.64
93246,See Activity_Supp For Individual Animal Data,17348791,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,ALP,U.L-1,233.6,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,9977.0,ALKALINE PHOSPHATASE,u/L,,233.6
93247,See Activity_Supp For Individual Animal Data,17348802,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,AST,U.L-1,81.4,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,9977.0,ASPARTATE AMINOTRANSFERASE,u/L,,81.4
93248,See Activity_Supp For Individual Animal Data,17348813,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834704,=,15,1,=,BUN,ug.mL-1,144.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,9977.0,BLOOD UREA NITROGEN,mg/dL,UO_0000274,14.4
93249,See Activity_Supp For Individual Animal Data,17348824,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,CHLORIDE,mEq.L-1,105.6,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,9977.0,CHLORIDE,MEQ/L,,105.6
93250,See Activity_Supp For Individual Animal Data,17348835,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834704,=,15,1,=,CHOL,ug.mL-1,692.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,9977.0,CHOLESTEROL,mg/dL,UO_0000274,69.2
93251,See Activity_Supp For Individual Animal Data,17348846,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,CK,U.L-1,303.2,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,9977.0,CREATINE PHOSPHOKINASE,u/L,,303.2
93252,See Activity_Supp For Individual Animal Data,17348857,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834704,=,15,1,=,CREAT,ug.mL-1,5.6,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,9977.0,CREATININE,mg/dL,UO_0000274,0.56
93253,See Activity_Supp For Individual Animal Data,17348868,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834704,=,15,1,=,GLUC,ug.mL-1,1254.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,9977.0,GLUCOSE,mg/dL,UO_0000274,125.4
93254,See Activity_Supp For Individual Animal Data,17348879,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,LDH,U.L-1,105.4,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,9977.0,LACTATE DEHYDROGENASE,u/L,,105.4
93255,See Activity_Supp For Individual Animal Data,17348890,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,LIPASE,U.L-1,22.4,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,9977.0,LIPASE,u/L,,22.4
93256,See Activity_Supp For Individual Animal Data,17348901,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834704,=,15,1,=,PHOS,ug.mL-1,114.8,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,9977.0,PHOSPHORUS,mg/dL,UO_0000274,11.48
93257,See Activity_Supp For Individual Animal Data,17348912,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,POTASSIUM,mEq.L-1,5.52,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,9977.0,POTASSIUM,MEQ/L,,5.52
93258,See Activity_Supp For Individual Animal Data,17348923,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,SODIUM,mEq.L-1,147.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,9977.0,SODIUM,MEQ/L,,147.0
93259,See Activity_Supp For Individual Animal Data,17348934,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834704,=,15,1,=,BILI,ug.mL-1,2.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,9977.0,TOTAL BILIRUBIN,mg/dL,UO_0000274,0.2
93260,See Activity_Supp For Individual Animal Data,17348945,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834704,=,15,1,=,PROT,ug.mL-1,61000.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,9977.0,TOTAL PROTEIN,G/DL,UO_0000274,6.1
93261,See Activity_Supp For Individual Animal Data,17348956,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834704,=,15,1,=,URATE,ug.mL-1,10.6,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,9977.0,URIC ACID,mg/dL,UO_0000274,1.06
93262,See Activity_Supp For Individual Animal Data,17348967,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,BASO,cells.uL-1,0.032,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,9977.0,ABSOLUTE BASOPHIL,CELLS/uL,,0.032
93263,See Activity_Supp For Individual Animal Data,17348978,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,EOS,cells.uL-1,0.11,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,9977.0,ABSOLUTE EOSINOPHIL,CELLS/uL,,0.11
93264,See Activity_Supp For Individual Animal Data,17348989,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,LYM,cells.uL-1,6.63,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,9977.0,ABSOLUTE LYMPHOCYTE,CELLS/uL,,6.63
93265,See Activity_Supp For Individual Animal Data,17349000,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,MONO,cells.uL-1,0.14,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,9977.0,ABSOLUTE MONOCYTE,CELLS/uL,,0.14
93266,See Activity_Supp For Individual Animal Data,17349011,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,NEUTSG,cells.uL-1,1.17,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,9977.0,ABSOLUTE SEGMENTED NEUTROPHIL,CELLS/uL,,1.17
93267,See Activity_Supp For Individual Animal Data,17349022,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://qudt.org/vocab/unit#Percent,2834704,=,15,1,=,BASOLE,%,0.38,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,9977.0,BASOPHIL,%,UO_0000187,0.38
93268,See Activity_Supp For Individual Animal Data,17349033,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://qudt.org/vocab/unit#Percent,2834704,=,15,1,=,EOSLE,%,1.28,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,9977.0,EOSINOPHIL,%,UO_0000187,1.28
93269,See Activity_Supp For Individual Animal Data,17349044,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,RBC,cells.uL-1,7450000.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,9977.0,ERYTHROCYTE COUNT,x10E6/uL,,7.45
93270,See Activity_Supp For Individual Animal Data,17349055,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://qudt.org/vocab/unit#Percent,2834704,=,15,1,=,HCT,%,45.74,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,9977.0,HEMATOCRIT,%,UO_0000187,45.74
93271,See Activity_Supp For Individual Animal Data,17349066,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834704,=,15,1,=,HGB,ug.mL-1,147200.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,9977.0,HEMOGLOBIN,G/DL,UO_0000274,14.72
93272,See Activity_Supp For Individual Animal Data,17349077,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,WBC,cells.uL-1,8110.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,9977.0,LEUKOCYTE COUNT,x10E3/uL,,8.11
93273,See Activity_Supp For Individual Animal Data,17349088,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://qudt.org/vocab/unit#Percent,2834704,=,15,1,=,LYMLE,%,81.3,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,9977.0,LYMPHOCYTE,%,UO_0000187,81.3
93274,See Activity_Supp For Individual Animal Data,17349099,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,MCH,pg,19.76,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,9977.0,MEAN CORPUSCULAR HEMOGLOBIN,PG,UO_0000025,19.76
93275,See Activity_Supp For Individual Animal Data,17349110,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834704,=,15,1,=,MCHC,ug.mL-1,321600.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,9977.0,MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION,G/DL,UO_0000274,32.16
93276,See Activity_Supp For Individual Animal Data,17349121,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,MCV,fL,61.38,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,9977.0,MEAN CORPUSCULAR VOLUME,FL,,61.38
93277,See Activity_Supp For Individual Animal Data,17349132,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://qudt.org/vocab/unit#Percent,2834704,=,15,1,=,MONOLE,%,1.76,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,9977.0,MONOCYTE,%,UO_0000187,1.76
93278,See Activity_Supp For Individual Animal Data,17349143,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://qudt.org/vocab/unit#Percent,2834704,=,15,1,=,NEUTLE,%,14.9,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,9977.0,NEUTROPHIL,%,UO_0000187,14.9
93279,See Activity_Supp For Individual Animal Data,17349154,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,PLAT,cells.uL-1,1322400.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,9977.0,PLATELET COUNT,x10E3/uL,,1322.4
93280,See Activity_Supp For Individual Animal Data,17349165,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,ALT,U.L-1,31.6,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,9988.0,ALANINE AMINOTRANSFERASE,u/L,,31.6
93281,See Activity_Supp For Individual Animal Data,17349176,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834704,=,15,1,=,ALB,ug.mL-1,36600.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,9988.0,ALBUMIN,G/DL,UO_0000274,3.66
93282,See Activity_Supp For Individual Animal Data,17349187,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,ALP,U.L-1,228.6,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,9988.0,ALKALINE PHOSPHATASE,u/L,,228.6
93283,See Activity_Supp For Individual Animal Data,17349198,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,AST,U.L-1,79.6,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,9988.0,ASPARTATE AMINOTRANSFERASE,u/L,,79.6
93284,See Activity_Supp For Individual Animal Data,17349209,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834704,=,15,1,=,BUN,ug.mL-1,112.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,9988.0,BLOOD UREA NITROGEN,mg/dL,UO_0000274,11.2
93285,See Activity_Supp For Individual Animal Data,17349220,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,CHLORIDE,mEq.L-1,107.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,9988.0,CHLORIDE,MEQ/L,,107.0
93286,See Activity_Supp For Individual Animal Data,17349231,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834704,=,15,1,=,CHOL,ug.mL-1,570.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,9988.0,CHOLESTEROL,mg/dL,UO_0000274,57.0
93287,See Activity_Supp For Individual Animal Data,17349242,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,CK,U.L-1,233.6,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,9988.0,CREATINE PHOSPHOKINASE,u/L,,233.6
93288,See Activity_Supp For Individual Animal Data,17349253,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834704,=,15,1,=,CREAT,ug.mL-1,5.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,9988.0,CREATININE,mg/dL,UO_0000274,0.5
93289,See Activity_Supp For Individual Animal Data,17349264,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834704,=,15,1,=,GLUC,ug.mL-1,1244.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,9988.0,GLUCOSE,mg/dL,UO_0000274,124.4
93290,See Activity_Supp For Individual Animal Data,17349275,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,LDH,U.L-1,106.4,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,9988.0,LACTATE DEHYDROGENASE,u/L,,106.4
93291,See Activity_Supp For Individual Animal Data,17349286,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,LIPASE,U.L-1,24.4,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,9988.0,LIPASE,u/L,,24.4
93292,See Activity_Supp For Individual Animal Data,17349297,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834704,=,15,1,=,PHOS,ug.mL-1,105.2,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,9988.0,PHOSPHORUS,mg/dL,UO_0000274,10.52
93293,See Activity_Supp For Individual Animal Data,17349308,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,POTASSIUM,mEq.L-1,6.34,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,9988.0,POTASSIUM,MEQ/L,,6.34
93294,See Activity_Supp For Individual Animal Data,17349319,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,SODIUM,mEq.L-1,149.2,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,9988.0,SODIUM,MEQ/L,,149.2
93295,See Activity_Supp For Individual Animal Data,17349330,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834704,=,15,1,=,BILI,ug.mL-1,2.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,9988.0,TOTAL BILIRUBIN,mg/dL,UO_0000274,0.2
93296,See Activity_Supp For Individual Animal Data,17349341,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834704,=,15,1,=,PROT,ug.mL-1,64800.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,9988.0,TOTAL PROTEIN,G/DL,UO_0000274,6.48
93297,See Activity_Supp For Individual Animal Data,17349352,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834704,=,15,1,=,URATE,ug.mL-1,9.4,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,9988.0,URIC ACID,mg/dL,UO_0000274,0.94
93298,See Activity_Supp For Individual Animal Data,17349363,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,BASO,cells.uL-1,0.13,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,9988.0,ABSOLUTE BASOPHIL,CELLS/uL,,0.13
93299,See Activity_Supp For Individual Animal Data,17349374,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,EOS,cells.uL-1,0.14,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,9988.0,ABSOLUTE EOSINOPHIL,CELLS/uL,,0.14
93300,See Activity_Supp For Individual Animal Data,17349385,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,LYM,cells.uL-1,13.53,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,9988.0,ABSOLUTE LYMPHOCYTE,CELLS/uL,,13.53
93301,See Activity_Supp For Individual Animal Data,17349396,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,MONO,cells.uL-1,0.4,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,9988.0,ABSOLUTE MONOCYTE,CELLS/uL,,0.4
93302,See Activity_Supp For Individual Animal Data,17349407,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,NEUTSG,cells.uL-1,2.33,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,9988.0,ABSOLUTE SEGMENTED NEUTROPHIL,CELLS/uL,,2.33
93303,See Activity_Supp For Individual Animal Data,17349418,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://qudt.org/vocab/unit#Percent,2834704,=,15,1,=,BASOLE,%,0.72,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,9988.0,BASOPHIL,%,UO_0000187,0.72
93304,See Activity_Supp For Individual Animal Data,17349429,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://qudt.org/vocab/unit#Percent,2834704,=,15,1,=,EOSLE,%,0.86,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,9988.0,EOSINOPHIL,%,UO_0000187,0.86
93305,See Activity_Supp For Individual Animal Data,17349440,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,RBC,cells.uL-1,7740000.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,9988.0,ERYTHROCYTE COUNT,x10E6/uL,,7.74
93306,See Activity_Supp For Individual Animal Data,17349451,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://qudt.org/vocab/unit#Percent,2834704,=,15,1,=,HCT,%,45.98,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,9988.0,HEMATOCRIT,%,UO_0000187,45.98
93307,See Activity_Supp For Individual Animal Data,17349462,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834704,=,15,1,=,HGB,ug.mL-1,138600.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,9988.0,HEMOGLOBIN,G/DL,UO_0000274,13.86
93308,See Activity_Supp For Individual Animal Data,17349473,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,WBC,cells.uL-1,16610.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,9988.0,LEUKOCYTE COUNT,x10E3/uL,,16.61
93309,See Activity_Supp For Individual Animal Data,17349484,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://qudt.org/vocab/unit#Percent,2834704,=,15,1,=,LYMLE,%,81.34,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,9988.0,LYMPHOCYTE,%,UO_0000187,81.34
93310,See Activity_Supp For Individual Animal Data,17349495,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,MCH,pg,18.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,9988.0,MEAN CORPUSCULAR HEMOGLOBIN,PG,UO_0000025,18.0
93311,See Activity_Supp For Individual Animal Data,17349506,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834704,=,15,1,=,MCHC,ug.mL-1,302200.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,9988.0,MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION,G/DL,UO_0000274,30.22
93312,See Activity_Supp For Individual Animal Data,17349517,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,MCV,fL,59.4,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,9988.0,MEAN CORPUSCULAR VOLUME,FL,,59.4
93313,See Activity_Supp For Individual Animal Data,17349528,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://qudt.org/vocab/unit#Percent,2834704,=,15,1,=,MONOLE,%,2.46,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,9988.0,MONOCYTE,%,UO_0000187,2.46
93314,See Activity_Supp For Individual Animal Data,17349539,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://qudt.org/vocab/unit#Percent,2834704,=,15,1,=,NEUTLE,%,14.14,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,9988.0,NEUTROPHIL,%,UO_0000187,14.14
93315,See Activity_Supp For Individual Animal Data,17349550,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,PLAT,cells.uL-1,1445500.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,9988.0,PLATELET COUNT,x10E3/uL,,1445.5
93316,See Activity_Supp For Individual Animal Data,17349561,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,ALT,U.L-1,30.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,9999.0,ALANINE AMINOTRANSFERASE,u/L,,30.0
93317,See Activity_Supp For Individual Animal Data,17349572,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834704,=,15,1,=,ALB,ug.mL-1,37100.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,9999.0,ALBUMIN,G/DL,UO_0000274,3.71
93318,See Activity_Supp For Individual Animal Data,17349583,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,ALP,U.L-1,186.8,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,9999.0,ALKALINE PHOSPHATASE,u/L,,186.8
93319,See Activity_Supp For Individual Animal Data,17349594,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,AST,U.L-1,78.2,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,9999.0,ASPARTATE AMINOTRANSFERASE,u/L,,78.2
93320,See Activity_Supp For Individual Animal Data,17349605,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834704,=,15,1,=,BUN,ug.mL-1,142.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,9999.0,BLOOD UREA NITROGEN,mg/dL,UO_0000274,14.2
93321,See Activity_Supp For Individual Animal Data,17349616,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,CHLORIDE,mEq.L-1,105.4,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,9999.0,CHLORIDE,MEQ/L,,105.4
93322,See Activity_Supp For Individual Animal Data,17349627,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834704,=,15,1,=,CHOL,ug.mL-1,449.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,9999.0,CHOLESTEROL,mg/dL,UO_0000274,44.9
93323,See Activity_Supp For Individual Animal Data,17349638,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,CK,U.L-1,334.3,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,9999.0,CREATINE PHOSPHOKINASE,u/L,,334.3
93324,See Activity_Supp For Individual Animal Data,17349649,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834704,=,15,1,=,CREAT,ug.mL-1,6.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,9999.0,CREATININE,mg/dL,UO_0000274,0.6
93325,See Activity_Supp For Individual Animal Data,17349660,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834704,=,15,1,=,GLUC,ug.mL-1,1472.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,9999.0,GLUCOSE,mg/dL,UO_0000274,147.2
93326,See Activity_Supp For Individual Animal Data,17349671,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,LDH,U.L-1,123.1,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,9999.0,LACTATE DEHYDROGENASE,u/L,,123.1
93327,See Activity_Supp For Individual Animal Data,17349682,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,LIPASE,U.L-1,9.6,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,9999.0,LIPASE,u/L,,9.6
93328,See Activity_Supp For Individual Animal Data,17349693,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834704,=,15,1,=,PHOS,ug.mL-1,100.1,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,9999.0,PHOSPHORUS,mg/dL,UO_0000274,10.01
93329,See Activity_Supp For Individual Animal Data,17349704,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,POTASSIUM,mEq.L-1,6.57,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,9999.0,POTASSIUM,MEQ/L,,6.57
93330,See Activity_Supp For Individual Animal Data,17349715,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,SODIUM,mEq.L-1,149.5,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,9999.0,SODIUM,MEQ/L,,149.5
93331,See Activity_Supp For Individual Animal Data,17349726,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834704,=,15,1,=,BILI,ug.mL-1,2.1,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,9999.0,TOTAL BILIRUBIN,mg/dL,UO_0000274,0.21
93332,See Activity_Supp For Individual Animal Data,17349737,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834704,=,15,1,=,PROT,ug.mL-1,66600.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,9999.0,TOTAL PROTEIN,G/DL,UO_0000274,6.66
93333,See Activity_Supp For Individual Animal Data,17349748,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834704,=,15,1,=,URATE,ug.mL-1,12.6,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,9999.0,URIC ACID,mg/dL,UO_0000274,1.26
93334,See Activity_Supp For Individual Animal Data,17349759,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,BASO,cells.uL-1,0.091,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,9999.0,ABSOLUTE BASOPHIL,CELLS/uL,,0.091
93335,See Activity_Supp For Individual Animal Data,17349770,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,EOS,cells.uL-1,0.11,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,9999.0,ABSOLUTE EOSINOPHIL,CELLS/uL,,0.11
93336,See Activity_Supp For Individual Animal Data,17349781,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,LYM,cells.uL-1,9.91,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,9999.0,ABSOLUTE LYMPHOCYTE,CELLS/uL,,9.91
93337,See Activity_Supp For Individual Animal Data,17349792,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,MONO,cells.uL-1,0.21,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,9999.0,ABSOLUTE MONOCYTE,CELLS/uL,,0.21
93338,See Activity_Supp For Individual Animal Data,17349803,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,NEUTSG,cells.uL-1,1.56,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,9999.0,ABSOLUTE SEGMENTED NEUTROPHIL,CELLS/uL,,1.56
93339,See Activity_Supp For Individual Animal Data,17349814,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://qudt.org/vocab/unit#Percent,2834704,=,15,1,=,BASOLE,%,0.77,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,9999.0,BASOPHIL,%,UO_0000187,0.77
93340,See Activity_Supp For Individual Animal Data,17349825,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://qudt.org/vocab/unit#Percent,2834704,=,15,1,=,EOSLE,%,0.92,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,9999.0,EOSINOPHIL,%,UO_0000187,0.92
93341,See Activity_Supp For Individual Animal Data,17349836,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,RBC,cells.uL-1,8210000.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,9999.0,ERYTHROCYTE COUNT,x10E6/uL,,8.21
93342,See Activity_Supp For Individual Animal Data,17349847,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://qudt.org/vocab/unit#Percent,2834704,=,15,1,=,HCT,%,47.53,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,9999.0,HEMATOCRIT,%,UO_0000187,47.53
93343,See Activity_Supp For Individual Animal Data,17349858,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834704,=,15,1,=,HGB,ug.mL-1,156500.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,9999.0,HEMOGLOBIN,G/DL,UO_0000274,15.65
93344,See Activity_Supp For Individual Animal Data,17349869,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,WBC,cells.uL-1,11910.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,9999.0,LEUKOCYTE COUNT,x10E3/uL,,11.91
93345,See Activity_Supp For Individual Animal Data,17349880,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://qudt.org/vocab/unit#Percent,2834704,=,15,1,=,LYMLE,%,83.34,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,9999.0,LYMPHOCYTE,%,UO_0000187,83.34
93346,See Activity_Supp For Individual Animal Data,17349891,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,MCH,pg,19.07,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,9999.0,MEAN CORPUSCULAR HEMOGLOBIN,PG,UO_0000025,19.07
93347,See Activity_Supp For Individual Animal Data,17349902,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834704,=,15,1,=,MCHC,ug.mL-1,329300.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,9999.0,MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION,G/DL,UO_0000274,32.93
93348,See Activity_Supp For Individual Animal Data,17349913,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,MCV,fL,57.9,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,9999.0,MEAN CORPUSCULAR VOLUME,FL,,57.9
93349,See Activity_Supp For Individual Animal Data,17349924,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://qudt.org/vocab/unit#Percent,2834704,=,15,1,=,MONOLE,%,1.68,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,9999.0,MONOCYTE,%,UO_0000187,1.68
93350,See Activity_Supp For Individual Animal Data,17349935,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://qudt.org/vocab/unit#Percent,2834704,=,15,1,=,NEUTLE,%,12.97,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,9999.0,NEUTROPHIL,%,UO_0000187,12.97
93351,See Activity_Supp For Individual Animal Data,17349946,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,PLAT,cells.uL-1,1323800.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,9999.0,PLATELET COUNT,x10E3/uL,,1323.8
93352,See Activity_Supp For Individual Animal Data,17350920,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,ALT,U.L-1,32.4,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10028.0,ALANINE AMINOTRANSFERASE,u/L,,32.4
93353,See Activity_Supp For Individual Animal Data,17350921,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834704,=,15,1,=,ALB,ug.mL-1,34200.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10028.0,ALBUMIN,G/DL,UO_0000274,3.42
93354,See Activity_Supp For Individual Animal Data,17350922,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,ALP,U.L-1,217.6,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10028.0,ALKALINE PHOSPHATASE,u/L,,217.6
93355,See Activity_Supp For Individual Animal Data,17350923,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,AST,U.L-1,80.2,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10028.0,ASPARTATE AMINOTRANSFERASE,u/L,,80.2
93356,See Activity_Supp For Individual Animal Data,17350924,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834704,=,15,1,=,BUN,ug.mL-1,148.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10028.0,BLOOD UREA NITROGEN,mg/dL,UO_0000274,14.8
93357,See Activity_Supp For Individual Animal Data,17350925,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,CHLORIDE,mEq.L-1,109.8,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10028.0,CHLORIDE,MEQ/L,,109.8
93358,See Activity_Supp For Individual Animal Data,17350926,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834704,=,15,1,=,CHOL,ug.mL-1,584.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10028.0,CHOLESTEROL,mg/dL,UO_0000274,58.4
93359,See Activity_Supp For Individual Animal Data,17350927,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,CK,U.L-1,257.6,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10028.0,CREATINE PHOSPHOKINASE,u/L,,257.6
93360,See Activity_Supp For Individual Animal Data,17350928,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834704,=,15,1,=,CREAT,ug.mL-1,5.2,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10028.0,CREATININE,mg/dL,UO_0000274,0.52
93361,See Activity_Supp For Individual Animal Data,17350929,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834704,=,15,1,=,GLUC,ug.mL-1,1272.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10028.0,GLUCOSE,mg/dL,UO_0000274,127.2
93362,See Activity_Supp For Individual Animal Data,17350930,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,LDH,U.L-1,84.6,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10028.0,LACTATE DEHYDROGENASE,u/L,,84.6
93363,See Activity_Supp For Individual Animal Data,17350931,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,LIPASE,U.L-1,17.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10028.0,LIPASE,u/L,,17.0
93364,See Activity_Supp For Individual Animal Data,17350932,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834704,=,15,1,=,PHOS,ug.mL-1,102.2,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10028.0,PHOSPHORUS,mg/dL,UO_0000274,10.22
93365,See Activity_Supp For Individual Animal Data,17350933,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,POTASSIUM,mEq.L-1,6.26,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10028.0,POTASSIUM,MEQ/L,,6.26
93366,See Activity_Supp For Individual Animal Data,17350934,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,SODIUM,mEq.L-1,151.2,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10028.0,SODIUM,MEQ/L,,151.2
93367,See Activity_Supp For Individual Animal Data,17350935,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834704,=,15,1,=,BILI,ug.mL-1,1.4,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10028.0,TOTAL BILIRUBIN,mg/dL,UO_0000274,0.14
93368,See Activity_Supp For Individual Animal Data,17350936,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834704,=,15,1,=,PROT,ug.mL-1,58400.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10028.0,TOTAL PROTEIN,G/DL,UO_0000274,5.84
93369,See Activity_Supp For Individual Animal Data,17350937,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834704,=,15,1,=,URATE,ug.mL-1,9.8,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10028.0,URIC ACID,mg/dL,UO_0000274,0.98
93370,See Activity_Supp For Individual Animal Data,17350938,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,BASO,cells.uL-1,0.078,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10028.0,ABSOLUTE BASOPHIL,CELLS/uL,,0.078
93371,See Activity_Supp For Individual Animal Data,17350939,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,EOS,cells.uL-1,0.12,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10028.0,ABSOLUTE EOSINOPHIL,CELLS/uL,,0.12
93372,See Activity_Supp For Individual Animal Data,17350940,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,LYM,cells.uL-1,8.04,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10028.0,ABSOLUTE LYMPHOCYTE,CELLS/uL,,8.04
93373,See Activity_Supp For Individual Animal Data,17350941,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,MONO,cells.uL-1,0.21,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10028.0,ABSOLUTE MONOCYTE,CELLS/uL,,0.21
93374,See Activity_Supp For Individual Animal Data,17350942,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,NEUTSG,cells.uL-1,0.92,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10028.0,ABSOLUTE SEGMENTED NEUTROPHIL,CELLS/uL,,0.92
93375,See Activity_Supp For Individual Animal Data,17350943,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://qudt.org/vocab/unit#Percent,2834704,=,15,1,=,BASOLE,%,0.78,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10028.0,BASOPHIL,%,UO_0000187,0.78
93376,See Activity_Supp For Individual Animal Data,17350944,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://qudt.org/vocab/unit#Percent,2834704,=,15,1,=,EOSLE,%,1.32,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10028.0,EOSINOPHIL,%,UO_0000187,1.32
93377,See Activity_Supp For Individual Animal Data,17350945,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,RBC,cells.uL-1,7610000.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10028.0,ERYTHROCYTE COUNT,x10E6/uL,,7.61
93378,See Activity_Supp For Individual Animal Data,17350946,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://qudt.org/vocab/unit#Percent,2834704,=,15,1,=,HCT,%,45.66,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10028.0,HEMATOCRIT,%,UO_0000187,45.66
93379,See Activity_Supp For Individual Animal Data,17350947,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834704,=,15,1,=,HGB,ug.mL-1,152200.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10028.0,HEMOGLOBIN,G/DL,UO_0000274,15.22
93380,See Activity_Supp For Individual Animal Data,17350948,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,WBC,cells.uL-1,9410.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10028.0,LEUKOCYTE COUNT,x10E3/uL,,9.41
93381,See Activity_Supp For Individual Animal Data,17350949,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://qudt.org/vocab/unit#Percent,2834704,=,15,1,=,LYMLE,%,84.78,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10028.0,LYMPHOCYTE,%,UO_0000187,84.78
93382,See Activity_Supp For Individual Animal Data,17350950,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,MCH,pg,20.04,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10028.0,MEAN CORPUSCULAR HEMOGLOBIN,PG,UO_0000025,20.04
93383,See Activity_Supp For Individual Animal Data,17350951,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834704,=,15,1,=,MCHC,ug.mL-1,333800.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10028.0,MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION,G/DL,UO_0000274,33.38
93384,See Activity_Supp For Individual Animal Data,17350952,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,MCV,fL,60.02,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10028.0,MEAN CORPUSCULAR VOLUME,FL,,60.02
93385,See Activity_Supp For Individual Animal Data,17350953,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://qudt.org/vocab/unit#Percent,2834704,=,15,1,=,MONOLE,%,2.34,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10028.0,MONOCYTE,%,UO_0000187,2.34
93386,See Activity_Supp For Individual Animal Data,17350954,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://qudt.org/vocab/unit#Percent,2834704,=,15,1,=,NEUTLE,%,10.36,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10028.0,NEUTROPHIL,%,UO_0000187,10.36
93387,See Activity_Supp For Individual Animal Data,17350955,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,PLAT,cells.uL-1,1436600.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10028.0,PLATELET COUNT,x10E3/uL,,1436.6
93388,See Activity_Supp For Individual Animal Data,17350956,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,ALT,U.L-1,28.8,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10029.0,ALANINE AMINOTRANSFERASE,u/L,,28.8
93389,See Activity_Supp For Individual Animal Data,17350957,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834704,=,15,1,=,ALB,ug.mL-1,35400.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10029.0,ALBUMIN,G/DL,UO_0000274,3.54
93390,See Activity_Supp For Individual Animal Data,17350958,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,ALP,U.L-1,192.8,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10029.0,ALKALINE PHOSPHATASE,u/L,,192.8
93391,See Activity_Supp For Individual Animal Data,17350959,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,AST,U.L-1,85.8,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10029.0,ASPARTATE AMINOTRANSFERASE,u/L,,85.8
93392,See Activity_Supp For Individual Animal Data,17350960,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834704,=,15,1,=,BUN,ug.mL-1,152.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10029.0,BLOOD UREA NITROGEN,mg/dL,UO_0000274,15.2
93393,See Activity_Supp For Individual Animal Data,17350961,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,CHLORIDE,mEq.L-1,108.8,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10029.0,CHLORIDE,MEQ/L,,108.8
93394,See Activity_Supp For Individual Animal Data,17350962,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834704,=,15,1,=,CHOL,ug.mL-1,558.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10029.0,CHOLESTEROL,mg/dL,UO_0000274,55.8
93395,See Activity_Supp For Individual Animal Data,17350963,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,CK,U.L-1,214.4,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10029.0,CREATINE PHOSPHOKINASE,u/L,,214.4
93396,See Activity_Supp For Individual Animal Data,17350964,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834704,=,15,1,=,CREAT,ug.mL-1,7.4,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10029.0,CREATININE,mg/dL,UO_0000274,0.74
93397,See Activity_Supp For Individual Animal Data,17350965,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834704,=,15,1,=,GLUC,ug.mL-1,1092.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10029.0,GLUCOSE,mg/dL,UO_0000274,109.2
93398,See Activity_Supp For Individual Animal Data,17350966,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,LDH,U.L-1,103.4,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10029.0,LACTATE DEHYDROGENASE,u/L,,103.4
93399,See Activity_Supp For Individual Animal Data,17350967,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,LIPASE,U.L-1,33.8,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10029.0,LIPASE,u/L,,33.8
93400,See Activity_Supp For Individual Animal Data,17350968,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834704,=,15,1,=,PHOS,ug.mL-1,98.8,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10029.0,PHOSPHORUS,mg/dL,UO_0000274,9.88
93401,See Activity_Supp For Individual Animal Data,17350969,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,POTASSIUM,mEq.L-1,5.88,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10029.0,POTASSIUM,MEQ/L,,5.88
93402,See Activity_Supp For Individual Animal Data,17350970,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,SODIUM,mEq.L-1,150.8,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10029.0,SODIUM,MEQ/L,,150.8
93403,See Activity_Supp For Individual Animal Data,17350971,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834704,=,15,1,=,BILI,ug.mL-1,2.2,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10029.0,TOTAL BILIRUBIN,mg/dL,UO_0000274,0.22
93404,See Activity_Supp For Individual Animal Data,17350972,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834704,=,15,1,=,PROT,ug.mL-1,62800.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10029.0,TOTAL PROTEIN,G/DL,UO_0000274,6.28
93405,See Activity_Supp For Individual Animal Data,17350973,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834704,=,15,1,=,URATE,ug.mL-1,9.2,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10029.0,URIC ACID,mg/dL,UO_0000274,0.92
93406,See Activity_Supp For Individual Animal Data,17350974,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,BASO,cells.uL-1,0.12,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10029.0,ABSOLUTE BASOPHIL,CELLS/uL,,0.12
93407,See Activity_Supp For Individual Animal Data,17350975,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,EOS,cells.uL-1,0.06,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10029.0,ABSOLUTE EOSINOPHIL,CELLS/uL,,0.06
93408,See Activity_Supp For Individual Animal Data,17350976,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,LYM,cells.uL-1,7.97,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10029.0,ABSOLUTE LYMPHOCYTE,CELLS/uL,,7.97
93409,See Activity_Supp For Individual Animal Data,17350977,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,MONO,cells.uL-1,0.18,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10029.0,ABSOLUTE MONOCYTE,CELLS/uL,,0.18
93410,See Activity_Supp For Individual Animal Data,17350978,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,NEUTSG,cells.uL-1,0.97,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10029.0,ABSOLUTE SEGMENTED NEUTROPHIL,CELLS/uL,,0.97
93411,See Activity_Supp For Individual Animal Data,17350979,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://qudt.org/vocab/unit#Percent,2834704,=,15,1,=,BASOLE,%,1.16,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10029.0,BASOPHIL,%,UO_0000187,1.16
93412,See Activity_Supp For Individual Animal Data,17350980,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://qudt.org/vocab/unit#Percent,2834704,=,15,1,=,EOSLE,%,0.6,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10029.0,EOSINOPHIL,%,UO_0000187,0.6
93413,See Activity_Supp For Individual Animal Data,17350981,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,RBC,cells.uL-1,7910000.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10029.0,ERYTHROCYTE COUNT,x10E6/uL,,7.91
93414,See Activity_Supp For Individual Animal Data,17350982,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://qudt.org/vocab/unit#Percent,2834704,=,15,1,=,HCT,%,46.26,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10029.0,HEMATOCRIT,%,UO_0000187,46.26
93415,See Activity_Supp For Individual Animal Data,17350983,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834704,=,15,1,=,HGB,ug.mL-1,152200.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10029.0,HEMOGLOBIN,G/DL,UO_0000274,15.22
93416,See Activity_Supp For Individual Animal Data,17350984,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,WBC,cells.uL-1,9340.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10029.0,LEUKOCYTE COUNT,x10E3/uL,,9.34
93417,See Activity_Supp For Individual Animal Data,17350985,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://qudt.org/vocab/unit#Percent,2834704,=,15,1,=,LYMLE,%,85.08,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10029.0,LYMPHOCYTE,%,UO_0000187,85.08
93418,See Activity_Supp For Individual Animal Data,17350986,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,MCH,pg,19.22,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10029.0,MEAN CORPUSCULAR HEMOGLOBIN,PG,UO_0000025,19.22
93419,See Activity_Supp For Individual Animal Data,17350987,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834704,=,15,1,=,MCHC,ug.mL-1,329000.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10029.0,MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION,G/DL,UO_0000274,32.9
93420,See Activity_Supp For Individual Animal Data,17350988,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,MCV,fL,58.56,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10029.0,MEAN CORPUSCULAR VOLUME,FL,,58.56
93421,See Activity_Supp For Individual Animal Data,17350989,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://qudt.org/vocab/unit#Percent,2834704,=,15,1,=,MONOLE,%,2.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10029.0,MONOCYTE,%,UO_0000187,2.0
93422,See Activity_Supp For Individual Animal Data,17350990,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://qudt.org/vocab/unit#Percent,2834704,=,15,1,=,NEUTLE,%,10.74,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10029.0,NEUTROPHIL,%,UO_0000187,10.74
93423,See Activity_Supp For Individual Animal Data,17350991,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,PLAT,cells.uL-1,1248400.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10029.0,PLATELET COUNT,x10E3/uL,,1248.4
93424,See Activity_Supp For Individual Animal Data,17350992,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,ALT,U.L-1,28.5,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10030.0,ALANINE AMINOTRANSFERASE,u/L,,28.5
93425,See Activity_Supp For Individual Animal Data,17350993,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834704,=,15,1,=,ALB,ug.mL-1,35600.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10030.0,ALBUMIN,G/DL,UO_0000274,3.56
93426,See Activity_Supp For Individual Animal Data,17350994,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,ALP,U.L-1,137.2,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10030.0,ALKALINE PHOSPHATASE,u/L,,137.2
93427,See Activity_Supp For Individual Animal Data,17350995,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,AST,U.L-1,79.3,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10030.0,ASPARTATE AMINOTRANSFERASE,u/L,,79.3
93428,See Activity_Supp For Individual Animal Data,17350996,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834704,=,15,1,=,BUN,ug.mL-1,163.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10030.0,BLOOD UREA NITROGEN,mg/dL,UO_0000274,16.3
93429,See Activity_Supp For Individual Animal Data,17350997,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,CHLORIDE,mEq.L-1,108.2,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10030.0,CHLORIDE,MEQ/L,,108.2
93430,See Activity_Supp For Individual Animal Data,17350998,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834704,=,15,1,=,CHOL,ug.mL-1,594.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10030.0,CHOLESTEROL,mg/dL,UO_0000274,59.4
93431,See Activity_Supp For Individual Animal Data,17350999,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,CK,U.L-1,132.4,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10030.0,CREATINE PHOSPHOKINASE,u/L,,132.4
93432,See Activity_Supp For Individual Animal Data,17351000,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834704,=,15,1,=,CREAT,ug.mL-1,6.8,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10030.0,CREATININE,mg/dL,UO_0000274,0.68
93433,See Activity_Supp For Individual Animal Data,17351001,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834704,=,15,1,=,GLUC,ug.mL-1,1272.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10030.0,GLUCOSE,mg/dL,UO_0000274,127.2
93434,See Activity_Supp For Individual Animal Data,17351002,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,LDH,U.L-1,83.6,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10030.0,LACTATE DEHYDROGENASE,u/L,,83.6
93435,See Activity_Supp For Individual Animal Data,17351003,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,LIPASE,U.L-1,12.4,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10030.0,LIPASE,u/L,,12.4
93436,See Activity_Supp For Individual Animal Data,17351004,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834704,=,15,1,=,PHOS,ug.mL-1,83.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10030.0,PHOSPHORUS,mg/dL,UO_0000274,8.3
93437,See Activity_Supp For Individual Animal Data,17351005,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,POTASSIUM,mEq.L-1,5.48,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10030.0,POTASSIUM,MEQ/L,,5.48
93438,See Activity_Supp For Individual Animal Data,17351006,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,SODIUM,mEq.L-1,152.3,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10030.0,SODIUM,MEQ/L,,152.3
93439,See Activity_Supp For Individual Animal Data,17351007,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834704,=,15,1,=,BILI,ug.mL-1,1.8,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10030.0,TOTAL BILIRUBIN,mg/dL,UO_0000274,0.18
93440,See Activity_Supp For Individual Animal Data,17351008,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834704,=,15,1,=,PROT,ug.mL-1,65300.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10030.0,TOTAL PROTEIN,G/DL,UO_0000274,6.53
93441,See Activity_Supp For Individual Animal Data,17351009,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834704,=,15,1,=,URATE,ug.mL-1,9.6,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10030.0,URIC ACID,mg/dL,UO_0000274,0.96
93442,See Activity_Supp For Individual Animal Data,17351010,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,BASO,cells.uL-1,0.11,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10030.0,ABSOLUTE BASOPHIL,CELLS/uL,,0.11
93443,See Activity_Supp For Individual Animal Data,17351011,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,EOS,cells.uL-1,0.14,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10030.0,ABSOLUTE EOSINOPHIL,CELLS/uL,,0.14
93444,See Activity_Supp For Individual Animal Data,17351012,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,LYM,cells.uL-1,11.02,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10030.0,ABSOLUTE LYMPHOCYTE,CELLS/uL,,11.02
93445,See Activity_Supp For Individual Animal Data,17351013,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,MONO,cells.uL-1,0.27,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10030.0,ABSOLUTE MONOCYTE,CELLS/uL,,0.27
93446,See Activity_Supp For Individual Animal Data,17351014,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,NEUTSG,cells.uL-1,2.01,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10030.0,ABSOLUTE SEGMENTED NEUTROPHIL,CELLS/uL,,2.01
93447,See Activity_Supp For Individual Animal Data,17351015,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://qudt.org/vocab/unit#Percent,2834704,=,15,1,=,BASOLE,%,0.75,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10030.0,BASOPHIL,%,UO_0000187,0.75
93448,See Activity_Supp For Individual Animal Data,17351016,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://qudt.org/vocab/unit#Percent,2834704,=,15,1,=,EOSLE,%,1.01,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10030.0,EOSINOPHIL,%,UO_0000187,1.01
93449,See Activity_Supp For Individual Animal Data,17351017,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,RBC,cells.uL-1,8160000.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10030.0,ERYTHROCYTE COUNT,x10E6/uL,,8.16
93450,See Activity_Supp For Individual Animal Data,17351018,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://qudt.org/vocab/unit#Percent,2834704,=,15,1,=,HCT,%,47.35,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10030.0,HEMATOCRIT,%,UO_0000187,47.35
93451,See Activity_Supp For Individual Animal Data,17351019,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834704,=,15,1,=,HGB,ug.mL-1,155600.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10030.0,HEMOGLOBIN,G/DL,UO_0000274,15.56
93452,See Activity_Supp For Individual Animal Data,17351020,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,WBC,cells.uL-1,13610.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10030.0,LEUKOCYTE COUNT,x10E3/uL,,13.61
93453,See Activity_Supp For Individual Animal Data,17351021,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://qudt.org/vocab/unit#Percent,2834704,=,15,1,=,LYMLE,%,82.08,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10030.0,LYMPHOCYTE,%,UO_0000187,82.08
93454,See Activity_Supp For Individual Animal Data,17351022,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,MCH,pg,19.08,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10030.0,MEAN CORPUSCULAR HEMOGLOBIN,PG,UO_0000025,19.08
93455,See Activity_Supp For Individual Animal Data,17351023,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834704,=,15,1,=,MCHC,ug.mL-1,328700.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10030.0,MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION,G/DL,UO_0000274,32.87
93456,See Activity_Supp For Individual Animal Data,17351024,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,MCV,fL,58.02,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10030.0,MEAN CORPUSCULAR VOLUME,FL,,58.02
93457,See Activity_Supp For Individual Animal Data,17351025,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://qudt.org/vocab/unit#Percent,2834704,=,15,1,=,MONOLE,%,1.93,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10030.0,MONOCYTE,%,UO_0000187,1.93
93458,See Activity_Supp For Individual Animal Data,17351026,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://qudt.org/vocab/unit#Percent,2834704,=,15,1,=,NEUTLE,%,13.77,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10030.0,NEUTROPHIL,%,UO_0000187,13.77
93459,See Activity_Supp For Individual Animal Data,17351027,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,PLAT,cells.uL-1,1300900.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10030.0,PLATELET COUNT,x10E3/uL,,1300.9
93460,See Activity_Supp For Individual Animal Data,17354525,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,ALT,U.L-1,20.5,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10153.0,ALANINE AMINOTRANSFERASE,u/L,,20.5
93461,See Activity_Supp For Individual Animal Data,17354531,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834704,=,15,1,=,ALB,ug.mL-1,43500.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10153.0,ALBUMIN,G/DL,UO_0000274,4.35
93462,See Activity_Supp For Individual Animal Data,17354537,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,AST,U.L-1,86.75,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10153.0,ASPARTATE AMINOTRANSFERASE,u/L,,86.75
93463,See Activity_Supp For Individual Animal Data,17354543,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834704,=,15,1,=,BUN,ug.mL-1,170.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10153.0,BLOOD UREA NITROGEN,mg/dL,UO_0000274,17.0
93464,See Activity_Supp For Individual Animal Data,17354549,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/Nanomolar,2834704,=,15,1,=,CO2,nM,29000000.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10153.0,CARBON DIOXIDE,MMOL/L,UO_0000065,29.0
93465,See Activity_Supp For Individual Animal Data,17354555,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,CHLORIDE,mEq.L-1,106.25,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10153.0,CHLORIDE,MEQ/L,,106.25
93466,See Activity_Supp For Individual Animal Data,17354561,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834704,=,15,1,=,CHOL,ug.mL-1,512.5,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10153.0,CHOLESTEROL,mg/dL,UO_0000274,51.25
93467,See Activity_Supp For Individual Animal Data,17354567,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,CK,U.L-1,384.75,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10153.0,CREATINE PHOSPHOKINASE,u/L,,384.75
93468,See Activity_Supp For Individual Animal Data,17354573,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834704,=,15,1,=,CREAT,ug.mL-1,4.7,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10153.0,CREATININE,mg/dL,UO_0000274,0.47
93469,See Activity_Supp For Individual Animal Data,17354579,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834704,=,15,1,=,GLUC,ug.mL-1,1287.5,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10153.0,GLUCOSE,mg/dL,UO_0000274,128.75
93470,See Activity_Supp For Individual Animal Data,17354585,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,LDH,U.L-1,145.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10153.0,LACTATE DEHYDROGENASE,u/L,,145.0
93471,See Activity_Supp For Individual Animal Data,17354591,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,LIPASE,U.L-1,13.25,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10153.0,LIPASE,u/L,,13.25
93472,See Activity_Supp For Individual Animal Data,17354597,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834704,=,15,1,=,PHOS,ug.mL-1,118.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10153.0,PHOSPHORUS,mg/dL,UO_0000274,11.8
93473,See Activity_Supp For Individual Animal Data,17354603,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,POTASSIUM,mEq.L-1,6.58,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10153.0,POTASSIUM,MEQ/L,,6.58
93474,See Activity_Supp For Individual Animal Data,17354609,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,SODIUM,mEq.L-1,151.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10153.0,SODIUM,MEQ/L,,151.0
93475,See Activity_Supp For Individual Animal Data,17354615,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834704,=,15,1,=,BILI,ug.mL-1,3.3,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10153.0,TOTAL BILIRUBIN,mg/dL,UO_0000274,0.33
93476,See Activity_Supp For Individual Animal Data,17354621,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834704,=,15,1,=,PROT,ug.mL-1,65300.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10153.0,TOTAL PROTEIN,G/DL,UO_0000274,6.53
93477,See Activity_Supp For Individual Animal Data,17354627,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834704,=,15,1,=,URATE,ug.mL-1,19.5,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10153.0,URIC ACID,mg/dL,UO_0000274,1.95
93478,See Activity_Supp For Individual Animal Data,17354633,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://qudt.org/vocab/unit#Percent,2834704,=,15,1,=,BASOLE,%,0.35,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10153.0,BASOPHIL,%,UO_0000187,0.35
93479,See Activity_Supp For Individual Animal Data,17354639,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://qudt.org/vocab/unit#Percent,2834704,=,15,1,=,EOSLE,%,0.62,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10153.0,EOSINOPHIL,%,UO_0000187,0.62
93480,See Activity_Supp For Individual Animal Data,17354645,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,RBC,cells.uL-1,7260000.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10153.0,ERYTHROCYTE COUNT,x10E6/uL,,7.26
93481,See Activity_Supp For Individual Animal Data,17354651,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://qudt.org/vocab/unit#Percent,2834704,=,15,1,=,HCT,%,47.97,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10153.0,HEMATOCRIT,%,UO_0000187,47.97
93482,See Activity_Supp For Individual Animal Data,17354657,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834704,=,15,1,=,HGB,ug.mL-1,153800.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10153.0,HEMOGLOBIN,G/DL,UO_0000274,15.38
93483,See Activity_Supp For Individual Animal Data,17354663,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,WBC,cells.uL-1,8680.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10153.0,LEUKOCYTE COUNT,x10E3/uL,,8.68
93484,See Activity_Supp For Individual Animal Data,17354669,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://qudt.org/vocab/unit#Percent,2834704,=,15,1,=,LYMLE,%,86.77,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10153.0,LYMPHOCYTE,%,UO_0000187,86.77
93485,See Activity_Supp For Individual Animal Data,17354675,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,MCH,pg,21.18,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10153.0,MEAN CORPUSCULAR HEMOGLOBIN,PG,UO_0000025,21.18
93486,See Activity_Supp For Individual Animal Data,17354681,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834704,=,15,1,=,MCHC,ug.mL-1,320500.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10153.0,MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION,G/DL,UO_0000274,32.05
93487,See Activity_Supp For Individual Animal Data,17354687,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,MCV,fL,66.15,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10153.0,MEAN CORPUSCULAR VOLUME,FL,,66.15
93488,See Activity_Supp For Individual Animal Data,17354693,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://qudt.org/vocab/unit#Percent,2834704,=,15,1,=,MONOLE,%,1.57,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10153.0,MONOCYTE,%,UO_0000187,1.57
93489,See Activity_Supp For Individual Animal Data,17354699,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://qudt.org/vocab/unit#Percent,2834704,=,15,1,=,NEUTLE,%,9.53,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10153.0,NEUTROPHIL,%,UO_0000187,9.53
93490,See Activity_Supp For Individual Animal Data,17354705,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,PLAT,cells.uL-1,1786000.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10153.0,PLATELET COUNT,x10E3/uL,,1786.0
93491,See Activity_Supp For Individual Animal Data,17354711,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,ALP,U.L-1,300.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10153.0,ALKALINE PHOSPHATASE,u/L,,300.0
93492,See Activity_Supp For Individual Animal Data,17354717,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,ALT,U.L-1,24.5,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10159.0,ALANINE AMINOTRANSFERASE,u/L,,24.5
93493,See Activity_Supp For Individual Animal Data,17354723,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834704,=,15,1,=,ALB,ug.mL-1,40500.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10159.0,ALBUMIN,G/DL,UO_0000274,4.05
93494,See Activity_Supp For Individual Animal Data,17354729,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,ALP,U.L-1,204.75,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10159.0,ALKALINE PHOSPHATASE,u/L,,204.75
93495,See Activity_Supp For Individual Animal Data,17354735,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,AST,U.L-1,86.5,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10159.0,ASPARTATE AMINOTRANSFERASE,u/L,,86.5
93496,See Activity_Supp For Individual Animal Data,17354741,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834704,=,15,1,=,BUN,ug.mL-1,127.5,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10159.0,BLOOD UREA NITROGEN,mg/dL,UO_0000274,12.75
93497,See Activity_Supp For Individual Animal Data,17354747,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/Nanomolar,2834704,=,15,1,=,CO2,nM,25000000.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10159.0,CARBON DIOXIDE,MMOL/L,UO_0000065,25.0
93498,See Activity_Supp For Individual Animal Data,17354753,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,CHLORIDE,mEq.L-1,106.5,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10159.0,CHLORIDE,MEQ/L,,106.5
93499,See Activity_Supp For Individual Animal Data,17354759,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834704,=,15,1,=,CHOL,ug.mL-1,517.5,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10159.0,CHOLESTEROL,mg/dL,UO_0000274,51.75
93500,See Activity_Supp For Individual Animal Data,17354765,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,CK,U.L-1,410.25,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10159.0,CREATINE PHOSPHOKINASE,u/L,,410.25
93501,See Activity_Supp For Individual Animal Data,17354771,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834704,=,15,1,=,CREAT,ug.mL-1,4.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10159.0,CREATININE,mg/dL,UO_0000274,0.4
93502,See Activity_Supp For Individual Animal Data,17354777,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834704,=,15,1,=,GLUC,ug.mL-1,1130.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10159.0,GLUCOSE,mg/dL,UO_0000274,113.0
93503,See Activity_Supp For Individual Animal Data,17354783,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,LDH,U.L-1,267.5,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10159.0,LACTATE DEHYDROGENASE,u/L,,267.5
93504,See Activity_Supp For Individual Animal Data,17354789,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,LIPASE,U.L-1,10.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10159.0,LIPASE,u/L,,10.0
93505,See Activity_Supp For Individual Animal Data,17354795,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834704,=,15,1,=,PHOS,ug.mL-1,124.7,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10159.0,PHOSPHORUS,mg/dL,UO_0000274,12.47
93506,See Activity_Supp For Individual Animal Data,17354801,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,POTASSIUM,mEq.L-1,5.8,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10159.0,POTASSIUM,MEQ/L,,5.8
93507,See Activity_Supp For Individual Animal Data,17354807,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,SODIUM,mEq.L-1,148.5,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10159.0,SODIUM,MEQ/L,,148.5
93508,See Activity_Supp For Individual Animal Data,17354813,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834704,=,15,1,=,BILI,ug.mL-1,1.5,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10159.0,TOTAL BILIRUBIN,mg/dL,UO_0000274,0.15
93509,See Activity_Supp For Individual Animal Data,17354819,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834704,=,15,1,=,PROT,ug.mL-1,61700.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10159.0,TOTAL PROTEIN,G/DL,UO_0000274,6.17
93510,See Activity_Supp For Individual Animal Data,17354825,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834704,=,15,1,=,URATE,ug.mL-1,15.7,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10159.0,URIC ACID,mg/dL,UO_0000274,1.57
93511,See Activity_Supp For Individual Animal Data,17354831,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://qudt.org/vocab/unit#Percent,2834704,=,15,1,=,BASOLE,%,0.6,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10159.0,BASOPHIL,%,UO_0000187,0.6
93512,See Activity_Supp For Individual Animal Data,17354837,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://qudt.org/vocab/unit#Percent,2834704,=,15,1,=,EOSLE,%,0.68,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10159.0,EOSINOPHIL,%,UO_0000187,0.68
93513,See Activity_Supp For Individual Animal Data,17354843,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,RBC,cells.uL-1,7480000.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10159.0,ERYTHROCYTE COUNT,x10E6/uL,,7.48
93514,See Activity_Supp For Individual Animal Data,17354849,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://qudt.org/vocab/unit#Percent,2834704,=,15,1,=,HCT,%,45.98,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10159.0,HEMATOCRIT,%,UO_0000187,45.98
93515,See Activity_Supp For Individual Animal Data,17354855,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834704,=,15,1,=,HGB,ug.mL-1,151700.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10159.0,HEMOGLOBIN,G/DL,UO_0000274,15.17
93516,See Activity_Supp For Individual Animal Data,17354861,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,WBC,cells.uL-1,12190.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10159.0,LEUKOCYTE COUNT,x10E3/uL,,12.19
93517,See Activity_Supp For Individual Animal Data,17354867,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://qudt.org/vocab/unit#Percent,2834704,=,15,1,=,LYMLE,%,85.22,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10159.0,LYMPHOCYTE,%,UO_0000187,85.22
93518,See Activity_Supp For Individual Animal Data,17354873,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,MCH,pg,20.27,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10159.0,MEAN CORPUSCULAR HEMOGLOBIN,PG,UO_0000025,20.27
93519,See Activity_Supp For Individual Animal Data,17354879,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834704,=,15,1,=,MCHC,ug.mL-1,330000.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10159.0,MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION,G/DL,UO_0000274,33.0
93520,See Activity_Supp For Individual Animal Data,17354885,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,MCV,fL,61.53,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10159.0,MEAN CORPUSCULAR VOLUME,FL,,61.53
93521,See Activity_Supp For Individual Animal Data,17354891,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://qudt.org/vocab/unit#Percent,2834704,=,15,1,=,MONOLE,%,1.38,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10159.0,MONOCYTE,%,UO_0000187,1.38
93522,See Activity_Supp For Individual Animal Data,17354897,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://qudt.org/vocab/unit#Percent,2834704,=,15,1,=,NEUTLE,%,10.35,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10159.0,NEUTROPHIL,%,UO_0000187,10.35
93523,See Activity_Supp For Individual Animal Data,17354903,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,PLAT,cells.uL-1,1359250.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10159.0,PLATELET COUNT,x10E3/uL,,1359.25
93524,See Activity_Supp For Individual Animal Data,17354968,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,ALT,U.L-1,20.5,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10162.0,ALANINE AMINOTRANSFERASE,u/L,,20.5
93525,See Activity_Supp For Individual Animal Data,17354969,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834704,=,15,1,=,ALB,ug.mL-1,41700.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10162.0,ALBUMIN,G/DL,UO_0000274,4.17
93526,See Activity_Supp For Individual Animal Data,17354970,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,ALP,U.L-1,314.25,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10162.0,ALKALINE PHOSPHATASE,u/L,,314.25
93527,See Activity_Supp For Individual Animal Data,17354971,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,AST,U.L-1,91.75,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10162.0,ASPARTATE AMINOTRANSFERASE,u/L,,91.75
93528,See Activity_Supp For Individual Animal Data,17354972,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834704,=,15,1,=,BUN,ug.mL-1,152.5,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10162.0,BLOOD UREA NITROGEN,mg/dL,UO_0000274,15.25
93529,See Activity_Supp For Individual Animal Data,17354973,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/Nanomolar,2834704,=,15,1,=,CO2,nM,25750000.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10162.0,CARBON DIOXIDE,MMOL/L,UO_0000065,25.75
93530,See Activity_Supp For Individual Animal Data,17354974,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,CHLORIDE,mEq.L-1,108.25,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10162.0,CHLORIDE,MEQ/L,,108.25
93531,See Activity_Supp For Individual Animal Data,17354975,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834704,=,15,1,=,CHOL,ug.mL-1,560.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10162.0,CHOLESTEROL,mg/dL,UO_0000274,56.0
93532,See Activity_Supp For Individual Animal Data,17354976,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,CK,U.L-1,601.5,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10162.0,CREATINE PHOSPHOKINASE,u/L,,601.5
93533,See Activity_Supp For Individual Animal Data,17354977,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834704,=,15,1,=,CREAT,ug.mL-1,5.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10162.0,CREATININE,mg/dL,UO_0000274,0.5
93534,See Activity_Supp For Individual Animal Data,17354978,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834704,=,15,1,=,GLUC,ug.mL-1,1217.5,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10162.0,GLUCOSE,mg/dL,UO_0000274,121.75
93535,See Activity_Supp For Individual Animal Data,17354979,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,LDH,U.L-1,185.75,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10162.0,LACTATE DEHYDROGENASE,u/L,,185.75
93536,See Activity_Supp For Individual Animal Data,17354980,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,LIPASE,U.L-1,8.25,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10162.0,LIPASE,u/L,,8.25
93537,See Activity_Supp For Individual Animal Data,17354981,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834704,=,15,1,=,PHOS,ug.mL-1,120.3,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10162.0,PHOSPHORUS,mg/dL,UO_0000274,12.03
93538,See Activity_Supp For Individual Animal Data,17354982,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,POTASSIUM,mEq.L-1,5.68,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10162.0,POTASSIUM,MEQ/L,,5.68
93539,See Activity_Supp For Individual Animal Data,17354983,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,SODIUM,mEq.L-1,152.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10162.0,SODIUM,MEQ/L,,152.0
93540,See Activity_Supp For Individual Animal Data,17354984,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834704,=,15,1,=,BILI,ug.mL-1,3.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10162.0,TOTAL BILIRUBIN,mg/dL,UO_0000274,0.3
93541,See Activity_Supp For Individual Animal Data,17354985,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834704,=,15,1,=,PROT,ug.mL-1,63800.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10162.0,TOTAL PROTEIN,G/DL,UO_0000274,6.38
93542,See Activity_Supp For Individual Animal Data,17354986,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834704,=,15,1,=,URATE,ug.mL-1,18.2,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10162.0,URIC ACID,mg/dL,UO_0000274,1.82
93543,See Activity_Supp For Individual Animal Data,17354987,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://qudt.org/vocab/unit#Percent,2834704,=,15,1,=,BASOLE,%,0.42,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10162.0,BASOPHIL,%,UO_0000187,0.42
93544,See Activity_Supp For Individual Animal Data,17354988,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://qudt.org/vocab/unit#Percent,2834704,=,15,1,=,EOSLE,%,0.7,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10162.0,EOSINOPHIL,%,UO_0000187,0.7
93545,See Activity_Supp For Individual Animal Data,17354989,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,RBC,cells.uL-1,7290000.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10162.0,ERYTHROCYTE COUNT,x10E6/uL,,7.29
93546,See Activity_Supp For Individual Animal Data,17354990,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://qudt.org/vocab/unit#Percent,2834704,=,15,1,=,HCT,%,46.27,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10162.0,HEMATOCRIT,%,UO_0000187,46.27
93547,See Activity_Supp For Individual Animal Data,17354991,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834704,=,15,1,=,HGB,ug.mL-1,149200.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10162.0,HEMOGLOBIN,G/DL,UO_0000274,14.92
93548,See Activity_Supp For Individual Animal Data,17354992,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,WBC,cells.uL-1,6740.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10162.0,LEUKOCYTE COUNT,x10E3/uL,,6.74
93549,See Activity_Supp For Individual Animal Data,17354993,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://qudt.org/vocab/unit#Percent,2834704,=,15,1,=,LYMLE,%,87.65,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10162.0,LYMPHOCYTE,%,UO_0000187,87.65
93550,See Activity_Supp For Individual Animal Data,17354994,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,MCH,pg,20.48,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10162.0,MEAN CORPUSCULAR HEMOGLOBIN,PG,UO_0000025,20.48
93551,See Activity_Supp For Individual Animal Data,17354995,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834704,=,15,1,=,MCHC,ug.mL-1,322500.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10162.0,MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION,G/DL,UO_0000274,32.25
93552,See Activity_Supp For Individual Animal Data,17354996,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,MCV,fL,63.45,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10162.0,MEAN CORPUSCULAR VOLUME,FL,,63.45
93553,See Activity_Supp For Individual Animal Data,17354997,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://qudt.org/vocab/unit#Percent,2834704,=,15,1,=,MONOLE,%,1.52,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10162.0,MONOCYTE,%,UO_0000187,1.52
93554,See Activity_Supp For Individual Animal Data,17354998,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://qudt.org/vocab/unit#Percent,2834704,=,15,1,=,NEUTLE,%,8.62,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10162.0,NEUTROPHIL,%,UO_0000187,8.62
93555,See Activity_Supp For Individual Animal Data,17354999,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,PLAT,cells.uL-1,1523000.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10162.0,PLATELET COUNT,x10E3/uL,,1523.0
93556,See Activity_Supp For Individual Animal Data,17355000,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,ALT,U.L-1,27.25,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10163.0,ALANINE AMINOTRANSFERASE,u/L,,27.25
93557,See Activity_Supp For Individual Animal Data,17355001,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834704,=,15,1,=,ALB,ug.mL-1,38800.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10163.0,ALBUMIN,G/DL,UO_0000274,3.88
93558,See Activity_Supp For Individual Animal Data,17355002,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,ALP,U.L-1,236.5,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10163.0,ALKALINE PHOSPHATASE,u/L,,236.5
93559,See Activity_Supp For Individual Animal Data,17355003,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,AST,U.L-1,89.5,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10163.0,ASPARTATE AMINOTRANSFERASE,u/L,,89.5
93560,See Activity_Supp For Individual Animal Data,17355004,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834704,=,15,1,=,BUN,ug.mL-1,132.5,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10163.0,BLOOD UREA NITROGEN,mg/dL,UO_0000274,13.25
93561,See Activity_Supp For Individual Animal Data,17355005,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/Nanomolar,2834704,=,15,1,=,CO2,nM,24000000.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10163.0,CARBON DIOXIDE,MMOL/L,UO_0000065,24.0
93562,See Activity_Supp For Individual Animal Data,17355006,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,CHLORIDE,mEq.L-1,105.5,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10163.0,CHLORIDE,MEQ/L,,105.5
93563,See Activity_Supp For Individual Animal Data,17355007,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834704,=,15,1,=,CHOL,ug.mL-1,557.5,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10163.0,CHOLESTEROL,mg/dL,UO_0000274,55.75
93564,See Activity_Supp For Individual Animal Data,17355008,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,CK,U.L-1,349.5,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10163.0,CREATINE PHOSPHOKINASE,u/L,,349.5
93565,See Activity_Supp For Individual Animal Data,17355009,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834704,=,15,1,=,CREAT,ug.mL-1,5.5,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10163.0,CREATININE,mg/dL,UO_0000274,0.55
93566,See Activity_Supp For Individual Animal Data,17355010,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834704,=,15,1,=,GLUC,ug.mL-1,1182.5,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10163.0,GLUCOSE,mg/dL,UO_0000274,118.25
93567,See Activity_Supp For Individual Animal Data,17355011,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,LDH,U.L-1,195.25,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10163.0,LACTATE DEHYDROGENASE,u/L,,195.25
93568,See Activity_Supp For Individual Animal Data,17355012,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,LIPASE,U.L-1,12.25,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10163.0,LIPASE,u/L,,12.25
93569,See Activity_Supp For Individual Animal Data,17355013,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834704,=,15,1,=,PHOS,ug.mL-1,135.8,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10163.0,PHOSPHORUS,mg/dL,UO_0000274,13.58
93570,See Activity_Supp For Individual Animal Data,17355014,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,POTASSIUM,mEq.L-1,5.65,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10163.0,POTASSIUM,MEQ/L,,5.65
93571,See Activity_Supp For Individual Animal Data,17355015,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,SODIUM,mEq.L-1,149.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10163.0,SODIUM,MEQ/L,,149.0
93572,See Activity_Supp For Individual Animal Data,17355016,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834704,=,15,1,=,BILI,ug.mL-1,2.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10163.0,TOTAL BILIRUBIN,mg/dL,UO_0000274,0.2
93573,See Activity_Supp For Individual Animal Data,17355017,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834704,=,15,1,=,PROT,ug.mL-1,60000.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10163.0,TOTAL PROTEIN,G/DL,UO_0000274,6.0
93574,See Activity_Supp For Individual Animal Data,17355018,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834704,=,15,1,=,URATE,ug.mL-1,18.2,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10163.0,URIC ACID,mg/dL,UO_0000274,1.82
93575,See Activity_Supp For Individual Animal Data,17355019,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://qudt.org/vocab/unit#Percent,2834704,=,15,1,=,BASOLE,%,0.57,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10163.0,BASOPHIL,%,UO_0000187,0.57
93576,See Activity_Supp For Individual Animal Data,17355020,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://qudt.org/vocab/unit#Percent,2834704,=,15,1,=,EOSLE,%,0.42,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10163.0,EOSINOPHIL,%,UO_0000187,0.42
93577,See Activity_Supp For Individual Animal Data,17355021,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,RBC,cells.uL-1,7690000.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10163.0,ERYTHROCYTE COUNT,x10E6/uL,,7.69
93578,See Activity_Supp For Individual Animal Data,17355022,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://qudt.org/vocab/unit#Percent,2834704,=,15,1,=,HCT,%,47.83,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10163.0,HEMATOCRIT,%,UO_0000187,47.83
93579,See Activity_Supp For Individual Animal Data,17355023,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834704,=,15,1,=,HGB,ug.mL-1,156300.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10163.0,HEMOGLOBIN,G/DL,UO_0000274,15.63
93580,See Activity_Supp For Individual Animal Data,17355024,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,WBC,cells.uL-1,11690.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10163.0,LEUKOCYTE COUNT,x10E3/uL,,11.69
93581,See Activity_Supp For Individual Animal Data,17355025,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://qudt.org/vocab/unit#Percent,2834704,=,15,1,=,LYMLE,%,86.55,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10163.0,LYMPHOCYTE,%,UO_0000187,86.55
93582,See Activity_Supp For Individual Animal Data,17355026,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,MCH,pg,20.3,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10163.0,MEAN CORPUSCULAR HEMOGLOBIN,PG,UO_0000025,20.3
93583,See Activity_Supp For Individual Animal Data,17355027,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834704,=,15,1,=,MCHC,ug.mL-1,326700.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10163.0,MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION,G/DL,UO_0000274,32.67
93584,See Activity_Supp For Individual Animal Data,17355028,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,MCV,fL,62.25,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10163.0,MEAN CORPUSCULAR VOLUME,FL,,62.25
93585,See Activity_Supp For Individual Animal Data,17355029,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://qudt.org/vocab/unit#Percent,2834704,=,15,1,=,MONOLE,%,2.05,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10163.0,MONOCYTE,%,UO_0000187,2.05
93586,See Activity_Supp For Individual Animal Data,17355030,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://qudt.org/vocab/unit#Percent,2834704,=,15,1,=,NEUTLE,%,9.38,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10163.0,NEUTROPHIL,%,UO_0000187,9.38
93587,See Activity_Supp For Individual Animal Data,17355031,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3885881,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2834704,=,15,1,=,PLAT,cells.uL-1,1334500.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,10163.0,PLATELET COUNT,x10E3/uL,,1334.5
93588,,17969297,CHEMBL3995599,Antibacterial activity against methicillin-resistant Staphylococcus aureus USA300 by broth microdilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL3994613,Eur J Med Chem,2017.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2977526,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
93589,Not Active,18043524,CHEMBL4010214,"Antibacterial activity against Pseudomonas aeruginosa PA1145 in BALB/c mouse model of lung infection assessed as reduction in log10CFU per gram of lung at 40 mg/kg, in bid administered 2 to 12 hrs of post-infection measured after 24 hrs relative to untreated control",F,BAO_0000375,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4007456,J Med Chem,2017.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2990054,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
93590,,18043525,CHEMBL4010213,Antibacterial activity against Pseudomonas aeruginosa PA1145 in BALB/c mouse model of lung infection administered intranasally as bid for 2 to 12 hrs of post-infection measured after 24 hrs,F,BAO_0002146,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4007456,J Med Chem,2017.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2990054,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,1.0
93591,,18071100,CHEMBL4015290,Antibacterial activity against Pseudomonas aeruginosa PAO1 after 18 hrs by microtiter dilution assay,F,BAO_0002146,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4014308,J Med Chem,2017.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2995404,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.25
93592,,18071101,CHEMBL4015289,Antibacterial activity against Klebsiella pneumoniae ATCC 13883 after 24 hrs by macrobroth dilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4014308,J Med Chem,2017.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2995404,<=,1,1,<=,MIC,ug.mL-1,0.25,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.25
93593,,18071102,CHEMBL4015288,Antibacterial activity against Acinetobacter baumannii isolate CAN-ICU 63169 after 24 hrs by macrobroth dilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4014308,J Med Chem,2017.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2995404,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,32.0
93594,,18071103,CHEMBL4015287,Antibacterial activity against Stenotrophomonas maltophilia isolate CAN-ICU 62584 after 24 hrs by macrobroth dilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4014308,J Med Chem,2017.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2995404,>,1,1,>,MIC,ug.mL-1,512.0,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,MIC,ug ml-1,UO_0000274,512.0
93595,,18071104,CHEMBL4015286,Antibacterial activity against gentamicin/tobramycin-resistant Pseudomonas aeruginosa isolate CANWARD-2011 96846 after 24 hrs by macrobroth dilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4014308,J Med Chem,2017.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2995404,=,1,1,=,MIC,ug.mL-1,256.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,256.0
93596,,18071105,CHEMBL4015285,Antibacterial activity against gentamicin-resistant Pseudomonas aeruginosa isolate CAN-ICU 62308 after 24 hrs by macrobroth dilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4014308,J Med Chem,2017.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2995404,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,16.0
93597,,18071106,CHEMBL4015284,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 after 24 hrs by macrobroth dilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4014308,J Med Chem,2017.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2995404,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.5
93598,,18071107,CHEMBL4015283,Antibacterial activity against gentamicin/tobramycin/ciprofloxacin-resistant Escherichia coli isolate CANWARD-2011 97615 harboring AAC3-2A after 24 hrs by macrobroth dilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4014308,J Med Chem,2017.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2995404,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,128.0
93599,,18071108,CHEMBL4015282,Antibacterial activity against amikacin-resistant Escherichia coli isolate CAN-ICU 63074 after 24 hrs by macrobroth dilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4014308,J Med Chem,2017.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2995404,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,8.0
93600,,18071109,CHEMBL4015281,Antibacterial activity against gentamicin-resistant Escherichia coli isolate CAN-ICU 61714 after 24 hrs by macrobroth dilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4014308,J Med Chem,2017.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2995404,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,8.0
93601,,18071110,CHEMBL4015280,Antibacterial activity against Escherichia coli ATCC 25922 after 24 hrs by macrobroth dilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4014308,J Med Chem,2017.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2995404,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.5
93602,,18071111,CHEMBL4015279,Antibacterial activity against Streptococcus pneumoniae ATCC 49619 after 24 hrs by macrobroth dilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4014308,J Med Chem,2017.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2995404,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,2.0
93603,,18071112,CHEMBL4015278,Antibacterial activity against Enterococcus faecium ATCC 27270 after 24 hrs by macrobroth dilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4014308,J Med Chem,2017.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2995404,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,8.0
93604,,18071113,CHEMBL4015277,Antibacterial activity against Enterococcus faecalis ATCC 29212 after 24 hrs by macrobroth dilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4014308,J Med Chem,2017.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2995404,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,8.0
93605,,18071114,CHEMBL4015276,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis isolate CAN-ICU 61589 after 24 hrs by macrobroth dilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4014308,J Med Chem,2017.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2995404,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,1.0
93606,,18071115,CHEMBL4015275,Antibacterial activity against methicillin-susceptible Staphylococcus epidermidis isolate CANWARD-2008 81388 after 24 hrs by macrobroth dilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4014308,J Med Chem,2017.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2995404,<=,1,1,<=,MIC,ug.mL-1,0.25,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.25
93607,,18071116,CHEMBL4015274,Antibacterial activity against methicillin resistant Staphylococcus aureus ATCC 33592 after 24 hrs by macrobroth dilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4014308,J Med Chem,2017.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2995404,<=,1,1,<=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
93608,,18071117,CHEMBL4015273,Antibacterial activity against Staphylococcus aureus ATCC 29213 after 24 hrs by macrobroth dilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4014308,J Med Chem,2017.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2995404,<=,1,1,<=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
93609,,18071187,CHEMBL4015291,Antibacterial activity against multidrug/extremely drug-resistant/colistin-susceptible Pseudomonas aeruginosa isolate 100036 after 18 hrs by microtiter dilution assay,F,BAO_0002146,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4014308,J Med Chem,2017.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2995404,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,64.0
93610,,18071201,CHEMBL4015292,Antibacterial activity against multidrug/extremely drug-resistant/colistin-susceptible Pseudomonas aeruginosa isolate 101885 after 18 hrs by microtiter dilution assay,F,BAO_0002146,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4014308,J Med Chem,2017.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2995404,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.25
93611,,18071215,CHEMBL4015293,Antibacterial activity against multidrug/extremely drug-resistant/colistin-susceptible Pseudomonas aeruginosa isolate P259-96918 after 18 hrs by microtiter dilution assay,F,BAO_0002146,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4014308,J Med Chem,2017.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2995404,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,128.0
93612,,18071229,CHEMBL4015294,Antibacterial activity against multidrug/extremely drug-resistant/colistin-susceptible Pseudomonas aeruginosa isolate P262-101856 after 18 hrs by microtiter dilution assay,F,BAO_0002146,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4014308,J Med Chem,2017.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2995404,=,1,1,=,MIC,ug.mL-1,512.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,512.0
93613,,18071243,CHEMBL4015295,Antibacterial activity against multidrug/extremely drug-resistant/colistin-susceptible Pseudomonas aeruginosa isolate P264-104354 after 18 hrs by microtiter dilution assay,F,BAO_0002146,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4014308,J Med Chem,2017.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2995404,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,128.0
93614,,18071257,CHEMBL4015296,Antibacterial activity against multidrug/extremely drug-resistant/colistin-resistant Pseudomonas aeruginosa isolate 91433 after 18 hrs by microtiter dilution assay,F,BAO_0002146,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4014308,J Med Chem,2017.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2995404,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,8.0
93615,,18071271,CHEMBL4015297,Antibacterial activity against multidrug/extremely drug-resistant/colistin-resistant Pseudomonas aeruginosa isolate 101243 after 18 hrs by microtiter dilution assay,F,BAO_0002146,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4014308,J Med Chem,2017.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2995404,=,1,1,=,MIC,ug.mL-1,256.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,256.0
93616,Not Active,18071287,CHEMBL4015299,Synergistic antibacterial activity against Pseudomonas aeruginosa PAO1 after 18 hrs in presence of minocycline by checkerboard assay,F,BAO_0000375,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4014308,J Med Chem,2017.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2995404,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
93617,Not Active,18071292,CHEMBL4015300,Synergistic antibacterial activity against Pseudomonas aeruginosa PAO1 after 18 hrs in presence of rifampicin by checkerboard assay,F,BAO_0000375,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4014308,J Med Chem,2017.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2995404,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
93618,,18071406,CHEMBL4015394,Antibacterial activity against Pseudomonas aeruginosa PAO1 assessed as ratio of MIC after 25 serial passages to MIC before 25 serial passages by microtiter dilution assay,F,BAO_0000193,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4014308,J Med Chem,2017.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2995404,=,1,0,=,Ratio,,256.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Ratio,,,256.0
93619,Dose-dependent effect,18071415,CHEMBL4015399,Induction of cytoplasmic membrane depolarization in Pseudomonas aeruginosa PAO1 up to 1200 secs by diSC3-5 staining based fluorescence assay,F,BAO_0000375,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4014308,J Med Chem,2017.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2995404,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
93620,Not Active,18071422,CHEMBL4015403,Disruption of proton motive force in Pseudomonas aeruginosa PAO1 cytoplasmic membrane assessed as repression of bacterial swimming motility at 0.0156 to 0.125 MIC after 20 hrs,F,BAO_0000375,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4014308,J Med Chem,2017.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2995404,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
93621,,18082630,CHEMBL4017853,Inhibition of RND efflux pump in Pseudomonas aeruginosa PAO1 assessed as potentiation of minocycline-induced antibacterial activity at 8 ug/ml after 18 to 24 hrs by checker board assay,B,BAO_0000179,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4017460,J Med Chem,2017.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2998027,=,1,0,=,FICI,,1.06,CHEMBL612545,,Unchecked,,,FICI,,,1.06
93622,,18082642,CHEMBL4017852,Antibacterial activity against Pseudomonas aeruginosa PAO1 after 18 to 24 hrs by microbroth dilution assay,F,BAO_0002146,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4017460,J Med Chem,2017.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2998027,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.25
93623,,18082798,CHEMBL4017932,Antibacterial activity against Pseudomonas aeruginosa PAO1 assessed as ratio of MIC after 25 serial passages at sub-MIC to MIC after 1 passage by microbroth dilution assay,F,BAO_0000193,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4017460,J Med Chem,2017.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,2998027,=,1,0,=,Ratio,,256.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Ratio,,,256.0
93624,,18138748,CHEMBL4030373,Antibacterial activity against Pseudomonas aeruginosa clinical isolate after 18 to 24 hrs,F,BAO_0000179,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4028845,J Med Chem,2017.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3008870,>,1,1,>,MIC90,ug.mL-1,128.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC90,ug ml-1,UO_0000274,128.0
93625,,18138759,CHEMBL4030373,Antibacterial activity against Pseudomonas aeruginosa clinical isolate after 18 to 24 hrs,F,BAO_0003035,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4028845,J Med Chem,2017.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3008870,=,1,1,=,MIC50,ug.mL-1,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC50,ug ml-1,UO_0000274,2.0
93626,,18192143,CHEMBL4041879,Antibacterial activity against Staphylococcus aureus 209P incubated at room temperature for 30 mins followed by incubation at 37 degC for 12 hrs by two-fold dilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4041483,J Nat Prod,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3017998,=,1,1,=,MIC,ug.mL-1,0.2,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.2
93627,,18192157,CHEMBL4041880,Antibacterial activity against Escherichia coli ATCC 0111 incubated at room temperature for 30 mins followed by incubation at 37 degC for 12 hrs by two-fold dilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4041483,J Nat Prod,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3017998,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,2.0
93628,Not Determined,18192167,CHEMBL4041881,Antifungal activity against Candida albicans FIM709 incubated at room temperature for 30 mins followed by incubation at 32 degC for 12 hrs by two-fold dilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4041483,J Nat Prod,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,3017998,,1,0,,MIC,,,CHEMBL366,Candida albicans,Candida albicans,5476.0,,MIC,,,
93629,Not Determined,18192177,CHEMBL4041882,Antifungal activity against Aspergillus niger R330 incubated at room temperature for 30 mins followed by incubation at 32 degC for 12 hrs by two-fold dilution method,F,BAO_0002146,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4041483,J Nat Prod,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,3017998,,1,0,,MIC,,,CHEMBL358,Aspergillus niger,Aspergillus niger,5061.0,,MIC,,,
93630,,18236829,CHEMBL4051382,Antibacterial activity against Escherichia coli MG1655 measured every 15 mins for 12 hrs,F,BAO_0002146,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4049433,J Med Chem,2017.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3026390,=,1,1,=,MIC,ug.mL-1,2.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,2.5
93631,,18357806,CHEMBL4140989,Antibacterial activity against vancomycin-resistant Enterococcus faecium 7 by dilution susceptibility test,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4138142,J Nat Prod,2017.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3047149,>,1,1,>,MIC,ug.mL-1,256.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,256.0
93632,,18357812,CHEMBL4140991,Antibacterial activity against vancomycin-resistant Enterococcus faecalis 12 by dilution susceptibility test,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4138142,J Nat Prod,2017.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3047149,>,1,1,>,MIC,ug.mL-1,256.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,256.0
93633,,18450882,CHEMBL4178465,Growth inhibition of Acinetobacter baumannii ATCC 19606 after 48 hrs by resazurin dye based microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4177542,J Med Chem,2017.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3061991,=,1,1,=,MIC,ug.mL-1,6.25,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,6.25
93634,,18450901,CHEMBL4178469,Growth inhibition of multidrug-resistant Acinetobacter baumannii ATCC BAA 18002 after 48 hrs by resazurin dye based broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4177542,J Med Chem,2017.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3061991,>,1,1,>,MIC,ug.mL-1,25.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,25.0
93635,,18450977,CHEMBL4178532,"Antibacterial activity against Acinetobacter baumannii ATCC 19606 infected in C57BL/6 mouse assessed as survival rate at 6 mg/kg, ip administered as single dose measured for 5 days (Rvb = <20%)",F,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4177542,J Med Chem,2017.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://qudt.org/vocab/unit#Percent,3061991,=,1,0,=,Survival,%,100.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,Survival,%,UO_0000187,100.0
93636,,18450989,CHEMBL4178525,Cytotoxicity against African green monkey Vero cells after 72 hrs by MTT assay,A,BAO_0000190,BAO_0000219,cell-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4177542,J Med Chem,2017.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3061991,>,1,1,>,IC50,ug.mL-1,200.0,CHEMBL391,Chlorocebus sabaeus,Vero,60711.0,,IC50,ug ml-1,UO_0000274,200.0
93637,,18495942,CHEMBL4188333,Antibacterial activity against Escherichia coli ATCC 25922 incubated at 37 degC for 20 hrs by standard broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4184257,Bioorg Med Chem Lett,2018.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3070111,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.25
93638,,18495987,CHEMBL4188344,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 incubated at 37 degC for 20 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4184257,Bioorg Med Chem Lett,2018.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3070111,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.25
93639,,18495991,CHEMBL4188345,Antibacterial activity against Pseudomonas aeruginosa ATCC 9027 incubated at 37 degC for 20 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4184257,Bioorg Med Chem Lett,2018.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3070111,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.5
93640,,18495995,CHEMBL4188346,Antibacterial activity against Pseudomonas aeruginosa CMCC 10104 incubated at 37 degC for 20 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4184257,Bioorg Med Chem Lett,2018.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3070111,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,2.0
93641,,18495999,CHEMBL4188347,Antibacterial activity against Klebsiella pneumoniae ATCC 4352 incubated at 37 degC for 20 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4184257,Bioorg Med Chem Lett,2018.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3070111,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,1.0
93642,,18496003,CHEMBL4188348,Antibacterial activity against Klebsiella pneumoniae ATCC 700603 incubated at 37 degC for 20 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4184257,Bioorg Med Chem Lett,2018.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3070111,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,4.0
93643,,18496007,CHEMBL4188349,Antibacterial activity against Klebsiella pneumoniae CMCC 46117 incubated at 37 degC for 20 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4184257,Bioorg Med Chem Lett,2018.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3070111,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.25
93644,,18554769,CHEMBL4200155,Antimicrobial activity against Staphylococcus aureus after 24 hrs by two-fold dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4196135,J Nat Prod,2018.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3080599,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
93645,,18554800,CHEMBL4200154,Antimicrobial activity against Streptococcus agalactiae after 24 hrs by two-fold dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4196135,J Nat Prod,2018.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3080599,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,MIC,ug ml-1,UO_0000274,32.0
93646,,18775127,CHEMBL4268987,Antibacterial activity against Staphylococcus aureus SA-1 expressing NorA pump by microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4265973,Eur J Med Chem,2018.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3119604,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
93647,,18775150,CHEMBL4268986,Antibacterial activity against Staphylococcus aureus ATCC 25923 by microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4265973,Eur J Med Chem,2018.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3119604,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
93648,,18775160,CHEMBL4268988,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33592 by microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4265973,Eur J Med Chem,2018.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3119604,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,64.0
93649,,18775183,CHEMBL4268989,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 by microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4265973,Eur J Med Chem,2018.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3119604,<,1,1,<,MIC,ug.mL-1,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.25
93650,,18775206,CHEMBL4268990,Antibacterial activity against Pseudomonas aeruginosa FO3 harboring AAC6'-2A by microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4265973,Eur J Med Chem,2018.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3119604,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,128.0
93651,,18775229,CHEMBL4268991,Antibacterial activity against Pseudomonas aeruginosa PA22 harboring surexp MexXY by microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4265973,Eur J Med Chem,2018.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3119604,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.5
93652,,18775252,CHEMBL4268992,Antibacterial activity against Pseudomonas aeruginosa PA406 harboring triABC deletion mutant by microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4265973,Eur J Med Chem,2018.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3119604,<,1,1,<,MIC,ug.mL-1,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.25
93653,,18775275,CHEMBL4268993,Antibacterial activity against Acinetobacter lwoffii ATCC 17925 by microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4265973,Eur J Med Chem,2018.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3119604,<,1,1,<,MIC,ug.mL-1,0.25,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,MIC,ug ml-1,UO_0000274,0.25
93654,,18775298,CHEMBL4268994,Antibacterial activity against Acinetobacter lwoffii AI.88-483 harboring APH3'-6A by microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4265973,Eur J Med Chem,2018.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3119604,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,MIC,ug ml-1,UO_0000274,0.5
93655,,18775321,CHEMBL4268995,Antibacterial activity against Escherichia coli ATCC 25922 by microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4265973,Eur J Med Chem,2018.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3119604,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,1.0
93656,,18775344,CHEMBL4268996,Antibacterial activity against Escherichia coli PAZ505H8101 harboring AAC6'-1B by microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4265973,Eur J Med Chem,2018.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3119604,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,32.0
93657,,18775367,CHEMBL4268997,Antibacterial activity against Escherichia coli L8058.1 harboring ANT2'-1A by microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4265973,Eur J Med Chem,2018.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3119604,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,64.0
93658,,18775390,CHEMBL4268998,Antibacterial activity against Klebsiella pneumoniae 700603 by microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4265973,Eur J Med Chem,2018.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3119604,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,4.0
93659,,18831771,CHEMBL4303805,Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of Caco-2 cells at 10 uM after 48 hours by high content imaging,F,BAO_0000201,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4303101,,2020.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://qudt.org/vocab/unit#Percent,3138269,=,52,1,=,Inhibition,%,2.66,CHEMBL4303835,Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2,2697049.0,,Inhibition,%,UO_0000187,2.66
93660,Active,18972920,CHEMBL4337371,Antimicrobial activity against Pseudomonas aeruginosa PAO1 assessed as inhibition of planktonic cells growth at >0.15 uM incubated for 24 to 25 hrs,F,BAO_0000375,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4334486,J Med Chem,2019.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,3164893,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
93661,Not Active,19145915,CHEMBL4378438,Induction of outer membrane permeabilization in Pseudomonas aeruginosa PAO1 assessed as increase in accumulation of NPN by measuring fluorescence intensity at 14 ug/ml measured immediately by NPN dye uptake assay,B,BAO_0000375,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4376820,J Med Chem,2019.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,3195337,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
93662,,19145922,CHEMBL4378444,Antibacterial activity against wild type Acinetobacter baumannii ATCC 17978 assessed as resistant development at sub-MIC measured after 7 days of passaging by microbroth dilution method relative to control,F,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4376820,J Med Chem,2019.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,3195337,=,1,0,=,FC,,512.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,FC,,,512.0
93663,,19145933,CHEMBL4378447,Antibacterial activity against novobiocin-resistant Acinetobacter baumannii ATCC 17978 mutant generated from seven serial passages by checkerboard assay,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4376820,J Med Chem,2019.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3195337,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,1.0
93664,,19145942,CHEMBL4378448,Antibacterial activity against colistin-resistant Acinetobacter baumannii ATCC 17978 mutant generated from seven serial passages by checkerboard assay,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4376820,J Med Chem,2019.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3195337,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,0.25
93665,,19145951,CHEMBL4378449,Antibacterial activity against novobiocin and test compound-resistant Acinetobacter baumannii ATCC 17978 mutant generated from seven serial passages in presence of novobiocin by checkerboard assay,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4376820,J Med Chem,2019.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3195337,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,1.0
93666,,19145964,CHEMBL4378453,Antibacterial activity against wild type Acinetobacter baumannii ATCC 17978 by checkerboard assay,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4376820,J Med Chem,2019.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3195337,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,1.0
93667,,19431943,CHEMBL4429180,Antimicrobial activity against Pseudomonas aeruginosa ATCC 47085 measured after 24 hrs by double-dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4428061,J Med Chem,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3245824,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,1.0
93668,,19431944,CHEMBL4429181,Antimicrobial activity against Pseudomonas aeruginosa ATCC 27853 measured after 24 hrs by double-dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4428061,J Med Chem,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3245824,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,1.0
93669,,19431945,CHEMBL4429182,Antimicrobial activity against Haemophilus influenzae ATCC 49247 measured after 24 hrs by double-dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4428061,J Med Chem,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3245824,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC,ug ml-1,UO_0000274,4.0
93670,,19431946,CHEMBL4429183,Antimicrobial activity against Haemophilus influenzae ATCC 10211 measured after 24 hrs by double-dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4428061,J Med Chem,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3245824,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC,ug ml-1,UO_0000274,4.0
93671,,19431947,CHEMBL4429184,Antimicrobial activity against Klebsiella pneumoniae ATCC 13883 measured after 24 hrs by double-dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4428061,J Med Chem,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3245824,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,1.0
93672,,19431948,CHEMBL4429185,Antimicrobial activity against Klebsiella pneumoniae ATCC 10031 measured after 24 hrs by double-dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4428061,J Med Chem,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3245824,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,1.0
93673,,19431949,CHEMBL4429186,Antimicrobial activity against Escherichia coli ATCC 25922 measured after 24 hrs by double-dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4428061,J Med Chem,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3245824,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,2.0
93674,,19431950,CHEMBL4429187,Antimicrobial activity against Acinetobacter baumannii ATCC 19606 measured after 24 hrs by double-dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4428061,J Med Chem,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3245824,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,2.0
93675,,19431951,CHEMBL4429188,Antimicrobial activity against aminoglycoside-resistant Burkholderia cepacia ATCC 25416 measured after 24 hrs by double-dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4428061,J Med Chem,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3245824,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL612499,Burkholderia cepacia,Burkholderia cepacia,292.0,,MIC,ug ml-1,UO_0000274,32.0
93676,,19431952,CHEMBL4429189,Antimicrobial activity against aminoglycoside-resistant Escherichia coli ATCC BAA-2452 measured after 24 hrs by double-dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4428061,J Med Chem,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3245824,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,32.0
93677,,19431953,CHEMBL4429190,Antimicrobial activity against aminoglycoside-resistant Klebsiella pneumoniae ATCC BAA-2470 measured after 24 hrs by double-dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4428061,J Med Chem,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3245824,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,32.0
93678,,19432015,CHEMBL4429191,Binding affinity to 16S rRNA A-site in Escherichia coli S30 extract assessed as inhibition of translation measured after 30 mins by coupled transcription/translation-based luciferase reporter gene assay,B,BAO_0000190,BAO_0000225,nucleic acid format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4428061,J Med Chem,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/Nanomolar,3245824,=,1,1,=,IC50,nM,70.0,CHEMBL614640,,Ribosomal RNA A-site,,,IC50,uM,UO_0000065,0.07
93679,,19432027,CHEMBL4429192,Inhibition of cytosolic eukaryotic translation in rabbit reticulocyte S30 extract measured after 60 mins by coupled transcription/translation-based luciferase reporter gene assay,A,BAO_0000190,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4428061,J Med Chem,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/Nanomolar,3245824,=,1,1,=,IC50,nM,42320.0,CHEMBL612545,,Unchecked,,,IC50,uM,UO_0000065,42.32
93680,,19432039,CHEMBL4429193,"Selectivity ratio, ratio of IC50 for cytosolic eukaryotic translation in rabbit reticulocyte S30 extract to IC50 for 16S rRNA A-site in Escherichia coli S30 extract",T,BAO_0000179,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4428061,J Med Chem,2016.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,3245824,=,1,0,=,Ratio IC50,,604.57,CHEMBL612545,,Unchecked,,,Ratio IC50,,,604.57
93681,,19964006,CHEMBL4495582,SARS-CoV-2 3CL-Pro protease inhibition percentage at 20µM  by FRET kind of response from peptide substrate,F,BAO_0000201,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4495564,,2020.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://qudt.org/vocab/unit#Percent,3350424,=,52,1,=,Inhibition,%,13.99,CHEMBL4523582,Severe acute respiratory syndrome coronavirus 2,Replicase polyprotein 1ab,2697049.0,,Inhibition,%,UO_0000187,13.99431434
93682,,20151143,CHEMBL4513082,Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging,F,BAO_0000201,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4495565,,2020.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://qudt.org/vocab/unit#Percent,3368296,=,52,1,=,Inhibition,%,-0.18,CHEMBL4303835,Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2,2697049.0,,inhibition,%,UO_0000187,-0.18
93683,Median N= 2; Maxinhib 3.1 Pct,20240092,CHEMBL4296189,"Antifungal activity against Candida albicans ATCC 90028 (CO-ADD:FG_001); MIC in YNB media using NBS plates, by OD630",F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4513161,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/Nanomolar,3391230,>,40,1,>,MIC,nM,20000.0,CHEMBL366,Candida albicans,Candida albicans,5476.0,,MIC,uM,UO_0000065,20.0
93684,Median N= 2; Maxinhib 8.6 Pct,20240093,CHEMBL4296190,"Antifungal activity against Cryptococcus neoformans H99 ATCC 208821 (CO-ADD:FG_002); MIC in YNB media using NBS plates, by Resazurin OD(600-570)",F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4513161,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/Nanomolar,3391230,>,40,1,>,MIC,nM,20000.0,CHEMBL365,Cryptococcus neoformans,Cryptococcus neoformans,5207.0,,MIC,uM,UO_0000065,20.0
93685,Median N= 2; Range 5 - 2.5  Um,20240094,CHEMBL4296185,"Antibacterial activity against Escherichia coli ATCC 25922 (CO-ADD:GN_001); MIC in CAMBH media using NBS plates, by OD(600)",F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4513161,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/Nanomolar,3391230,=,40,1,=,MIC,nM,2500.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,uM,UO_0000065,2.5
93686,Median N= 2; Maxinhib 36.2 Pct,20240095,CHEMBL4296186,"Antibacterial activity against Klebsiella pneumoniae MDR ATCC 70063 (CO-ADD:GN_003); MIC in CAMBH media using NBS plates, by OD(600)",F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4513161,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/Nanomolar,3391230,>,40,1,>,MIC,nM,20000.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,uM,UO_0000065,20.0
93687,Median N= 2,20240096,CHEMBL4296187,"Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 (CO-ADD:GN_042); MIC in CAMBH media using NBS plates, by OD(600)",F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4513161,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/Nanomolar,3391230,=,40,1,=,MIC,nM,20000.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,uM,UO_0000065,20.0
93688,Median N= 2,20240097,CHEMBL4296188,"Antibacterial activity against Acinetobacter baumannii ATCC 19606 (CO-ADD:GN_034); MIC in CAMBH media using NBS plates, by OD600",F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4513161,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/Nanomolar,3391230,=,40,1,=,MIC,nM,2500.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,uM,UO_0000065,2.5
93689,Median N= 2,20240098,CHEMBL4296802,"Antibacterial activity against Pseudomonas aeruginosa PAO397 [PAO1 d(mexAB-oprM) d(mexCD-oprJ) d(mexEF-oprN) d(mexJKL) d(mexXY) d(opmH)] (CO-ADD:GN_211); MIC in CAMBH media using NBS plates, by OD(600)",F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4513161,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/Nanomolar,3391230,=,40,1,=,MIC,nM,1250.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,uM,UO_0000065,1.25
93690,Median N= 2; Maxinhib 0.6 Pct,20240099,CHEMBL4296184,"Antibacterial activity against Staphylococcus aureus MRSA ATCC 43300 (CO-ADD:GP_020); MIC in CAMBH media, using NBS plates, by OD(600)",F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4513161,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/Nanomolar,3391230,>,40,1,>,MIC,nM,20000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,20.0
93691,,20644769,CHEMBL4613956,"Anti-leprotic activity against Mycobacterium leprae infected in BALB/c weanling mouse assessed as bacteria killing at 20 mg/kg, ip administrated for 60 days and measured after 1 year by most probable number technique analysis relative to control",F,BAO_0001103,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4613212,Bioorg Med Chem,2019.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://qudt.org/vocab/unit#Percent,3474763,=,1,0,=,Activity,%,28.7,CHEMBL3301409,Mycobacterium leprae,Mycobacterium leprae,1769.0,,Activity,%,UO_0000187,28.7
93692,,20644775,CHEMBL4613960,"Anti-leprotic activity against Mycobacterium leprae infected in BALB/c weanling mouse assessed as bacteria killing at 20 mg/kg, ip administrated for 60 days and measured after 1 year by Spearman-Karber technique analysis relative to control",F,BAO_0001103,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4613212,Bioorg Med Chem,2019.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://qudt.org/vocab/unit#Percent,3474763,=,1,0,=,Activity,%,37.0,CHEMBL3301409,Mycobacterium leprae,Mycobacterium leprae,1769.0,,Activity,%,UO_0000187,37.0
93693,Not Active,20704081,CHEMBL4627921,Inhibition of swarming motility of Pseudomonas aeruginosa HONKR at 10 ug incubated for 18 to 24 hrs,F,BAO_0000201,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4627274,Bioorg Med Chem,2020.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://qudt.org/vocab/unit#Percent,3486860,,1,0,,Inhibition,%,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,INH,,UO_0000187,
93694,,22079786,CHEMBL4513082,Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging,F,BAO_0000201,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4495565,,2020.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://qudt.org/vocab/unit#Percent,3368296,=,52,1,=,Inhibition,%,-0.18,CHEMBL4303835,Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2,2697049.0,,inhibition,%,UO_0000187,-0.18
93695,,22412267,CHEMBL4671681,Antibacterial activity against Pseudomonas aeruginosa PAO750 harboring mexAB-oprM/mexCD-oprJ/mexEF-oprN/mexJK/mexXY/opmH efflux deficient mutant,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4665836,Bioorg Med Chem Lett,2020.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3511673,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,1.0
93696,,22412276,CHEMBL4671682,Antibacterial activity against Pseudomonas aeruginosa PAO200 harboring mexAB-oprM efflux deficient mutant,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4665836,Bioorg Med Chem Lett,2020.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3511673,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,1.0
93697,,22412292,CHEMBL4671683,Antibacterial activity against wild type Pseudomonas aeruginosa PAO1,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4665836,Bioorg Med Chem Lett,2020.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3511673,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,1.0
93698,,22420051,CHEMBL4673410,Antibacterial activity against Klebsiella pneumoniae ATCC 700603 using cyrene as solvent by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4673173,RSC Med Chem,2020.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/Nanomolar,3513098,=,1,1,=,MIC80,nM,13000.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC80,uM,UO_0000065,13.0
93699,,22420059,CHEMBL4673411,Antibacterial activity against Klebsiella pneumoniae ATCC 700603 using DMSO as solvent by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4673173,RSC Med Chem,2020.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/Nanomolar,3513098,=,1,1,=,MIC80,nM,13000.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC80,uM,UO_0000065,13.0
93700,,22420067,CHEMBL4673412,Antibacterial activity against Acinetobacter baumannii ATCC 19606 using cyrene as solvent by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4673173,RSC Med Chem,2020.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/Nanomolar,3513098,=,1,1,=,MIC80,nM,3100.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC80,uM,UO_0000065,3.1
93701,,22420075,CHEMBL4673413,Antibacterial activity against Acinetobacter baumannii ATCC 19606 using DMSO as solvent by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4673173,RSC Med Chem,2020.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/Nanomolar,3513098,=,1,1,=,MIC80,nM,3100.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC80,uM,UO_0000065,3.1
93702,,22420083,CHEMBL4673414,Antibacterial activity against Pseudomonas aeruginosa ATCC 27893 using cyrene as solvent by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4673173,RSC Med Chem,2020.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/Nanomolar,3513098,=,1,1,=,MIC80,nM,1600.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC80,uM,UO_0000065,1.6
93703,,22420091,CHEMBL4673415,Antibacterial activity against Pseudomonas aeruginosa ATCC 27893 using DMSO as solvent by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4673173,RSC Med Chem,2020.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/Nanomolar,3513098,=,1,1,=,MIC80,nM,1600.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC80,uM,UO_0000065,1.6
93704,,22420099,CHEMBL4673416,Antibacterial activity against Escherichia coli ATCC 25922 using cyrene as solvent by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4673173,RSC Med Chem,2020.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/Nanomolar,3513098,=,1,1,=,MIC80,nM,780.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC80,uM,UO_0000065,0.78
93705,,22420107,CHEMBL4673417,Antibacterial activity against Escherichia coli ATCC 25922 using DMSO as solvent by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4673173,RSC Med Chem,2020.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/Nanomolar,3513098,=,1,1,=,MIC80,nM,780.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC80,uM,UO_0000065,0.78
93706,Not Active,22420115,CHEMBL4673418,Antibacterial activity against Enterococcus faecalis ATCC 51299 using DMSO as solvent by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4673173,RSC Med Chem,2020.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,3513098,,1,0,,MIC80,,,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC80,,,
93707,Not Active,22420123,CHEMBL4673419,Antibacterial activity against Staphylococcus aureus ATCC 43300 using Cyrene as solvent by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4673173,RSC Med Chem,2020.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,3513098,,1,0,,MIC80,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC80,,,
93708,Not Active,22420131,CHEMBL4673420,Antibacterial activity against Staphylococcus aureus ATCC 43300 using DMSO as solvent by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4673173,RSC Med Chem,2020.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,3513098,,1,0,,MIC80,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC80,,,
93709,Not Active,22420155,CHEMBL4673431,Antibacterial activity against Enterococcus faecalis ATCC 51299 using Cyrene as solvent by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4673173,RSC Med Chem,2020.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,3513098,,1,0,,MIC80,,,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC80,,,
93710,,22478757,CHEMBL4686831,Antibacterial activity against Pseudomonas aeruginosa PAO1 planktonic cells assessed as reduction in bacterial growth after 18 hrs by resazurin dye based assay,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4680247,Eur J Med Chem,2020.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3523300,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,2.0
93711,,22478764,CHEMBL4686832,Antibacterial activity against Pseudomonas aeruginosa PAO1 biofilm cells assessed as reduction in bacterial growth after 2 days by resazurin dye based assay,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4680247,Eur J Med Chem,2020.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3523300,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,8.0
93712,,22845987,CHEMBL4722010,Antibacterial activity against wild type Pseudomonas aeruginosa PAO1 assessed as reduction in bacterial growth by measuring chloramphenicol MIC at 0.25 ug/ml incubated for 18 hrs in presence of chloramphenicol by broth microdilution assay (Rvb = 32 ug/ml),F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4715829,Eur J Med Chem,2019.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3547163,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,32.0
93713,,22845993,CHEMBL4722016,Antibacterial activity against Pseudomonas aeruginosa 264-101354 assessed as reduction in bacterial growth by measuring chloramphenicol MIC at 8 ug/ml incubated for 18 hrs in presence of chloramphenicol by broth microdilution assay (Rvb = 4096 ug/ml),F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4715829,Eur J Med Chem,2019.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3547163,=,1,1,=,MIC,ug.mL-1,4096.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,4096.0
93714,,22845994,CHEMBL4722017,Antibacterial activity against Pseudomonas aeruginosa 262-101856 assessed as reduction in bacterial growth by measuring chloramphenicol MIC at 8 ug/ml incubated for 18 hrs in presence of chloramphenicol by broth microdilution assay (Rvb = 2048 ug/ml),F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4715829,Eur J Med Chem,2019.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3547163,=,1,1,=,MIC,ug.mL-1,2048.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,2048.0
93715,,22845995,CHEMBL4722018,Antibacterial activity against Pseudomonas aeruginosa 260-97103 assessed as reduction in bacterial growth by measuring chloramphenicol MIC at 8 ug/ml incubated for 18 hrs in presence of chloramphenicol by broth microdilution assay (Rvb = 128 ug/ml),F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4715829,Eur J Med Chem,2019.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3547163,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,128.0
93716,,22845996,CHEMBL4722019,Antibacterial activity against Pseudomonas aeruginosa 259-96918 assessed as reduction in bacterial growth by measuring chloramphenicol MIC at 8 ug/ml incubated for 18 hrs in presence of chloramphenicol by broth microdilution assay (Rvb = 1024 ug/ml),F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4715829,Eur J Med Chem,2019.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3547163,=,1,1,=,MIC,ug.mL-1,1024.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,1024.0
93717,,22845997,CHEMBL4722020,Antibacterial activity against Pseudomonas aeruginosa 100036 assessed as reduction in bacterial growth by measuring chloramphenicol MIC at 8 ug/ml incubated for 18 hrs in presence of chloramphenicol by broth microdilution assay (Rvb = 1024 ug/ml),F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4715829,Eur J Med Chem,2019.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3547163,=,1,1,=,MIC,ug.mL-1,1024.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,1024.0
93718,,22845999,CHEMBL4722021,Antibacterial activity against Escherichia coli ATCC 25922 assessed as reduction in bacterial growth incubated for 18 hrs by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4715829,Eur J Med Chem,2019.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3547163,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.5
93719,,22846004,CHEMBL4722022,Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as reduction in bacterial growth incubated for 18 hrs by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4715829,Eur J Med Chem,2019.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3547163,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
93720,,22846019,CHEMBL4722029,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 assessed as reduction in bacterial growth incubated for 18 hrs by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4715829,Eur J Med Chem,2019.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3547163,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,1.0
93721,,22846024,CHEMBL4722030,Antibacterial activity against methicillin-resistance Staphylococcus aureus ATCC 33592 assessed as reduction in bacterial growth incubated for 18 hrs by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4715829,Eur J Med Chem,2019.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3547163,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
93722,,22846029,CHEMBL4722031,Antibacterial activity against methicillin-susceptible Staphylococcus epidermidis CANWARD 81388 assessed as reduction in bacterial growth incubated for 18 hrs by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4715829,Eur J Med Chem,2019.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3547163,<=,1,1,<=,MIC,ug.mL-1,0.25,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.25
93723,,22846034,CHEMBL4722032,Antibacterial activity against methicillin-resistance Staphylococcus epidermidis CAN-ICU 61589 (CAZ>32) assessed as reduction in bacterial growth incubated for 18 hrs by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4715829,Eur J Med Chem,2019.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3547163,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,2.0
93724,,22846039,CHEMBL4722033,Antibacterial activity against Enterococcus faecalis ATCC 29212 assessed as reduction in bacterial growth incubated for 18 hrs by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4715829,Eur J Med Chem,2019.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3547163,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,8.0
93725,,22846044,CHEMBL4722034,Antibacterial activity against Enterococcus faecium ATCC 27270 assessed as reduction in bacterial growth incubated for 18 hrs by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4715829,Eur J Med Chem,2019.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3547163,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,16.0
93726,,22846049,CHEMBL4722035,Antibacterial activity against Streptococcus pneumoniae ATCC 49619 assessed as reduction in bacterial growth incubated for 18 hrs by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4715829,Eur J Med Chem,2019.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3547163,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,2.0
93727,,22846054,CHEMBL4722036,Antibacterial activity against gentamicin-resistant Escherichia coli CAN-ICU 61714 assessed as reduction in bacterial growth incubated for 18 hrs by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4715829,Eur J Med Chem,2019.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3547163,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,8.0
93728,,22846059,CHEMBL4722037,Antibacterial activity against Escherichia coli CAN-ICU 63074 (AMK 32) assessed as reduction in bacterial growth incubated for 18 hrs by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4715829,Eur J Med Chem,2019.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3547163,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,8.0
93729,,22846064,CHEMBL4722038,"Antibacterial activity against gentamicin, tobramycin, ciprofloxacin-resistant Escherichia coli ATCC 97615 harboring aac(3')IIa gene assessed as reduction in bacterial growth incubated for 18 hrs by broth microdilution assay",F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4715829,Eur J Med Chem,2019.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3547163,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,128.0
93730,,22846069,CHEMBL4722039,Antibacterial activity against gentamicin-resistant Pseudomonas aeruginosa CAN-ICU 62308 assessed as reduction in bacterial growth incubated for 18 hrs by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4715829,Eur J Med Chem,2019.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3547163,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,16.0
93731,,22846074,CHEMBL4722040,"Antibacterial activity against gentamicin, tobramycin-resistant Pseudomonas aeruginosa CANWARD 96846 assessed as reduction in bacterial growth incubated for 18 hrs by broth microdilution assay",F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4715829,Eur J Med Chem,2019.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3547163,=,1,1,=,MIC,ug.mL-1,256.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,256.0
93732,,22846079,CHEMBL4722041,Antibacterial activity against Stenotrophomonas maltophilia CAN-ICU 62584 assessed as reduction in bacterial growth incubated for 18 hrs by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4715829,Eur J Med Chem,2019.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3547163,>,1,1,>,MIC,ug.mL-1,512.0,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,MIC,ug ml-1,UO_0000274,512.0
93733,,22846084,CHEMBL4722042,Antibacterial activity against Acinetobacter baumannii CAN-ICU 63169 assessed as reduction in bacterial growth incubated for 18 hrs by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4715829,Eur J Med Chem,2019.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3547163,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,32.0
93734,,22846089,CHEMBL4722043,Antibacterial activity against Klebsiella pneumoniae ATCC 13883 assessed as reduction in bacterial growth incubated for 18 hrs by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4715829,Eur J Med Chem,2019.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3547163,<=,1,1,<=,MIC,ug.mL-1,0.25,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.25
93735,,22846094,CHEMBL4722044,Antibacterial activity against wild type Pseudomonas aeruginosa PAO1 assessed as reduction in bacterial growth incubated for 18 hrs by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4715829,Eur J Med Chem,2019.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3547163,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,1.0
93736,,22846099,CHEMBL4722045,Antibacterial activity against Pseudomonas aeruginosa 200 harboring efflux mutant assessed as reduction in bacterial growth incubated for 18 hrs by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4715829,Eur J Med Chem,2019.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3547163,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.5
93737,,22846104,CHEMBL4722046,Antibacterial activity against Pseudomonas aeruginosa 750 harboring efflux mutant assessed as reduction in bacterial growth incubated for 18 hrs by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4715829,Eur J Med Chem,2019.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3547163,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.5
93738,,22846241,CHEMBL4722093,Antibacterial activity against Pseudomonas aeruginosa 100036 assessed as fractional inhibitory concentration index in presence of doxycycline incubated for 18 hrs by broth microdilution assay,F,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4715829,Eur J Med Chem,2019.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,3547163,=,1,0,=,FICI,,1.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,FICI,,,1.5
93739,,22846246,CHEMBL4722095,Antibacterial activity against Pseudomonas aeruginosa 100036 assessed as fractional inhibitory concentration index in presence of chloramphenicol incubated for 18 hrs by broth microdilution assay,F,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4715829,Eur J Med Chem,2019.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,3547163,=,1,0,=,FICI,,1.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,FICI,,,1.5
93740,,22846251,CHEMBL4722097,Antibacterial activity against Pseudomonas aeruginosa 264-101354 assessed as fractional inhibitory concentration index in presence of doxycycline incubated for 18 hrs by broth microdilution assay,F,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4715829,Eur J Med Chem,2019.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,3547163,=,1,0,=,FICI,,1.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,FICI,,,1.5
93741,,22846256,CHEMBL4722099,Antibacterial activity against Pseudomonas aeruginosa 264-101354 assessed as fractional inhibitory concentration index in presence of chloramphenicol incubated for 18 hrs by broth microdilution assay,F,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4715829,Eur J Med Chem,2019.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,3547163,=,1,0,=,FICI,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,FICI,,,1.0
93742,,22846262,CHEMBL4722101,Antibacterial activity against Pseudomonas aeruginosa 101243 assessed as fractional inhibitory concentration index in presence of doxycycline incubated for 18 hrs by broth microdilution assay,F,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4715829,Eur J Med Chem,2019.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,3547163,=,1,0,=,FICI,,1.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,FICI,,,1.5
93743,,22846266,CHEMBL4722103,Antibacterial activity against Pseudomonas aeruginosa 101243 assessed as fractional inhibitory concentration index in presence of chloramphenicol incubated for 18 hrs by broth microdilution assay,F,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4715829,Eur J Med Chem,2019.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,3547163,=,1,0,=,FICI,,1.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,FICI,,,1.5
93744,,22846271,CHEMBL4722105,Antibacterial activity against Pseudomonas aeruginosa 262-101856 assessed as fractional inhibitory concentration index in presence of doxycycline incubated for 18 hrs by broth microdilution assay,F,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4715829,Eur J Med Chem,2019.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,3547163,<=,1,0,<=,FICI,,1.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,FICI,,,1.5
93745,,22846276,CHEMBL4722107,Antibacterial activity against Pseudomonas aeruginosa 262-101856 assessed as fractional inhibitory concentration index in presence of chloramphenicol incubated for 18 hrs by broth microdilution assay,F,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4715829,Eur J Med Chem,2019.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,3547163,<=,1,0,<=,FICI,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,FICI,,,1.0
93746,,22846287,CHEMBL4722113,Antibacterial activity against Pseudomonas aeruginosa 259-96918 assessed as fractional inhibitory concentration index in presence of doxycycline incubated for 18 hrs by broth microdilution assay,F,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4715829,Eur J Med Chem,2019.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,3547163,=,1,0,=,FICI,,1.125,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,FICI,,,1.125
93747,,22846291,CHEMBL4722115,Antibacterial activity against Pseudomonas aeruginosa 259-96918 assessed as fractional inhibitory concentration index in presence of chloramphenicol incubated for 18 hrs by broth microdilution assay,F,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4715829,Eur J Med Chem,2019.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,3547163,=,1,0,=,FICI,,1.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,FICI,,,1.25
93748,,22846295,CHEMBL4722117,Antibacterial activity against Pseudomonas aeruginosa 260-97103 assessed as fractional inhibitory concentration index in presence of doxycycline incubated for 18 hrs by broth microdilution assay,F,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4715829,Eur J Med Chem,2019.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,3547163,=,1,0,=,FICI,,1.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,FICI,,,1.5
93749,,22846299,CHEMBL4722119,Antibacterial activity against Pseudomonas aeruginosa 260-97103 assessed as fractional inhibitory concentration index in presence of chloramphenicol incubated for 18 hrs by broth microdilution assay,F,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4715829,Eur J Med Chem,2019.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,3547163,=,1,0,=,FICI,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,FICI,,,1.0
93750,,22846303,CHEMBL4722121,Antibacterial activity against Pseudomonas aeruginosa 91433 assessed as fractional inhibitory concentration index in presence of doxycycline incubated for 18 hrs by broth microdilution assay,F,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4715829,Eur J Med Chem,2019.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,3547163,=,1,0,=,FICI,,1.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,FICI,,,1.5
93751,,22846307,CHEMBL4722123,Antibacterial activity against Pseudomonas aeruginosa 91433 assessed as fractional inhibitory concentration index in presence of chloramphenicol incubated for 18 hrs by broth microdilution assay,F,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4715829,Eur J Med Chem,2019.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,3547163,=,1,0,=,FICI,,1.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,FICI,,,1.5
93752,,22846354,CHEMBL4722150,Antibacterial activity against Pseudomonas aeruginosa 100036 assessed as reduction in bacterial growth by measuring doxycycline MIC at 8 ug/ml incubated for 18 hrs in presence of doxycycline by broth microdilution assay (Rvb = 64 ug/ml),F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4715829,Eur J Med Chem,2019.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3547163,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,64.0
93753,,22846355,CHEMBL4722151,Antibacterial activity against Pseudomonas aeruginosa 259-96918 assessed as reduction in bacterial growth by measuring doxycycline MIC at 8 ug/ml incubated for 18 hrs in presence of doxycycline by broth microdilution assay (Rvb = 32 ug/ml),F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4715829,Eur J Med Chem,2019.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3547163,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,32.0
93754,,22846356,CHEMBL4722152,Antibacterial activity against Pseudomonas aeruginosa 260-97103 assessed as reduction in bacterial growth by measuring doxycycline MIC at 8 ug/ml incubated for 18 hrs in presence of doxycycline by broth microdilution assay (Rvb = 16 ug/ml),F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4715829,Eur J Med Chem,2019.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3547163,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,16.0
93755,,22846357,CHEMBL4722153,Antibacterial activity against Pseudomonas aeruginosa 262-101856 assessed as reduction in bacterial growth by measuring doxycycline MIC at 8 ug/ml incubated for 18 hrs in presence of doxycycline by broth microdilution assay (Rvb = 1024 ug/ml),F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4715829,Eur J Med Chem,2019.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3547163,=,1,1,=,MIC,ug.mL-1,1024.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,1024.0
93756,,22846358,CHEMBL4722154,Antibacterial activity against Pseudomonas aeruginosa 264-101354 assessed as reduction in bacterial growth by measuring doxycycline MIC at 8 ug/ml incubated for 18 hrs in presence of doxycycline by broth microdilution assay (Rvb = 64 ug/ml),F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4715829,Eur J Med Chem,2019.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3547163,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,64.0
93757,,22846464,CHEMBL4722246,Antibacterial activity against wild type Pseudomonas aeruginosa PAO1 assessed as reduction in bacterial growth by measuring doxycycline MIC at 0.25 ug/ml incubated for 18 hrs in presence of doxycycline by broth microdilution assay (Rvb = 16 ug/ml),F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4715829,Eur J Med Chem,2019.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3547163,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,8.0
93758,,22846467,CHEMBL4722248,Antibacterial activity against Pseudomonas aeruginosa 100036 assessed as reduction in bacterial growth incubated for 18 hrs by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4715829,Eur J Med Chem,2019.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3547163,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,128.0
93759,,22846472,CHEMBL4722249,Antibacterial activity against Pseudomonas aeruginosa 101885 assessed as reduction in bacterial growth incubated for 18 hrs by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4715829,Eur J Med Chem,2019.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3547163,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,1.0
93760,,22846477,CHEMBL4722250,Antibacterial activity against Pseudomonas aeruginosa 259-96918 assessed as reduction in bacterial growth incubated for 18 hrs by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4715829,Eur J Med Chem,2019.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3547163,=,1,1,=,MIC,ug.mL-1,256.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,256.0
93761,,22846482,CHEMBL4722251,Antibacterial activity against Pseudomonas aeruginosa 260-97103 assessed as reduction in bacterial growth incubated for 18 hrs by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4715829,Eur J Med Chem,2019.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3547163,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,32.0
93762,,22846487,CHEMBL4722252,Antibacterial activity against Pseudomonas aeruginosa 262-101856 assessed as reduction in bacterial growth incubated for 18 hrs by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4715829,Eur J Med Chem,2019.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3547163,=,1,1,=,MIC,ug.mL-1,1024.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,1024.0
93763,,22846492,CHEMBL4722253,Antibacterial activity against Pseudomonas aeruginosa 264-101354 assessed as reduction in bacterial growth incubated for 18 hrs by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4715829,Eur J Med Chem,2019.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3547163,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,128.0
93764,,22846497,CHEMBL4722254,Antibacterial activity against Pseudomonas aeruginosa 91433 assessed as reduction in bacterial growth incubated for 18 hrs by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4715829,Eur J Med Chem,2019.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3547163,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,16.0
93765,,22846502,CHEMBL4722255,Antibacterial activity against Pseudomonas aeruginosa 101243 assessed as reduction in bacterial growth incubated for 18 hrs by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4715829,Eur J Med Chem,2019.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3547163,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,128.0
93766,,22846509,CHEMBL4722256,Antibacterial activity against Pseudomonas aeruginosa 114228 assessed as reduction in bacterial growth incubated for 18 hrs by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4715829,Eur J Med Chem,2019.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3547163,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,8.0
93767,Not Determined,22880986,CHEMBL4727099,Antibacterial activity against Staphylococcus aureus ATCC 29213 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4725293,Bioorg Med Chem Lett,2020.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,3551040,,1,0,,MIC,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,,,
93768,,22880999,CHEMBL4727100,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4725293,Bioorg Med Chem Lett,2020.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3551040,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,4.0
93769,,23292516,CHEMBL4839890,Antibacterial activity against wild type Pseudomonas aeruginosa LESB58 assessed as reduction in bacterial growth by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4837258,J Med Chem,2021.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3624495,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,4.0
93770,,23292522,CHEMBL4839891,Antibacterial activity against wild type Pseudomonas aeruginosa LESB58 LpxA Ser150Ala mutant assessed as reduction in bacterial growth by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4837258,J Med Chem,2021.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3624495,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,8.0
93771,,23292528,CHEMBL4839892,Antibacterial activity against wild type Pseudomonas aeruginosa LESB58 LpxA Gly120Ala mutant assessed as reduction in bacterial growth by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4837258,J Med Chem,2021.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3624495,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,4.0
93772,,23292534,CHEMBL4839893,Antibacterial activity against wild type Pseudomonas aeruginosa LESB58 RS21000 and RS21005 mutant assessed as reduction in bacterial growth by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4837258,J Med Chem,2021.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3624495,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,8.0
93773,,23292540,CHEMBL4839894,Antibacterial activity against wild type Pseudomonas aeruginosa LESB58 LpxA Ser150Ala mutant assessed as resistance development by measuring fold increase in MIC,F,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4837258,J Med Chem,2021.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,3624495,=,1,0,=,FC,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,FC,,,2.0
93774,,23292546,CHEMBL4839895,Antibacterial activity against wild type Pseudomonas aeruginosa LESB58 LpxA Gly120Ala mutant assessed as resistance development by measuring fold increase in MIC,F,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4837258,J Med Chem,2021.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,3624495,=,1,0,=,FC,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,FC,,,1.0
93775,,23292552,CHEMBL4839896,Antibacterial activity against wild type Pseudomonas aeruginosa LESB58 RS21000 and RS21005 mutant assessed as resistance development by measuring fold increase in MIC,F,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL4837258,J Med Chem,2021.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,3624495,=,1,0,=,FC,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,FC,,,2.0
93776,,24349444,CHEMBL5031847,Anti-bioflim activity against Pseudomonas aeruginosa PAO1 assessed as inhibition of bioflim formation measured at MBIC50 concentration incubated for 24 hrs by crystal violet staining based assay,F,BAO_0000201,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL5030542,J Med Chem,2021.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://qudt.org/vocab/unit#Percent,3772399,=,1,1,=,Inhibition,%,92.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,INH,%,UO_0000187,92.0
93777,,24349446,CHEMBL5031848,Antibacterial activity against Pseudomonas aeruginosa PAO1 assessed as inhibition of bacterial growth for complete inhibition of bacterial growth incubated for 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL5030542,J Med Chem,2021.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/Nanomolar,3772399,=,1,1,=,MIC,nM,2000.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,uM,UO_0000065,2.0
93778,Not Active,24356999,CHEMBL5033557,Antibiofilm activity against Pseudomonas aeruginosa assessed as reduction in CFU at 0.5 ug/ml,F,BAO_0000375,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL5032519,Eur J Med Chem,2021.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,3773828,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
93779,,24416923,CHEMBL5047613,Antibacterial activity against Pseudomonas aeruginosa PAO1 assessed as bacterial growth inhibition by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL5046248,J Med Chem,2022.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3783789,=,1,1,=,MIC,ug.mL-1,5.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,5.0
93780,,24416926,CHEMBL5047614,Antibacterial activity against Pseudomonas aeruginosa 1121 assessed as bacterial growth inhibition by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL5046248,J Med Chem,2022.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3783789,=,1,1,=,MIC,ug.mL-1,10.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,10.0
93781,,24416929,CHEMBL5047615,Antibacterial activity against Pseudomonas aeruginosa 1129 assessed as bacterial growth inhibition by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL5046248,J Med Chem,2022.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3783789,=,1,1,=,MIC,ug.mL-1,10.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,10.0
93782,,24416932,CHEMBL5047616,Antibacterial activity against Pseudomonas aeruginosa 1167 assessed as bacterial growth inhibition by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL5046248,J Med Chem,2022.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3783789,=,1,1,=,MIC,ug.mL-1,10.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,10.0
93783,,24416935,CHEMBL5047617,Antibacterial activity against Pseudomonas aeruginosa FB assessed as bacterial growth inhibition by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL5046248,J Med Chem,2022.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3783789,=,1,1,=,MIC,ug.mL-1,10.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,10.0
93784,,24663176,CHEMBL5097500,Bactericidal activity against Pseudomonas aeruginosa K1525 mexY mutant persisters assessed as reduction in CFU at 20 times MIC incubated for 24 hrs by planktonic persistance assay,F,BAO_0000181,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL5096174,J Nat Prod,2021.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,3842865,=,1,0,=,Activity,CFU/ml,250000.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,CFU/ml,,250000.0
93785,,24663177,CHEMBL5097501,Bactericidal activity against Pseudomonas aeruginosa K767 wild type assessed as decrease in cell fluorescence in presence of berberine by ethidium bromide efflux assay (Rvb = 10%),F,BAO_0001103,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL5096174,J Nat Prod,2021.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://qudt.org/vocab/unit#Percent,3842865,=,1,0,=,Activity,%,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,%,UO_0000187,2.0
93786,Active,24663184,CHEMBL5097508,Antibacterial activity against wild type Pseudomonas aeruginosa K767 assessed as reduction in bacterial growth rate in presence of berberine,F,BAO_0000375,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL5096174,J Nat Prod,2021.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,3842865,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
93787,Active,24663185,CHEMBL5097509,Antibacterial activity against Pseudomonas aeruginosa K1525 mexY mutant assessed as reduction in bacterial growth rate in presence of berberine,F,BAO_0000375,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL5096174,J Nat Prod,2021.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,3842865,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
93788,,24663186,CHEMBL5097510,Antibacterial activity against Pseudomonas aeruginosa NC01 cystic fibrosis assessed as reduction in bacterial growth,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL5096174,J Nat Prod,2021.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3842865,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,16.0
93789,,24663187,CHEMBL5097511,Antibacterial activity against Pseudomonas aeruginosa NC01 cystic fibrosis assessed as tobramycin MIC in presence of berberine,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL5096174,J Nat Prod,2021.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3842865,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,8.0
93790,,24663188,CHEMBL5097512,Antibacterial activity against Pseudomonas aeruginosa NC02 cystic fibrosis assessed as reduction in bacterial growth,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL5096174,J Nat Prod,2021.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3842865,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,32.0
93791,,24663189,CHEMBL5097513,Antibacterial activity against Pseudomonas aeruginosa NC02 cystic fibrosis assessed as tobramycin MIC in presence of berberine,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL5096174,J Nat Prod,2021.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3842865,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,16.0
93792,,24663190,CHEMBL5097514,Antibacterial activity against Pseudomonas aeruginosa NC04 cystic fibrosis assessed as reduction in bacterial growth,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL5096174,J Nat Prod,2021.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3842865,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.5
93793,,24663191,CHEMBL5097515,Antibacterial activity against Pseudomonas aeruginosa NC04 cystic fibrosis assessed as tobramycin MIC in presence of berberine,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL5096174,J Nat Prod,2021.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3842865,<,1,1,<,MIC,ug.mL-1,0.125,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.125
93794,,24663192,CHEMBL5097516,Antibacterial activity against Pseudomonas aeruginosa NC06 cystic fibrosis assessed as reduction in bacterial growth,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL5096174,J Nat Prod,2021.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3842865,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,2.0
93795,,24663193,CHEMBL5097517,Antibacterial activity against Pseudomonas aeruginosa NC06 cystic fibrosis assessed as tobramycin MIC in presence of berberine,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL5096174,J Nat Prod,2021.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3842865,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.5
93796,,24663194,CHEMBL5097518,Antibacterial activity against Pseudomonas aeruginosa NC10 cystic fibrosis assessed as reduction in bacterial growth,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL5096174,J Nat Prod,2021.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3842865,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,1.0
93797,,24663195,CHEMBL5097519,Antibacterial activity against Pseudomonas aeruginosa NC10 cystic fibrosis assessed as tobramycin MIC in presence of berberine,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL5096174,J Nat Prod,2021.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3842865,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.25
93798,,24663196,CHEMBL5097520,Antibacterial activity against cystic fibrosis isolate Pseudomonas aeruginosa C25 assessed as fold reduction in MIC in presence of berberine by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL5096174,J Nat Prod,2021.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,3842865,=,1,0,=,FC,,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,FC,,,16.0
93799,,24663197,CHEMBL5097521,Antibacterial activity against cystic fibrosis isolate Pseudomonas aeruginosa C30 assessed as reduction in MIC in presence of berberine by broth microdilution method,F,BAO_0000375,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL5096174,J Nat Prod,2021.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,3842865,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
93800,,24663198,CHEMBL5097522,Antibacterial activity against cystic fibrosis isolate Pseudomonas aeruginosa C31 assessed as reduction in MIC in presence of berberine by broth microdilution method,F,BAO_0000375,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL5096174,J Nat Prod,2021.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,3842865,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
93801,,24663199,CHEMBL5097523,Antibacterial activity against clinical isolate Pseudomonas aeruginosa C54 assessed as fold reduction in MIC in presence of berberine by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL5096174,J Nat Prod,2021.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,3842865,=,1,0,=,FC,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,FC,,,2.0
93802,,24663200,CHEMBL5097524,Antibacterial activity against clinical isolate Pseudomonas aeruginosa C59 assessed as fold reduction in MIC in presence of berberine by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL5096174,J Nat Prod,2021.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,3842865,=,1,0,=,FC,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,FC,,,2.0
93803,,24663201,CHEMBL5097525,Antibacterial activity against clinical isolate Pseudomonas aeruginosa C84 assessed as fold reduction in MIC in presence of berberine by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL5096174,J Nat Prod,2021.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,3842865,=,1,0,=,FC,,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,FC,,,4.0
93804,,24663202,CHEMBL5097526,Antibacterial activity against cystic fibrosis isolate Pseudomonas aeruginosa AR48 assessed as fold reduction in MIC in presence of berberine by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL5096174,J Nat Prod,2021.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,3842865,=,1,0,=,FC,,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,FC,,,4.0
93805,,24663203,CHEMBL5097527,Antibacterial activity against cystic fibrosis isolate Pseudomonas aeruginosa NC06 assessed as fold reduction in MIC in presence of berberine by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL5096174,J Nat Prod,2021.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,3842865,=,1,0,=,FC,,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,FC,,,4.0
93806,,24663206,CHEMBL5097530,Antibacterial activity against cystic fibrosis isolate Pseudomonas aeruginosa C31 assessed as reduction in tolerant cell in presence of berberine by broth microdilution method,F,BAO_0000375,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL5096174,J Nat Prod,2021.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,3842865,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
93807,,24663208,CHEMBL5097532,Antibacterial activity against clinical isolate Pseudomonas aeruginosa C59 assessed as reduction in tolerant cell in presence of berberine by broth microdilution method,F,BAO_0000375,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL5096174,J Nat Prod,2021.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,3842865,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
93808,,24663210,CHEMBL5097534,Antibacterial activity against cystic fibrosis isolate Pseudomonas aeruginosa AR48 assessed as reduction in tolerant cell in presence of berberine by broth microdilution method,F,BAO_0000375,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL5096174,J Nat Prod,2021.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,3842865,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
93809,,24691105,CHEMBL5105714,Binding affinity to human telomeric i-motif DNA by SPR analysis,B,BAO_0000034,BAO_0000225,nucleic acid format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL5104132,Bioorg Med Chem Lett,2022.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/Nanomolar,3849829,=,1,1,=,Kd,nM,17000.0,CHEMBL4845622,,i-motif DNA,,,Kd,uM,UO_0000065,17.0
93810,,24691106,CHEMBL5105715,Binding affinity to human c-Myc promoter i-motif DNA by SPR analysis,B,BAO_0000034,BAO_0000225,nucleic acid format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL5104132,Bioorg Med Chem Lett,2022.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/Nanomolar,3849829,=,1,1,=,Kd,nM,13000.0,CHEMBL4845622,,i-motif DNA,,,Kd,uM,UO_0000065,13.0
93811,,24780388,CHEMBL5129399,Antibacterial activity against Staphylococcus aureus incubated for 16 to 20 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL5126592,Eur J Med Chem,2022.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3867944,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
93812,,24780488,CHEMBL5129400,Antibacterial activity against Staphylococcus aureus ATCC 25923 incubated for 16 to 20 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL5126592,Eur J Med Chem,2022.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3867944,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
93813,,24780573,CHEMBL5129401,Antibacterial activity against Escherichia coli ATCC 25922 incubated for 16 to 20 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL5126592,Eur J Med Chem,2022.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3867944,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,8.0
93814,,24780658,CHEMBL5129402,Antibacterial activity against Cronobacter sakazakii ATCC 29544 incubated for 16 to 20 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL5126592,Eur J Med Chem,2022.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3867944,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL4523084,Cronobacter sakazakii,Cronobacter sakazakii,28141.0,,MIC,ug ml-1,UO_0000274,16.0
93815,,24780743,CHEMBL5129403,Antibacterial activity against Klebsiella pneumoniae ATCC 13883 incubated for 16 to 20 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL5126592,Eur J Med Chem,2022.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3867944,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,8.0
93816,,24780744,CHEMBL5129404,Antibacterial activity against Enterococcus faecium incubated for 16 to 20 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL5126592,Eur J Med Chem,2022.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3867944,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,32.0
93817,,24780760,CHEMBL5129405,Antibacterial activity against Streptococcus dysgalactiae incubated for 16 to 20 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL5126592,Eur J Med Chem,2022.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3867944,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL1075341,Streptococcus dysgalactiae,Streptococcus dysgalactiae,1334.0,,MIC,ug ml-1,UO_0000274,16.0
93818,,24780776,CHEMBL5129406,Antibacterial activity against Staphylococcus chromogenes incubated for 16 to 20 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL5126592,Eur J Med Chem,2022.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3867944,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL5209647,Staphylococcus chromogenes,Staphylococcus chromogenes,46126.0,,MIC,ug ml-1,UO_0000274,2.0
93819,,24780792,CHEMBL5129407,Antibacterial activity against Escherichia coli incubated for 16 to 20 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL5126592,Eur J Med Chem,2022.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3867944,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,32.0
93820,,24780808,CHEMBL5129408,Antibacterial activity against Pseudomonas aeruginosa LTP-3 incubated for 16 to 20 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL5126592,Eur J Med Chem,2022.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3867944,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,32.0
93821,,24812821,CHEMBL5137390,Antibacterial activity against Pseudomonas aeruginosa PAO1 assessed as reduction in bacterial growth after 18 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL5136969,RSC Med Chem,2021.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3874022,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.5
93822,,24812824,CHEMBL5137391,Antibacterial activity against Acinetobacter baumannii ATCC 17978 assessed as reduction in bacterial growth after 18 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL5136969,RSC Med Chem,2021.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3874022,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,0.5
93823,,24812828,CHEMBL5137392,Antibacterial activity against Escherichia coli ATCC 25922 assessed as reduction in bacterial growth after 18 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL5136969,RSC Med Chem,2021.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3874022,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,2.0
93824,,24812832,CHEMBL5137393,Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as reduction in bacterial growth after 18 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL5136969,RSC Med Chem,2021.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3874022,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
93825,,24812835,CHEMBL5137394,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33592 assessed as reduction in bacterial growth after 18 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL5136969,RSC Med Chem,2021.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3874022,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
93826,,24812838,CHEMBL5137395,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis 61589 assessed as reduction in bacterial growth after 18 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL5136969,RSC Med Chem,2021.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3874022,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,8.0
93827,,24812841,CHEMBL5137396,Antibacterial activity against Enterococcus faecalis ATCC 29212 assessed as reduction in bacterial growth after 18 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL5136969,RSC Med Chem,2021.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3874022,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,8.0
93828,,24812844,CHEMBL5137397,Antibacterial activity against Enterococcus faecium ATCC 27270 assessed as reduction in bacterial growth after 18 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL5136969,RSC Med Chem,2021.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3874022,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,16.0
93829,,24909963,CHEMBL5162990,Antibacterial activity against Methicillin resistant Staphylococcus aureus ATCC BAA -1556 assessed as reduction in microbial growth incubated for 24 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL5154823,Eur J Med Chem,2022.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3893126,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
93830,,24909976,CHEMBL5162991,Antibacterial activity against Escherichia coli ATCC 25922 assessed as reduction in microbial growth incubated for 24 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL5154823,Eur J Med Chem,2022.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3893126,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,8.0
93831,,24909993,CHEMBL5162993,Antibacterial activity against imipenem resistant Klebsiella pneumoniae ATCC BAA 1705 assessed as reduction in microbial growth incubated for 24 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL5154823,Eur J Med Chem,2022.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3893126,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,16.0
93832,,24910006,CHEMBL5162994,Antibacterial activity against Pseudomonas aeruginosa ATCC 27883 assessed as reduction in microbial growth incubated for 24 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL5154823,Eur J Med Chem,2022.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3893126,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.5
93833,,24992106,CHEMBL5230211,Antibacterial activity against multi drug resistant Pseudomonas aeruginosa assessed as reduction in microbial growth after 16 to 18 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL5230081,J Med Chem,2019.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/Nanomolar,3907964,=,1,1,=,MIC,nM,700.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,uM,UO_0000065,0.7
93834,,25003371,CHEMBL5233815,Inhibition of miR-27a (unknown origin) maturation at 5 uM relative to control,B,BAO_0000201,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL5233220,Eur J Med Chem,2020.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://qudt.org/vocab/unit#Percent,3911855,=,1,1,=,Inhibition,%,10.0,CHEMBL612545,,Unchecked,,,INH,%,UO_0000187,10.0
93835,,25019287,CHEMBL5239023,Antibacterial activity against methicillin resistant Staphylococcus aureus ATCC BAA-1556 incubated for 24 hrs by checkerboard assay,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL5236607,J Med Chem,2022.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3916298,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
93836,,25019298,CHEMBL5239024,Antibacterial activity against Pseudomonas aeruginosa ATCC 27883 incubated for 24 hrs by checkerboard assay,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL5236607,J Med Chem,2022.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3916298,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.5
93837,,25019309,CHEMBL5239025,Antibacterial activity against Escherichia coli ATCC 25922 incubated for 24 hrs by checkerboard assay,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL5236607,J Med Chem,2022.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3916298,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,8.0
93838,,25019320,CHEMBL5239026,Antibacterial activity against Klebsiella pneumoniae ATCC BAA-1705 incubated for 24 hrs by checkerboard assay,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL5236607,J Med Chem,2022.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3916298,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,16.0
93839,,25023519,CHEMBL5240104,In vivo antibacterial activity against Pseudomonas aeruginosa ATCC 9027 infected in C57BL/6 mouse keratitis model assessed as reduction in number of viable bacterial colonies in infected cornea at 3 mg/kg topically 4 times per day for 3 consecutive days,F,BAO_0000181,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL5236632,J Med Chem,2022.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,,3916908,=,1,0,=,Activity,log10CFU/ml,4.64,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,log10CFU/ml,,4.64
93840,,25065701,CHEMBL5251425,Antibacterial activity against clinical isolate Acinetobacter baumannii assessed as bacterial growth inhibition at 32 ug/ml by CLSI based broth microdilution method relative to control,F,BAO_0000201,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL5247650,J Med Chem,2023.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://qudt.org/vocab/unit#Percent,3928738,=,1,1,=,Inhibition,%,100.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,INH,%,UO_0000187,100.0
93841,,25078174,CHEMBL5255043,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 assessed as bacterial growth inhibition resazurin dye based microplate analysis,F,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL5252577,J Nat Prod,2023.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3931099,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC90,ug ml-1,UO_0000274,1.0
93842,,25095365,CHEMBL5259862,Antibacterial activity against Escherichia coli ATCC 8730 assessed as bacterial growth inhibition,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL5257111,RSC Med Chem,2023.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3934995,>,1,1,>,MIC,ug.mL-1,512.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,512.0
93843,,25095368,CHEMBL5259863,Antibacterial activity against Klebsiella pneumoniae ATCC 10031 assessed as reduction in microbial growth,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL5257111,RSC Med Chem,2023.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3934995,>,1,1,>,MIC,ug.mL-1,512.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,512.0
93844,,25095371,CHEMBL5259864,Antibacterial activity against Enterobacter aerogenes ATCC 13048 assessed as reduction in bacterial growth,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL5257111,RSC Med Chem,2023.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3934995,>,1,1,>,MIC,ug.mL-1,512.0,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC,ug ml-1,UO_0000274,512.0
93845,,25095374,CHEMBL5259865,Antibacterial activity against Enterobacter cloacae ATCC 29893 assessed as reduction in microbial growth,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL5257111,RSC Med Chem,2023.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3934995,>,1,1,>,MIC,ug.mL-1,512.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC,ug ml-1,UO_0000274,512.0
93846,,25095377,CHEMBL5259866,Antibacterial activity against Citrobacter amalonaticus assessed as reduction in microbial growth,F,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,CHEMBL5257111,RSC Med Chem,2023.0,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3934995,>,1,1,>,MIC,ug.mL-1,512.0,CHEMBL615077,Citrobacter amalonaticus,Citrobacter amalonaticus,35703.0,,MIC,ug ml-1,UO_0000274,512.0
93847,,77835,CHEMBL680694,"Inhibition of [3H]tetracycline uptake into everted membrane vesicles, prepared from tetracycline resistant Escherichia coli D1-209",F,BAO_0000190,BAO_0000019,assay format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1126586,J Med Chem,1993.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://www.openphacts.org/units/Nanomolar,235764,=,1,1,=,IC50,nM,13200.0,CHEMBL4785,Escherichia coli K-12,Multidrug translocase mdfA,83333.0,,IC50,uM,UO_0000065,13.2
93848,,356971,CHEMBL842630,Compound was evaluated for the inhibition of cell proliferation of human ocular lens epithelium (CECH).,F,BAO_0000190,BAO_0000221,tissue-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1152061,Bioorg Med Chem Lett,1996.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://www.openphacts.org/units/Nanomolar,133423,=,1,1,=,IC50,nM,207000.0,CHEMBL612545,,Unchecked,,,IC50,uM,UO_0000065,207.0
93849,,356972,CHEMBL851780,"Cytotoxicity ratio for Human hepatocellular carcinoma, HepG2 (ATCC HB 8065) cells",F,BAO_0000193,BAO_0000219,cell-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1152061,Bioorg Med Chem Lett,1996.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,,133423,=,1,0,=,Ratio,,1.62,CHEMBL3879801,,NON-PROTEIN TARGET,,,Ratio,,,1.62
93850,,646797,CHEMBL807074,Minimum inhibitory concentration against Staphylococcus aureus,F,BAO_0003035,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1149101,J Med Chem,2004.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://www.openphacts.org/units/MicrogramPerMilliliter,58613,>,1,1,>,MIC50,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC50,ug ml-1,UO_0000274,16.0
93851,,646798,CHEMBL806953,Minimum inhibitory concentration against Staphylococcus aureus,F,BAO_0000179,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1149101,J Med Chem,2004.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://www.openphacts.org/units/MicrogramPerMilliliter,58613,>,1,1,>,MIC90,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,ug ml-1,UO_0000274,16.0
93852,,657044,CHEMBL676723,In vitro minimum inhibitory concentration against Escherichia coli UBMS 88-1 (tet B efflux).,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1127493,J Med Chem,1994.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://www.openphacts.org/units/MicrogramPerMilliliter,94147,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,32.0
93853,,657045,CHEMBL676722,In vitro minimum inhibitory concentration against Escherichia coli PRP-1 (tet A efflux).,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1127493,J Med Chem,1994.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://www.openphacts.org/units/MicrogramPerMilliliter,94147,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,32.0
93854,,657046,CHEMBL677725,In vitro minimum inhibitory concentration against Escherichia coli J3272 (tet C efflux).,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1127493,J Med Chem,1994.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://www.openphacts.org/units/MicrogramPerMilliliter,94147,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,32.0
93855,,657047,CHEMBL677726,In vitro minimum inhibitory concentration against Escherichia coli J3272 (tet D efflux).,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1127493,J Med Chem,1994.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://www.openphacts.org/units/MicrogramPerMilliliter,94147,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,32.0
93856,,657048,CHEMBL676724,In vitro minimum inhibitory concentration against Escherichia coli UBMS 90-4 (tet M ribosomal protection).,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1127493,J Med Chem,1994.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://www.openphacts.org/units/MicrogramPerMilliliter,94147,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,32.0
93857,,657049,CHEMBL676725,In vitro minimum inhibitory concentration against Escherichia coli UBMS 90-5 (sensitive).,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1127493,J Med Chem,1994.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://www.openphacts.org/units/MicrogramPerMilliliter,94147,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,1.0
93858,,657050,CHEMBL880926,In vitro minimum inhibitory concentration against Staphylococcus aureus UBMS 88-7 (tet K efflux).,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1127493,J Med Chem,1994.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://www.openphacts.org/units/MicrogramPerMilliliter,94147,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,32.0
93859,,657051,CHEMBL805469,In vitro minimum inhibitory concentration against Staphylococcus aureus UBMS 90-1 (tet M ribosomal protection).,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1127493,J Med Chem,1994.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://www.openphacts.org/units/MicrogramPerMilliliter,94147,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,32.0
93860,,657052,CHEMBL805470,In vitro minimum inhibitory concentration against Staphylococcus aureus UBMS 90-3 (sensitive).,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1127493,J Med Chem,1994.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://www.openphacts.org/units/MicrogramPerMilliliter,94147,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
93861,,657053,CHEMBL805471,In vitro minimum inhibitory concentration against Staphylococcus aureus smith (sensitive).,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1127493,J Med Chem,1994.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://www.openphacts.org/units/MicrogramPerMilliliter,94147,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
93862,,657054,CHEMBL676522,In vitro minimum inhibitory concentration against Enterococcus faecalis ATCC 29212.,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1127493,J Med Chem,1994.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://www.openphacts.org/units/MicrogramPerMilliliter,94147,=,1,1,=,MIC,ug.mL-1,18.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,18.0
93863,,749877,CHEMBL636723,Evaluated for the in vitro minimum bactericidal concentration (MBC) against periopathogenic Actinomycetes viscosus bacteria,F,BAO_0000179,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1123582,J Med Chem,1987.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://www.openphacts.org/units/MicrogramPerMilliliter,112271,=,1,0,=,MBC,ug ml-1,0.5,CHEMBL613078,Actinomyces viscosus,Actinomyces viscosus,1656.0,,MBC,ug ml-1,UO_0000274,0.5
93864,,749878,CHEMBL647224,Evaluated for the in vitro minimum bactericidal concentration (MBC) against periopathogenic Bacteroides gingivalis bacteria,F,BAO_0000179,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1123582,J Med Chem,1987.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://www.openphacts.org/units/MicrogramPerMilliliter,112271,=,1,0,=,MBC,ug ml-1,0.05,CHEMBL614414,Porphyromonas gingivalis,Porphyromonas gingivalis,837.0,,MBC,ug ml-1,UO_0000274,0.05
93865,,749879,CHEMBL636949,Evaluated for the in vitro minimum bactericidal concentration (MBC) against periopathogenic Actinobacillus actinomycetemcommitans bacteria,F,BAO_0000179,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1123582,J Med Chem,1987.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://www.openphacts.org/units/MicrogramPerMilliliter,112271,=,1,0,=,MBC,ug ml-1,0.5,CHEMBL614406,Aggregatibacter actinomycetemcomitans,Aggregatibacter actinomycetemcomitans,714.0,,MBC,ug ml-1,UO_0000274,0.5
93866,,1116674,CHEMBL654358,In vitro inhibition of human recombinant IL-1-beta-induced breakdown of bovine cartilage in a cartilage organ culture assay,F,BAO_0000190,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1127463,J Med Chem,1994.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://www.openphacts.org/units/Nanomolar,195088,>,1,1,>,IC50,nM,30000.0,CHEMBL613489,Bos taurus,Bos taurus,9913.0,,IC50,uM,UO_0000065,30.0
93867,,1228412,CHEMBL679856,In vitro antibacterial activity against Escherichia coli UBMS 88-1 Tet B,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1131723,Bioorg Med Chem Lett,1999.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,,53020,>,1,0,>,MIC,ug mg-1,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug mg-1,,32.0
93868,,1228413,CHEMBL679697,In vitro antibacterial activity against Escherichia coli PRP1 Tet A,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1131723,Bioorg Med Chem Lett,1999.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,,53020,=,1,0,=,MIC,ug mg-1,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug mg-1,,32.0
93869,,1228414,CHEMBL679691,In vitro antibacterial activity against Escherichia coli J3272 Tet C,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1131723,Bioorg Med Chem Lett,1999.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,,53020,>,1,0,>,MIC,ug mg-1,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug mg-1,,32.0
93870,,1228415,CHEMBL679692,In vitro antibacterial activity against Escherichia coli J3272 Tet D,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1131723,Bioorg Med Chem Lett,1999.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,,53020,=,1,0,=,MIC,ug mg-1,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug mg-1,,8.0
93871,,1228416,CHEMBL679857,In vitro antibacterial activity against Escherichia coli UBMS 90-4 Tet M,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1131723,Bioorg Med Chem Lett,1999.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,,53020,>,1,0,>,MIC,ug mg-1,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug mg-1,,32.0
93872,,1228417,CHEMBL679859,In vitro antibacterial activity against Escherichia coli UBMS 90-5 sensitive,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1131723,Bioorg Med Chem Lett,1999.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,,53020,=,1,0,=,MIC,ug mg-1,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug mg-1,,1.0
93873,,1228418,CHEMBL858627,In vitro antibacterial activity against Staphylococcus aureus UBMS 88-7 Tet K,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1131723,Bioorg Med Chem Lett,1999.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,,53020,>,1,0,>,MIC,ug mg-1,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug mg-1,,32.0
93874,,1228419,CHEMBL810419,In vitro antibacterial activity against Staphylococcus aureus UBMS 90-1 Tet M,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1131723,Bioorg Med Chem Lett,1999.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,,53020,>,1,0,>,MIC,ug mg-1,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug mg-1,,32.0
93875,,1228420,CHEMBL810420,In vitro antibacterial activity against Staphylococcus aureus UBMS 90-3 sensitive,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1131723,Bioorg Med Chem Lett,1999.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,,53020,=,1,0,=,MIC,ug mg-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug mg-1,,0.25
93876,,1228421,CHEMBL810418,In vitro antibacterial activity against Staphylococcus aureus Smith sensitive,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1131723,Bioorg Med Chem Lett,1999.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,,53020,=,1,0,=,MIC,ug mg-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug mg-1,,0.25
93877,,1228422,CHEMBL674209,In vitro antibacterial activity against Enterococcus ATCC 29212,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1131723,Bioorg Med Chem Lett,1999.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,,53020,=,1,0,=,MIC,ug mg-1,16.0,CHEMBL612318,Enterococcus,Enterococcus,1350.0,,MIC,ug mg-1,,16.0
93878,,1230236,CHEMBL694417,Minimum inhibitory concentration against Helicobacter pylori (Helicobacter pylori) ARHp strain 80,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1135789,J Med Chem,2002.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://www.openphacts.org/units/MicrogramPerMilliliter,261598,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL612600,Helicobacter pylori,Helicobacter pylori,210.0,,MIC,ug ml-1,UO_0000274,1.0
93879,,1230237,CHEMBL694418,Minimum inhibitory concentration against Helicobacter pylori (Helicobacter pylori) ARHp strain 81,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1135789,J Med Chem,2002.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://www.openphacts.org/units/MicrogramPerMilliliter,261598,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL612600,Helicobacter pylori,Helicobacter pylori,210.0,,MIC,ug ml-1,UO_0000274,1.0
93880,,1230238,CHEMBL694415,Minimum inhibitory concentration against Helicobacter pylori (Helicobacter pylori) ARHp strain 115,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1135789,J Med Chem,2002.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://www.openphacts.org/units/MicrogramPerMilliliter,261598,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL612600,Helicobacter pylori,Helicobacter pylori,210.0,,MIC,ug ml-1,UO_0000274,1.0
93881,,1230239,CHEMBL694416,Minimum inhibitory concentration against Helicobacter pylori (Helicobacter pylori) ARHp strain 206,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1135789,J Med Chem,2002.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://www.openphacts.org/units/MicrogramPerMilliliter,261598,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL612600,Helicobacter pylori,Helicobacter pylori,210.0,,MIC,ug ml-1,UO_0000274,1.0
93882,,1270425,CHEMBL812638,Inhibition of telomerase before assembly using recombinant Tetraymena thermophilia TR and TERT at 50 uM,B,BAO_0000201,BAO_0000019,assay format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1147465,Bioorg Med Chem Lett,2004.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://qudt.org/vocab/unit#Percent,220401,=,1,1,=,Inhibition,%,0.0,CHEMBL612545,,Unchecked,,,Inhibition,%,UO_0000187,0.0
93883,,1270426,CHEMBL812637,Inhibition of telomerase after assembly using recombinant Tetraymena thermophilia TR and TERT at 50 uM,B,BAO_0000201,BAO_0000019,assay format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1147465,Bioorg Med Chem Lett,2004.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://qudt.org/vocab/unit#Percent,220401,=,1,1,=,Inhibition,%,0.0,CHEMBL612545,,Unchecked,,,Inhibition,%,UO_0000187,0.0
93884,,1270427,CHEMBL812636,Inhibition of purified telomerase of Euplotes aediculatus at 50 uM,B,BAO_0000201,BAO_0000019,assay format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1147465,Bioorg Med Chem Lett,2004.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://qudt.org/vocab/unit#Percent,220401,=,1,1,=,Inhibition,%,0.0,CHEMBL612545,,Unchecked,,,Inhibition,%,UO_0000187,0.0
93885,,1274546,CHEMBL653386,In vitro ability to inhibit cartilage breakdown by using 1L-1beta stimulated bovine nasal cartilage assay,F,BAO_0000190,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1127174,Bioorg Med Chem Lett,1993.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://www.openphacts.org/units/Nanomolar,180818,>,1,1,>,IC50,nM,30000.0,CHEMBL613489,Bos taurus,Bos taurus,9913.0,,IC50,uM,UO_0000065,30.0
93886,Susceptible,1498842,CHEMBL836753,Susceptibility testing against Pseudomonas aeruginosa ATCC 27853; S=Susceptible,F,BAO_0000375,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1143542,Bioorg Med Chem Lett,2005.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,,394543,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
93887,Resistant,1498843,CHEMBL835992,Susceptibility testing against Pseudomonas aeruginosa PAE_NUH18; R=Resistant,F,BAO_0000375,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1143542,Bioorg Med Chem Lett,2005.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,,394543,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
93888,Resistant,1498844,CHEMBL835993,Susceptibility testing against Pseudomonas aeruginosa PAE_NUH19; R=Resistant,F,BAO_0000375,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1143542,Bioorg Med Chem Lett,2005.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,,394543,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
93889,Resistant,1498845,CHEMBL835994,Susceptibility testing against Pseudomonas aeruginosa PAE_NUH20; R=Resistant,F,BAO_0000375,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1143542,Bioorg Med Chem Lett,2005.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,,394543,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
93890,Partial resistance,1498846,CHEMBL836145,Susceptibility testing against Pseudomonas aeruginosa PAE_NUH21; I=Intermediate,F,BAO_0000375,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1143542,Bioorg Med Chem Lett,2005.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,,394543,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
93891,Resistant,1498847,CHEMBL835996,Susceptibility testing against Pseudomonas aeruginosa PAE_NUH22; R=Resistant,F,BAO_0000375,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1143542,Bioorg Med Chem Lett,2005.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,,394543,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
93892,Resistant,1498848,CHEMBL835997,Susceptibility testing against Pseudomonas aeruginosa PAE_NUH23; R=Resistant,F,BAO_0000375,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1143542,Bioorg Med Chem Lett,2005.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,,394543,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
93893,Resistant,1498849,CHEMBL835998,Susceptibility testing against Pseudomonas aeruginosa PAE_NUH24; R=Resistant,F,BAO_0000375,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1143542,Bioorg Med Chem Lett,2005.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,,394543,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
93894,Resistant,1498850,CHEMBL835999,Susceptibility testing against Pseudomonas aeruginosa PAE_NUH25; R=Resistant,F,BAO_0000375,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1143542,Bioorg Med Chem Lett,2005.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,,394543,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
93895,Resistant,1498851,CHEMBL835984,Susceptibility testing against Pseudomonas aeruginosa PAE_NUH01; R=Resistant,F,BAO_0000375,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1143542,Bioorg Med Chem Lett,2005.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,,394543,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
93896,Resistant,1498852,CHEMBL835985,Susceptibility testing against Pseudomonas aeruginosa PAE_NUH02; R=Resistant,F,BAO_0000375,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1143542,Bioorg Med Chem Lett,2005.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,,394543,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
93897,Resistant,1498853,CHEMBL835986,Susceptibility testing against Pseudomonas aeruginosa PAE_NUH03; R=Resistant,F,BAO_0000375,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1143542,Bioorg Med Chem Lett,2005.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,,394543,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
93898,Resistant,1498854,CHEMBL835987,Susceptibility testing against Pseudomonas aeruginosa PAE_NUH04; R=Resistant,F,BAO_0000375,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1143542,Bioorg Med Chem Lett,2005.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,,394543,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
93899,Resistant,1498855,CHEMBL835988,Susceptibility testing against Pseudomonas aeruginosa PAE_NUH05; R=Resistant,F,BAO_0000375,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1143542,Bioorg Med Chem Lett,2005.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,,394543,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
93900,Resistant,1498856,CHEMBL835989,Susceptibility testing against Pseudomonas aeruginosa PAE_NUH06; R=Resistant,F,BAO_0000375,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1143542,Bioorg Med Chem Lett,2005.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,,394543,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
93901,Resistant,1498857,CHEMBL835990,Susceptibility testing against Pseudomonas aeruginosa PAE_NUH07; R=Resistant,F,BAO_0000375,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1143542,Bioorg Med Chem Lett,2005.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,,394543,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
93902,Resistant,1498858,CHEMBL835991,Susceptibility testing against Pseudomonas aeruginosa PAE_NUH17; R=Resistant,F,BAO_0000375,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1143542,Bioorg Med Chem Lett,2005.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,,394543,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
93903,,1684967,CHEMBL868315,Antibacterial activity against Xanthomonas campestris pvs by disk diffusion method at 10 ug/disk,F,BAO_0003039,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1138110,Bioorg Med Chem Lett,2006.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://qudt.org/vocab/unit#Millimeter,428043,=,1,1,=,IZ,mm,12.0,CHEMBL612276,Xanthomonas campestris,Xanthomonas campestris,339.0,,IZ,millimeter,UO_0000016,12.0
93904,,1684968,CHEMBL868317,Antibacterial activity against Xanthomonas oryzae by disk diffusion method at 10 ug/disk,F,BAO_0003039,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1138110,Bioorg Med Chem Lett,2006.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://qudt.org/vocab/unit#Millimeter,428043,=,1,1,=,IZ,mm,11.0,CHEMBL613861,Xanthomonas oryzae,Xanthomonas oryzae,347.0,,IZ,millimeter,UO_0000016,11.0
93905,,1794941,CHEMBL908714,Inhibition of protein synthesis in Escherichia coli S30 extracts by coupled transcription-translation assay,F,BAO_0000190,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1137289,Bioorg Med Chem Lett,2006.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://www.openphacts.org/units/Nanomolar,619488,=,1,1,=,IC50,nM,2800.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,IC50,uM,UO_0000065,2.8
93906,,1804666,CHEMBL910461,Antibacterial activity against Escherichia coli W3110,F,BAO_0003039,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1138862,J Med Chem,2006.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://qudt.org/vocab/unit#Millimeter,620825,=,1,1,=,IZ,mm,21.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,IZ,mm,UO_0000016,21.0
93907,,1804772,CHEMBL910462,Antibacterial activity against Escherichia coli pTMV19,F,BAO_0003039,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1138862,J Med Chem,2006.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://qudt.org/vocab/unit#Millimeter,620825,=,1,1,=,IZ,mm,21.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,IZ,mm,UO_0000016,21.0
93908,,1804820,CHEMBL910463,Antibacterial activity against Escherichia coli pTMV19 in presence of mevalonate,F,BAO_0003039,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1138862,J Med Chem,2006.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://qudt.org/vocab/unit#Millimeter,620825,=,1,1,=,IZ,mm,22.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,IZ,mm,UO_0000016,22.0
93909,,1808216,CHEMBL911295,Antimicrobial activity against Helicobacter pylori DSMZ 4867,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1139707,Bioorg Med Chem Lett,2006.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://www.openphacts.org/units/MicrogramPerMilliliter,622789,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL612600,Helicobacter pylori,Helicobacter pylori,210.0,,MIC,ug ml-1,UO_0000274,4.0
93910,,1827811,CHEMBL912647,Inhibition of Plasmodium falciparum FCK2 growth as [3H]hypoxanthine uptake after 48 hrs,F,BAO_0000190,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1142150,Antimicrob Agents Chemother,2007.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://www.openphacts.org/units/Nanomolar,625662,=,1,1,=,IC50,nM,134900.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,IC50,uM,UO_0000065,134.9
93911,,1827812,CHEMBL912647,Inhibition of Plasmodium falciparum FCK2 growth as [3H]hypoxanthine uptake after 48 hrs,F,BAO_0000179,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1142150,Antimicrob Agents Chemother,2007.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://www.openphacts.org/units/Nanomolar,625662,=,1,1,=,MIC90,nM,562300.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,MIC90,uM,UO_0000065,562.3
93912,,1827838,CHEMBL912648,Inhibition of Plasmodium falciparum FCK2 growth as [3H]hypoxanthine uptake after 96 hrs,F,BAO_0000190,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1142150,Antimicrob Agents Chemother,2007.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://www.openphacts.org/units/Nanomolar,625662,=,1,1,=,IC50,nM,2190.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,IC50,uM,UO_0000065,2.19
93913,,1827839,CHEMBL912648,Inhibition of Plasmodium falciparum FCK2 growth as [3H]hypoxanthine uptake after 96 hrs,F,BAO_0000179,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1142150,Antimicrob Agents Chemother,2007.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://www.openphacts.org/units/Nanomolar,625662,=,1,1,=,MIC90,nM,26900.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,MIC90,uM,UO_0000065,26.9
93914,Active,1827981,CHEMBL912650,Decrease in Plasmodium falciparum FCK2 in erythrocytes at 50 uM after 84 hrs,F,BAO_0000375,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1142150,Antimicrob Agents Chemother,2007.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,,625662,,1,0,,Activity,,,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,Activity,,,
93915,Active,1827982,CHEMBL912651,Inhibition of Plasmodium falciparum FCK2 second cycle growth in erythrocytes at 48 hrs,F,BAO_0000375,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1142150,Antimicrob Agents Chemother,2007.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,,625662,,1,0,,Activity,,,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,Activity,,,
93916,,1827986,CHEMBL912652,Reduction in Plasmodium falciparum FCK2 in human blood cell culture after 96 hrs,F,BAO_0001103,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1142150,Antimicrob Agents Chemother,2007.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://qudt.org/vocab/unit#Percent,625662,=,1,0,=,Activity,%,10.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,Activity,%,UO_0000187,10.0
93917,Not Active,1827987,CHEMBL912653,Reduction in Plasmodium falciparum FCK2 in human erythrocyte culture after 48 hrs,F,BAO_0000375,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1142150,Antimicrob Agents Chemother,2007.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,,625662,,1,0,,Activity,,,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,Activity,,,
93918,,1828058,CHEMBL912047,Reduced apicoplast DNA/nuclear DNA ratio in Plasmodium falciparum FCK2 at 100 uM after 72 hrs by competitive PCR,F,BAO_0000375,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1142150,Antimicrob Agents Chemother,2007.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,,625662,=,1,0,=,Activity,,0.1,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,Activity,,,0.1
93919,,1828343,CHEMBL853485,Antibacterial activity against vancomycin-resistant Staphylococcus aureus isolate 595,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1142154,Antimicrob Agents Chemother,2007.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625684,>,1,1,>,MIC,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,16.0
93920,,1828350,CHEMBL853486,Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 5737,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1142154,Antimicrob Agents Chemother,2007.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625684,<=,1,1,<=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
93921,,1828357,CHEMBL853487,Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 5739,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1142154,Antimicrob Agents Chemother,2007.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625684,<=,1,1,<=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
93922,,1828364,CHEMBL853488,Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 2513,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1142154,Antimicrob Agents Chemother,2007.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625684,<=,1,1,<=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
93923,,1828371,CHEMBL854617,Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 2530,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1142154,Antimicrob Agents Chemother,2007.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625684,<=,1,1,<=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
93924,,1828378,CHEMBL854618,Antibacterial activity against vancomycin-resistant Staphylococcus aureus isolate 2514,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1142154,Antimicrob Agents Chemother,2007.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625684,>,1,1,>,MIC,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,16.0
93925,,1828385,CHEMBL854619,Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 5735,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1142154,Antimicrob Agents Chemother,2007.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625684,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
93926,,1828392,CHEMBL854620,Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 5736,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1142154,Antimicrob Agents Chemother,2007.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625684,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
93927,,1828399,CHEMBL854621,Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 5733,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1142154,Antimicrob Agents Chemother,2007.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625684,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
93928,,1828406,CHEMBL854622,Antibacterial activity against vancomycin-resistant Staphylococcus aureus isolate 5734,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1142154,Antimicrob Agents Chemother,2007.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625684,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,16.0
93929,,1828458,CHEMBL854623,Antibacterial activity against Enterococcus faecalis isolate 5744,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1142154,Antimicrob Agents Chemother,2007.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625684,>,1,1,>,MIC,ug.mL-1,16.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,16.0
93930,,1828466,CHEMBL854624,Antibacterial activity against Enterococcus faecalis isolate 5743,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1142154,Antimicrob Agents Chemother,2007.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625684,>,1,1,>,MIC,ug.mL-1,16.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,16.0
93931,,1828475,CHEMBL854625,Antibacterial activity against Enterococcus faecalis isolate 5742,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1142154,Antimicrob Agents Chemother,2007.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625684,>,1,1,>,MIC,ug.mL-1,16.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,16.0
93932,,1828483,CHEMBL854626,Antibacterial activity against Enterococcus faecium isolate 2547,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1142154,Antimicrob Agents Chemother,2007.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625684,>,1,1,>,MIC,ug.mL-1,16.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,16.0
93933,,1828490,CHEMBL854627,Antibacterial activity against Enterococcus faecium isolate 5749,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1142154,Antimicrob Agents Chemother,2007.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625684,>,1,1,>,MIC,ug.mL-1,16.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,16.0
93934,,1828498,CHEMBL854628,Antibacterial activity against Enterococcus faecium isolate 5750,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1142154,Antimicrob Agents Chemother,2007.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625684,>,1,1,>,MIC,ug.mL-1,16.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,16.0
93935,,1828506,CHEMBL854629,Antibacterial activity against Enterococcus faecium isolate 5751,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1142154,Antimicrob Agents Chemother,2007.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625684,>,1,1,>,MIC,ug.mL-1,16.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,16.0
93936,,1828513,CHEMBL854630,Antibacterial activity against Enterococcus faecium isolate 5752,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1142154,Antimicrob Agents Chemother,2007.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625684,>,1,1,>,MIC,ug.mL-1,16.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,16.0
93937,,1828520,CHEMBL854631,Antibacterial activity against Enterococcus faecium isolate 5753,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1142154,Antimicrob Agents Chemother,2007.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625684,>,1,1,>,MIC,ug.mL-1,16.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,16.0
93938,,1828527,CHEMBL854632,Antibacterial activity against Enterococcus faecalis isolate 5745,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1142154,Antimicrob Agents Chemother,2007.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625684,>,1,1,>,MIC,ug.mL-1,16.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,16.0
93939,,1828534,CHEMBL854633,Antibacterial activity against Enterococcus faecalis isolate 5746,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1142154,Antimicrob Agents Chemother,2007.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625684,<=,1,1,<=,MIC,ug.mL-1,0.5,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,0.5
93940,,1828971,CHEMBL909773,Increase in lactate production in primary human osteoblasts at 190 ug/ml by ELISA,F,BAO_0001103,BAO_0000219,cell-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1142165,Antimicrob Agents Chemother,2007.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://qudt.org/vocab/unit#Percent,625756,=,1,0,=,Activity,%,30.0,CHEMBL612582,,Osteoblast,,,Activity,%,UO_0000187,30.0
93941,,1829069,CHEMBL909765,Antiproliferative effect against primary human osteoblasts assessed as BrdU incorporation into DNA after 48 hrs,F,BAO_0000190,BAO_0000219,cell-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1142165,Antimicrob Agents Chemother,2007.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625756,=,1,1,=,IC50,ug.mL-1,180.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,IC50,ug ml-1,UO_0000274,180.0
93942,Not Determined,1829070,CHEMBL909766,Inhibition of metabolic activity in primary human osteoblasts assessed as MTT reduction after 48 hrs,F,BAO_0000190,BAO_0000219,cell-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1142165,Antimicrob Agents Chemother,2007.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,,625756,,1,0,,IC50,,,CHEMBL612582,,Osteoblast,,,IC50,,,
93943,,1833688,CHEMBL856444,Antibacterial activity against methicillin-resistant Staphylococcus aureus isolates from skin or soft tissue infection outpatients,F,BAO_0001103,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1142184,Antimicrob Agents Chemother,2007.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://qudt.org/vocab/unit#Percent,625862,=,1,0,=,Activity,%,53.8,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,53.8
93944,,1833696,CHEMBL855426,Antibacterial activity against methicillin-susceptible Staphylococcus aureus isolates from skin or soft tissue infection outpatients,F,BAO_0001103,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1142184,Antimicrob Agents Chemother,2007.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://qudt.org/vocab/unit#Percent,625862,=,1,0,=,Activity,%,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,0.0
93945,,1835802,CHEMBL854042,Antimicrobial activity against Salmonella enterica serovar Typhimurium S21,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625594,<,1,1,<,MIC,ug.mL-1,4.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,MIC,ug ml-1,UO_0000274,4.0
93946,,1835817,CHEMBL854043,Antimicrobial activity against Salmonella enterica serovar Typhimurium S21 gyrA+,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625594,<,1,1,<,MIC,ug.mL-1,4.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,MIC,ug ml-1,UO_0000274,4.0
93947,,1835832,CHEMBL854044,Antimicrobial activity against Salmonella enterica serovar Typhimurium S21 acrAB::Kan,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625594,<,1,1,<,MIC,ug.mL-1,4.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,MIC,ug ml-1,UO_0000274,4.0
93948,,1835847,CHEMBL854045,Antimicrobial activity against Salmonella enterica serovar Typhimurium S21 tolC::Kan,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625594,<,1,1,<,MIC,ug.mL-1,4.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,MIC,ug ml-1,UO_0000274,4.0
93949,,1835862,CHEMBL854046,Antimicrobial activity against Salmonella enterica serovar Typhimurium S21-1 GyrA S83F mutant,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625594,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,MIC,ug ml-1,UO_0000274,32.0
93950,,1835877,CHEMBL854047,Antimicrobial activity against Salmonella enterica serovar Typhimurium S21-1 gyrA+,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625594,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,MIC,ug ml-1,UO_0000274,32.0
93951,,1835892,CHEMBL854048,Antimicrobial activity against Salmonella enterica serovar Typhimurium GyrA S21-1 acrAB::Kan with GyrA S83F mutation,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625594,<,1,1,<,MIC,ug.mL-1,4.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,MIC,ug ml-1,UO_0000274,4.0
93952,,1835907,CHEMBL854049,Antimicrobial activity against Salmonella enterica serovar Typhimurium S21-1 tolC::Kan with GyrA S83F mutation,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625594,<,1,1,<,MIC,ug.mL-1,4.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,MIC,ug ml-1,UO_0000274,4.0
93953,,1835922,CHEMBL854050,"Antimicrobial activity against Salmonella enterica serovar Typhimurium S21-2 with GyrA S83F, ParC S80I mutation",F,BAO_0002146,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625594,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,MIC,ug ml-1,UO_0000274,32.0
93954,,1835937,CHEMBL854051,Antimicrobial activity against Salmonella enterica serovar Typhimurium S21-2 gyrA+ with ParC S80I mutation,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625594,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,MIC,ug ml-1,UO_0000274,32.0
93955,,1835952,CHEMBL854052,"Antimicrobial activity against Salmonella enterica serovar Typhimurium S21-2 acrAB::Kan with GyrA S83F, ParC S80I mutation",F,BAO_0002146,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625594,<,1,1,<,MIC,ug.mL-1,4.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,MIC,ug ml-1,UO_0000274,4.0
93956,,1835967,CHEMBL854053,"Antimicrobial activity against Salmonella enterica serovar Typhimurium S21-2 tolC::Kan with GyrA S83F, ParC S80I mutation",F,BAO_0002146,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625594,<,1,1,<,MIC,ug.mL-1,4.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,MIC,ug ml-1,UO_0000274,4.0
93957,,1835982,CHEMBL854054,"Antimicrobial activity against Salmonella enterica serovar Typhimurium S21-3 with GyrA S83F, ParC S80I mutation",F,BAO_0002146,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625594,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,MIC,ug ml-1,UO_0000274,32.0
93958,,1835997,CHEMBL854140,Antimicrobial activity against Salmonella enterica serovar Typhimurium S21-3 gyrA+ with ParC S80I mutation,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625594,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,MIC,ug ml-1,UO_0000274,32.0
93959,,1836012,CHEMBL854141,"Antimicrobial activity against Salmonella enterica serovar Typhimurium S21-3 acrAB::Kan with GyrA S83F, ParC S80I mutation",F,BAO_0002146,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625594,<,1,1,<,MIC,ug.mL-1,4.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,MIC,ug ml-1,UO_0000274,4.0
93960,,1836027,CHEMBL855232,"Antimicrobial activity against Salmonella enterica serovar Typhimurium S21-3 tolC::Kan with GyrA S83F, ParC S80I mutation",F,BAO_0002146,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625594,<,1,1,<,MIC,ug.mL-1,4.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,MIC,ug ml-1,UO_0000274,4.0
93961,,1836042,CHEMBL855233,"Antimicrobial activity against Salmonella enterica serovar Typhimurium S21-4 with GyrA S83F, ParC S80I mutation",F,BAO_0002146,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625594,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,MIC,ug ml-1,UO_0000274,32.0
93962,,1836057,CHEMBL855234,Antimicrobial activity against Salmonella enterica serovar Typhimurium S21-4 gyrA+ with ParC S80I mutation,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625594,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,MIC,ug ml-1,UO_0000274,32.0
93963,,1836072,CHEMBL855231,"Antimicrobial activity against Salmonella enterica serovar Typhimurium S21-4 acrAB::Kan with GyrA S83F, ParC S80I mutation",F,BAO_0002146,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625594,<,1,1,<,MIC,ug.mL-1,4.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,MIC,ug ml-1,UO_0000274,4.0
93964,,1836087,CHEMBL855786,"Antimicrobial activity against Salmonella enterica serovar Typhimurium S21-4 tolC::Kan with GyrA S83F, ParC S80I mutation",F,BAO_0002146,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625594,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,MIC,ug ml-1,UO_0000274,8.0
93965,,1836102,CHEMBL855787,"Antimicrobial activity against Salmonella enterica serovar Typhimurium CS1 with GyrA S83F, D87N, ParC S80I mutation",F,BAO_0002146,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625594,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,MIC,ug ml-1,UO_0000274,32.0
93966,,1836117,CHEMBL855788,"Antimicrobial activity against Salmonella enterica serovar Typhimurium CS1 gyrA+ with GyrA S83F, D87N, ParC S80I mutation",F,BAO_0002146,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625594,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,MIC,ug ml-1,UO_0000274,32.0
93967,,1836132,CHEMBL855789,"Antimicrobial activity against Salmonella enterica serovar Typhimurium CS1 acrAB::Kan with GyrA S83F, D87N, ParC S80I mutation",F,BAO_0002146,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625594,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,MIC,ug ml-1,UO_0000274,32.0
93968,,1836147,CHEMBL855790,"Antimicrobial activity against Salmonella enterica serovar Typhimurium CS1 tolC::Kan with GyrA S83F, D87N, ParC S80I mutation",F,BAO_0002146,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625594,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,MIC,ug ml-1,UO_0000274,32.0
93969,,1836162,CHEMBL855791,"Antimicrobial activity against Salmonella enterica serovar Typhimurium CS3 with GyrA S83F, D87N, ParC S80I mutation",F,BAO_0002146,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625594,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,MIC,ug ml-1,UO_0000274,32.0
93970,,1836177,CHEMBL855792,"Antimicrobial activity against Salmonella enterica serovar Typhimurium CS3 gyrA+ with GyrA S83F, D87N, ParC S80I mutation",F,BAO_0002146,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625594,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,MIC,ug ml-1,UO_0000274,32.0
93971,,1836192,CHEMBL855793,"Antimicrobial activity against Salmonella enterica serovar Typhimurium CS3 acrAB::Kan with GyrA S83F, D87N, ParC S80I mutation",F,BAO_0002146,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625594,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,MIC,ug ml-1,UO_0000274,32.0
93972,,1836207,CHEMBL855794,"Antimicrobial activity against Salmonella enterica serovar Typhimurium CS3 tolC::Kan with GyrA S83F, D87N, parC S80I mutation",F,BAO_0002146,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625594,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,MIC,ug ml-1,UO_0000274,32.0
93973,,1836222,CHEMBL855795,"Antimicrobial activity against Salmonella enterica serovar Typhimurium CS9 with GyrA S83F, D87N, ParC S80I mutation",F,BAO_0002146,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625594,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,MIC,ug ml-1,UO_0000274,32.0
93974,,1836237,CHEMBL855796,"Antimicrobial activity against Salmonella enterica serovar Typhimurium CS9 gyrA+ with GyrA S83F, D87N, ParC S80I mutation",F,BAO_0002146,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625594,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,MIC,ug ml-1,UO_0000274,32.0
93975,,1836252,CHEMBL855797,"Antimicrobial activity against Salmonella enterica serovar Typhimurium CS9 acrAB::Kan with GyrA S83F, D87N, ParC S80I mutation",F,BAO_0002146,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625594,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,MIC,ug ml-1,UO_0000274,32.0
93976,,1836267,CHEMBL855798,"Antimicrobial activity against Salmonella enterica serovar Typhimurium CS9 tolC::Kan with GyrA S83F, D87N, ParC S80I mutation",F,BAO_0002146,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625594,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,MIC,ug ml-1,UO_0000274,32.0
93977,,1836282,CHEMBL855799,Antimicrobial activity against Salmonella enterica serovar Typhimurium CHS14 with GyrA D87G mutation,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625594,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,MIC,ug ml-1,UO_0000274,32.0
93978,,1836297,CHEMBL854744,Antimicrobial activity against Salmonella enterica serovar Typhimurium CHS14 gyrA+ with GyrA D87G mutation,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625594,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,MIC,ug ml-1,UO_0000274,32.0
93979,,1836312,CHEMBL854745,Antimicrobial activity against Salmonella enterica serovar Typhimurium CHS14 acrAB::Kan with GyrA D87G mutation,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625594,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,MIC,ug ml-1,UO_0000274,32.0
93980,,1836326,CHEMBL854746,Antimicrobial activity against Salmonella enterica serovar Typhimurium CHS14 tolC::Kan with GyrA D87G mutant,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625594,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,MIC,ug ml-1,UO_0000274,32.0
93981,,1836341,CHEMBL854747,Antimicrobial activity against Salmonella enterica serovar Typhimurium CHS18 with GyrA S38F mutation,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625594,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,MIC,ug ml-1,UO_0000274,4.0
93982,,1836356,CHEMBL854748,Antimicrobial activity against Salmonella enterica serovar Typhimurium CHS18 gyrA+ with GyrA S38F mutation,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625594,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,MIC,ug ml-1,UO_0000274,4.0
93983,,1836371,CHEMBL854749,Antimicrobial activity against Salmonella enterica serovar Typhimurium CHS18 acrAB::Kan with GyrA S38F mutation,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625594,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,MIC,ug ml-1,UO_0000274,4.0
93984,,1836386,CHEMBL854750,Antimicrobial activity against Salmonella enterica serovar Typhimurium CHS18 tolC::Kan with GyrA S38F mutation,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625594,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,MIC,ug ml-1,UO_0000274,4.0
93985,,1836401,CHEMBL855813,Antimicrobial activity against Salmonella enterica serovar Typhimurium CHS38 with GyrA D87G mutation,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625594,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,MIC,ug ml-1,UO_0000274,32.0
93986,,1836416,CHEMBL855814,Antimicrobial activity against Salmonella enterica serovar Typhimurium CHS38 gyrA+ with GyrA D87G mutation,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625594,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,MIC,ug ml-1,UO_0000274,32.0
93987,,1836431,CHEMBL855815,Antimicrobial activity against Salmonella enterica serovar Typhimurium CHS38 acrAB::Kan with GyrA D87G mutation,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625594,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,MIC,ug ml-1,UO_0000274,16.0
93988,,1836446,CHEMBL855816,Antimicrobial activity against Salmonella enterica serovar Typhimurium CHS38 tolC::Kan with GyrA D87G mutation,F,BAO_0002146,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625594,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,MIC,ug ml-1,UO_0000274,16.0
93989,,1847482,CHEMBL919647,Antimicrobial susceptibility of Staphylococcus lugdunensis isolates by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1142066,Antimicrob Agents Chemother,2007.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632009,=,1,1,=,MIC50,ug.mL-1,0.25,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,MIC50,ug ml-1,UO_0000274,0.25
93990,,1847494,CHEMBL919647,Antimicrobial susceptibility of Staphylococcus lugdunensis isolates by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1142066,Antimicrob Agents Chemother,2007.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632009,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,MIC90,ug ml-1,UO_0000274,1.0
93991,,1847502,CHEMBL919647,Antimicrobial susceptibility of Staphylococcus lugdunensis isolates by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1142066,Antimicrob Agents Chemother,2007.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632009,>,1,0,>,MBC50,ug ml-1,32.0,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,MBC50,ug ml-1,UO_0000274,32.0
93992,,1847510,CHEMBL919647,Antimicrobial susceptibility of Staphylococcus lugdunensis isolates by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1142066,Antimicrob Agents Chemother,2007.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632009,>,1,0,>,MBC90,ug ml-1,32.0,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,MBC90,ug ml-1,UO_0000274,32.0
93993,,1847518,CHEMBL919668,Increase in biofilm formation of Staphylococcus lugdunensis assessed as percent biofilm forming isolates,F,BAO_0001103,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1142066,Antimicrob Agents Chemother,2007.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://qudt.org/vocab/unit#Percent,632009,=,1,0,=,Activity,%,7.0,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,Activity,%,UO_0000187,7.0
93994,,1847526,CHEMBL919669,Decrease in biofilm formation of Staphylococcus lugdunensis assessed as percent biofilm forming isolates,F,BAO_0001103,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1142066,Antimicrob Agents Chemother,2007.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://qudt.org/vocab/unit#Percent,632009,=,1,0,=,Activity,%,93.0,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,Activity,%,UO_0000187,93.0
93995,Active,1847534,CHEMBL919113,Stimulation of Staphylococcus lugdunensis IDRL5256 biofilm formation,F,BAO_0000375,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1142066,Antimicrob Agents Chemother,2007.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,,632009,,1,0,,Activity,,,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,Activity,,,
93996,,1847539,CHEMBL919653,Antimicrobial susceptibility of Staphylococcus lugdunensis IDRL856 biofilms after 24 hrs assessed as bacterial regrowth,F,BAO_0000179,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1142066,Antimicrob Agents Chemother,2007.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632009,=,1,0,=,BBC,ug ml-1,128.0,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,BBC,ug ml-1,UO_0000274,128.0
93997,,1847547,CHEMBL919654,Antimicrobial susceptibility of Staphylococcus lugdunensis IDRL2394 biofilms after 24 hrs assessed as bacterial regrowth,F,BAO_0000179,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1142066,Antimicrob Agents Chemother,2007.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632009,=,1,0,=,BBC,ug ml-1,128.0,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,BBC,ug ml-1,UO_0000274,128.0
93998,,1847555,CHEMBL919655,Antimicrobial susceptibility of Staphylococcus lugdunensis IDRL2414 biofilms after 24 hrs assessed as bacterial regrowth,F,BAO_0000179,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1142066,Antimicrob Agents Chemother,2007.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632009,=,1,0,=,BBC,ug ml-1,128.0,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,BBC,ug ml-1,UO_0000274,128.0
93999,,1847563,CHEMBL919656,Antimicrobial susceptibility of Staphylococcus lugdunensis IDRL2492 biofilms after 24 hrs assessed as bacterial regrowth,F,BAO_0000179,BAO_0000218,organism-based format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,CHEMBL1142066,Antimicrob Agents Chemother,2007.0,CHEMBL1440,TETRACYCLINE,CHEMBL1440,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632009,=,1,0,=,BBC,ug ml-1,128.0,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,BBC,ug ml-1,UO_0000274,128.0
